Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3027273	vb-ahco3	mmol/l (mmol/l)	9322	33740	0.00%
3027273	vb-shco3	mmol/l (mmol/l)	6832	20792	0.00%
3027273	vp-shco3	mmol/l (mmol/l)	1157	6215	0.00%
3027273	vb-ahco3	— (—)	932	1637	100.00%	Distribution not available
3027273	vb-hco3	mmol/l (mmol/l)	332	1204	0.00%
3027273	vb-ahco3vt	— (—)	260	347	100.00%	Distribution not available
3027273	vb-he-tase,vb-hco3	mmol/l (mmol/l)	240	330	0.00%
3027273	vb-ahco3vt	mmol/l (mmol/l)	215	326	0.00%
3027273	vb-shco3	— (—)	135	183	100.00%	Distribution not available
3027273	vb-hco3	— (—)	120	144	100.00%	Distribution not available
3027273	vp-hco3st	mmol/l (mmol/l)	45	123	0.00%
3027273	vb-vekaas5,chco3	mmol/l (mmol/l)	43	73	0.00%
3027273	vp-shco3	— (—)	37	46	100.00%	Distribution not available
3027273	vbhco3pika	mmol/l (mmol/l)	24	26	0.00%
3027273	vp-hco3st	— (—)	7	9	100.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Presence of cardiac and vascular implants and grafts

2292

7117

2.55

322.10

4.5

3.0

25.12

25.21

mmol/l

0.54

2230

6896

Transplanted organ and tissue status

659

1349

5.62

311.72

14.0

2.8

23.75

25.27

mmol/l

20.87

641

1302

Nausea and vomiting

1345

4405

3.19

308.99

5.8

3.2

25.02

25.22

mmol/l

1.11

1298

4272

Covid-19 confirmed case

1753

6774

2.75

308.83

5.5

3.3

25.32

25.05

mmol/l

2.29

1697

6552

Atrial fibrillation and flutter with reimbursement

1220

1506

5.55

307.65

3.9

2.2

25.34

25.54

mmol/l

0.98

1181

1460

Other (not insulin) diabetes medications

4076

10227

2.46

307.65

3.7

3.0

25.12

25.40

mmol/l

4.91

3969

9891

Provisional assignment of new diseases of uncertain etiology

3516

9328

4.14

307.65

4.4

3.3

25.47

25.10

mmol/l

7.57

3450

9028

Atrial fibrillation and flutter

1405

1906

5.10

307.65

4.4

2.1

25.32

25.57

mmol/l

1.55

1355

1846

Erysipelas

3050

10063

2.41

307.65

4.6

2.7

25.25

25.37

mmol/l

1.05

2967

9765

All kidney diseases

5041

11581

3.15

307.65

5.8

2.4

24.62

25.56

mmol/l

54.34

4900

11215

Any reimbursement code in KELA

1664

2588

3.31

307.65

4.1

1.9

25.08

25.40

mmol/l

2.69

1603

2498

Viral Sepsis

1262

3423

4.09

307.65

6.4

2.7

25.15

25.23

mmol/l

0.29

1213

3330

Erysipelas

2478

9224

2.50

307.65

4.7

2.7

25.29

25.33

mmol/l

0.21

2413

8959

Bacterial infection, other or unspecified

3416

8893

3.52

307.65

6.1

2.7

24.96

25.33

mmol/l

6.93

3308

8638

Abnormalities of breathing

3605

8765

2.48

307.65

4.4

3.0

25.38

25.09

mmol/l

4.68

3502

8478

Other disorders of fluid, electrolyte and acid-base balance

1964

5309

3.88

307.65

6.4

2.8

25.00

25.32

mmol/l

2.65

1907

5166

Type 2 diabetes, wide definition

4243

8784

3.30

307.65

4.4

3.0

25.07

25.47

mmol/l

8.76

4130

8497

Implicit bacterial Sepsis

2572

7172

3.48

307.65

6.4

2.8

24.97

25.28

mmol/l

3.13

2480

6990

Codes for special purposes

3520

9343

4.14

307.65

4.4

3.3

25.47

25.11

mmol/l

7.70

3454

9043

Pneumonia, organism unspecified

4007

11575

2.54

307.65

5.0

2.9

25.38

25.15

mmol/l

3.41

3888

11237

Diabetes mellitus

4559

10001

2.79

307.65

4.2

3.0

25.08

25.41

mmol/l

7.05

4433

9659

Covid-19 suspected case

1974

2784

8.42

307.65

3.9

3.5

25.61

25.07

mmol/l

8.53

1959

2684

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4128

13332

2.22

307.65

5.5

2.9

24.77

25.37

mmol/l

20.68

4001

12926

Renal failure

3405

8430

4.01

307.65

7.8

2.7

23.85

25.50

mmol/l

100.27

3307

8184

Diabetes medication

4628

10722

2.68

307.65

4.2

3.1

25.07

25.37

mmol/l

6.01

4493

10365

Influenza and pneumonia

4624

12059

2.54

307.65

4.8

2.9

25.37

25.13

mmol/l

3.93

4472

11699

Hypertensive Heart Disease

1251

2793

3.80

307.65

5.2

2.6

25.20

25.31

mmol/l

0.41

1237

2731

Condition for Implicit Sepsis (Organ dysfunction codes)

3912

11030

2.55

307.65

5.0

2.7

25.04

25.35

mmol/l

5.03

3769

10747

Insulin, combination of fast acting with intermediate-acting or long-acting

3530

11236

3.08

307.65

5.2

3.1

24.89

25.26

mmol/l

6.93

3431

10879

Implicit Sepsis

3971

10953

2.80

307.65

5.3

2.7

25.02

25.34

mmol/l

5.48

3838

10659

3988

9524

2.65

307.65

4.9

2.8

25.41

25.11

mmol/l

5.15

3863

9242

Cardiovascular diseases

1766

3048

3.21

307.65

4.5

2.4

25.06

25.20

mmol/l

0.87

1699

2933

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3988

9524

2.65

307.65

4.9

2.8

25.41

25.11

mmol/l

5.15

3863

9242

Type 2 diabetes, strict (exclude DM1)

3876

9507

2.49

307.65

3.6

3.0

25.11

25.45

mmol/l

6.62

3777

9186

Infections, IBD-co-morbidities

772

930

6.38

307.65

7.2

2.7

24.67

25.24

mmol/l

3.06

744

901

Heart failure, not strict

4122

8898

3.39

307.65

5.7

2.6

25.10

25.28

mmol/l

2.02

4004

8648

Emergency coronary revascularization (for ACS)

3727

10070

2.35

307.65

4.6

3.1

25.18

25.33

mmol/l

1.71

3614

9778

Malaise and fatigue

2485

6988

3.03

307.65

4.8

2.9

25.26

25.17

mmol/l

0.64

2421

6772

Heart failure and antihypertensive medication

1434

1650

6.26

307.65

6.4

2.4

25.35

25.59

mmol/l

1.17

1396

1613

Diabetes, varying definitions

4518

10025

2.76

307.65

4.2

3.0

25.09

25.41

mmol/l

6.56

4393

9682

Type 2 diabetes, definitions combined, including avohilmo

3840

9279

2.51

307.65

3.6

3.0

25.14

25.44

mmol/l

5.09

3744

8960

Biguanides

4007

10825

2.35

307.65

3.6

3.3

25.13

25.37

mmol/l

3.64

3906

10466

Implicit Sepsis

3890

10526

2.96

307.65

5.5

2.7

25.02

25.34

mmol/l

5.04

3764

10243

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4375

12393

2.52

307.65

4.9

3.0

25.41

25.14

mmol/l

4.77

4241

12019

Chronic kidney disease

2351

6102

4.30

307.65

9.4

2.7

23.78

25.46

mmol/l

80.67

2288

5923

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3016

8404

3.10

307.65

4.2

3.3

24.88

25.39

mmol/l

10.47

2939

8137

Insulin, fast-acting

2090

6270

3.63

307.65

6.0

3.2

24.98

25.21

mmol/l

1.80

2027

6073

Insulin medication

3518

8795

3.63

307.65

5.2

3.2

24.88

25.36

mmol/l

10.29

3419

8503

Insulin, fast-acting or short human

2097

6795

3.34

307.65

6.0

3.3

24.99

25.17

mmol/l

1.28

2034

6580

Bacterial infection, other or unspecified

3181

8564

3.50

307.65

6.2

2.7

24.99

25.32

mmol/l

4.96

3078

8322

Ischemic heart diseases

3331

9099

2.29

307.65

4.6

3.0

25.21

25.35

mmol/l

1.42

3232

8837

Implicit bacterial Sepsis

2723

7552

3.39

307.65

6.3

2.8

24.97

25.29

mmol/l

3.49

2624

7364

Diseases of arteries, arterioles and capillaries (FINNGEN)

1031

1508

5.05

307.65

6.2

2.2

24.88

25.53

mmol/l

5.48

1003

1462

STROKE

2222

5317

2.98

307.65

4.0

2.6

25.27

25.50

mmol/l

2.32

2167

5152

Hypertensive diseases (excluding secondary)

2013

2801

4.38

307.65

5.1

2.2

25.01

25.44

mmol/l

5.10

1942

2705

Condition for Implicit Sepsis (Organ dysfunction codes)

3958

10986

2.67

307.65

5.2

2.7

24.99

25.36

mmol/l

6.77

3824

10699

Insulin, intermediate and long-acting

3254

10498

3.26

307.65

5.1

3.2

24.90

25.25

mmol/l

5.56

3165

10168

Certain infectious and parasitic diseases

3533

8341

2.18

307.65

4.6

2.4

25.12

25.36

mmol/l

3.55

3433

8070

Dialysis, with operation codes

995

1963

5.99

307.65

15.6

2.6

23.54

25.51

mmol/l

51.78

973

1899

Care involving dialysis

695

1111

7.67

307.65

17.9

2.7

23.51

25.05

mmol/l

22.64

686

1073

Heart failure and coronary heart disease

2365

5859

3.09

307.65

5.6

3.0

25.24

mmol/l

0.02

2295

5691

Endocrine, nutritional and metabolic diseases

2817

5235

2.81

307.65

4.2

2.5

25.03

25.41

mmol/l

5.89

2718

5057

Heart failure, strict

3188

8591

2.81

307.65

5.4

3.0

25.34

25.13

mmol/l

2.00

3099

8349

Hypertensive diseases

3033

6197

2.88

307.65

4.8

2.6

25.09

25.41

mmol/l

4.85

2930

6002

Nephropathy related operations

981

2035

5.73

307.65

15.5

2.9

23.59

25.26

mmol/l

37.07

958

1972

Speech therapy

1750

4757

4.12

307.65

4.5

3.5

25.54

25.21

mmol/l

3.33

1726

4610

Hypertensive heart and/or renal disease

1442

2937

3.98

307.65

5.8

2.6

25.02

25.31

mmol/l

1.79

1422

2870

General symptoms and signs

4282

9227

2.41

307.65

4.3

2.9

25.24

25.21

mmol/l

0.18

4154

8915

Type 1 diabetes

1283

3358

4.11

307.65

6.5

3.2

24.74

25.31

mmol/l

5.52

1242

3234

Septicaemia

2552

7349

3.54

307.65

6.3

2.8

24.70

25.29

mmol/l

11.09

2457

7139

Heart failure,strict

2945

6829

3.29

307.65

5.5

2.6

25.34

25.20

mmol/l

1.01

2864

6641

Cardiac arrhythmias

2134

3988

3.63

307.65

4.1

2.6

25.28

25.44

mmol/l

1.26

2064

3852

Hyperlipidaemia, other/unspecified

1908

6831

2.74

307.65

4.3

2.9

25.25

25.31

mmol/l

0.31

1882

6652

Implicit viral Sepsis

1259

3418

4.08

307.65

6.4

2.7

25.16

25.24

mmol/l

0.26

1210

3326

Other heart diseases, wide

3515

8940

2.49

307.65

4.6

2.9

25.23

25.24

mmol/l

0.05

3410

8664

Major coronary heart disease event

3518

9518

2.33

307.65

4.6

3.1

25.22

25.35

mmol/l

1.32

3419

9236

Hypertension

3028

6192

2.87

307.65

4.8

2.6

25.08

25.42

mmol/l

4.91

2925

5997

Bleeding

3531

12241

2.13

307.65

4.8

3.2

25.08

25.30

mmol/l

2.97

3446

11861

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3732

11957

2.10

307.65

5.4

2.8

25.01

25.29

mmol/l

4.92

3640

11563

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

4524

9650

2.97

307.65

4.3

3.0

25.00

25.44

mmol/l

11.48

4402

9323

Anaemias

959

687

9.70

307.65

7.4

2.3

24.73

25.36

mmol/l

4.08

924

658

Implicit viral Sepsis

1527

5119

3.22

307.65

5.9

2.8

25.11

25.23

mmol/l

0.58

1468

4975

Coronary revascularization (ANGIO or CABG)

3360

8893

2.42

307.65

4.7

3.0

25.20

25.35

mmol/l

1.70

3258

8638

Other bacterial diseases

4952

11283

2.93

307.65

5.2

2.7

25.05

25.36

mmol/l

6.90

4800

10935

Metabolic disorders

4384

10279

2.73

307.65

4.9

2.9

25.09

25.32

mmol/l

3.55

4252

9976

Hard cardiovascular diseases

3396

8564

2.47

307.65

4.5

3.0

25.24

25.35

mmol/l

0.99

3305

8300

Other septicaemia

2339

6771

3.63

307.65

6.4

2.8

24.62

25.29

mmol/l

12.56

2248

6574

Non-invasive ventilation

1187

1707

6.72

307.65

4.9

2.6

26.04

25.50

mmol/l

3.27

1062

1663

Angina pectoris

2663

7143

2.63

307.65

4.3

2.9

25.37

25.33

mmol/l

0.19

2583

6947

All chronic kidney diseases

3574

7981

4.02

307.65

7.6

2.4

24.16

25.56

mmol/l

82.23

3483

7748

Type 2 diabetes

4332

9631

2.75

307.65

4.2

2.9

25.09

25.45

mmol/l

7.45

4221

9304

Cerebrovascular diseases (FINNGEN)

1255

2019

4.66

307.65

4.2

2.2

25.24

25.53

mmol/l

2.00

1221

1958

Fever of other and unknown origin

2746

8095

3.20

307.65

5.1

2.9

25.08

25.18

mmol/l

0.85

2671

7835

Care involving use of rehabilitation procedures

3240

10396

3.04

307.65

4.6

2.6

25.46

25.23

mmol/l

2.87

3135

10066

Bacterial Sepsis

2859

7783

3.42

307.65

6.3

2.7

24.99

25.29

mmol/l

3.23

2754

7583

All pneumoniae

4480

12321

2.54

307.65

4.9

2.9

25.38

25.14

mmol/l

4.05

4337

11952

Hypertension, essential

3072

6074

2.99

307.65

4.3

2.5

25.15

25.43

mmol/l

3.78

2976

5881

Type 1 diabetes, wide definition

1099

2840

4.17

307.65

6.2

3.2

24.85

25.28

mmol/l

3.20

1061

2735

Renal tubulo-interstitial diseases

4895

11438

3.41

307.65

6.2

2.5

24.46

25.55

mmol/l

69.35

4749

11092

Other heart diseases

1932

2865

4.64

307.65

5.3

2.3

25.29

25.39

mmol/l

0.47

1865

2765

Diabetes, insulin treatment (Kela reimbursement)

4807

10958

2.79

307.65

4.3

3.1

25.00

25.41

mmol/l

10.73

4676

10593

Percutaneous Coronary Intervention

3381

8886

2.44

307.65

4.7

3.0

25.19

25.35

mmol/l

1.75

3280

8631

Type 2 diabetes, definitions combined

3862

9437

2.50

307.65

3.6

3.0

25.11

25.45

mmol/l

6.40

3765

9120

Other bacterial diseases

5037

11459

3.14

307.65

5.2

2.7

25.02

25.36

mmol/l

7.45

4888

11110

Explicit Sepsis

2602

7696

3.42

307.65

6.2

2.7

24.70

25.28

mmol/l

10.92

2503

7494

Acute tubulo-interstitial nephritis

2801

9541

2.66

307.65

5.0

2.5

24.88

25.56

mmol/l

17.81

2711

9262

Persons encountering health services for specific procedures and health care

4745

11539

2.57

307.65

5.2

2.6

25.17

25.22

mmol/l

0.39

4597

11169

All-cause Heart Failure

3142

8490

2.80

307.65

5.4

3.0

25.36

25.13

mmol/l

2.36

3054

8254

Pain in throat and chest

3300

8607

2.38

307.65

3.8

3.0

25.35

25.10

mmol/l

3.51

3196

8323

Acute renal failure

1497

4101

4.12

307.65

7.3

2.7

23.71

25.45

mmol/l

41.31

1447

3978

Pneumonias (Asthma/COPD co-morbidities)

4457

12308

2.54

307.65

4.9

2.9

25.39

25.14

mmol/l

4.13

4318

11935

Cardiovascular diseases (excluding rheumatic etc)

2037

3485

3.48

307.65

4.7

2.4

25.07

25.28

mmol/l

1.64

1960

3359

Disorders of lipoprotein metabolism and other lipidaemias

3445

9486

2.34

307.65

4.2

2.9

25.14

25.34

mmol/l

2.49

3337

9223

Type 1 diabetes, wide definition, subgroup 1

1081

2581

4.54

307.65

6.2

3.2

24.86

25.30

mmol/l

3.30

1043

2485

Dyspnoea

4077

13016

2.42

307.65

4.5

3.2

25.42

25.17

mmol/l

4.05

3963

12614

Kidney transplant status

462

691

8.34

307.23

17.3

3.1

23.23

25.12

mmol/l

21.60

453

671

Extracorporeal dialysis

546

987

6.91

302.25

19.3

3.1

23.65

25.17

mmol/l

18.09

539

952

Asthma, unspecified (mode), excluding more controls

1908

5592

2.65

301.29

4.2

2.6

25.68

25.15

mmol/l

7.72

1842

5429

Bacterial pneumoniae

1907

6765

2.62

299.70

5.4

2.9

25.79

25.04

mmol/l

12.62

1828

6577

Glomerular diseases

1068

3213

3.68

298.29

11.2

3.2

24.01

25.23

mmol/l

23.86

1047

3101

Antihypertensive medication - note that there are other indications

1735

3284

2.88

292.11

4.7

2.4

24.90

25.41

mmol/l

6.97

1666

3177

Complications of surgical and medical care, not elsewhere classified

3857

13906

1.96

291.17

4.8

3.1

25.05

25.28

mmol/l

3.42

3749

13475

Ischaemic heart disease, wide definition

3069

9250

2.14

283.69

4.4

3.0

25.26

25.36

mmol/l

0.84

2978

9001

Other nutritional deficiencies

2473

10770

2.24

283.52

4.1

3.3

25.40

25.21

mmol/l

1.69

2404

10430

Bacterial pneumonia, not elsewhere classified

1808

6442

2.61

280.92

5.4

2.9

25.81

25.04

mmol/l

12.58

1730

6266

Hypo-osmolality and hyponatraemia

1016

3063

3.63

279.28

5.5

2.9

24.92

25.32

mmol/l

2.63

988

2982

Paroxysmal tachycardia

803

1649

4.29

279.13

4.0

2.2

25.18

25.39

mmol/l

0.90

778

1601

Asthma, excluding more controls

2546

5921

2.31

274.84

3.8

2.6

25.54

25.14

mmol/l

6.28

2466

5741

Obesity due to excess calories

1825

7590

2.51

272.69

4.3

3.4

25.36

25.18

mmol/l

1.40

1786

7361

Other medical care

1975

7607

2.45

271.64

4.5

2.6

25.16

25.20

mmol/l

0.15

1906

7373

L04AD Calcineurin inhibitors

654

1496

4.94

269.50

13.1

3.3

23.83

25.29

mmol/l

20.41

636

1450

Hypothyroidism (congenital or acquired)

674

714

5.50

269.16

4.1

2.2

25.01

25.41

mmol/l

1.96

643

685

Other CVD (FINNGEN)

559

790

5.99

269.10

5.2

2.2

25.06

25.35

mmol/l

0.98

542

772

Headache

2263

8109

2.30

268.94

3.7

2.8

25.24

25.25

mmol/l

0.08

2195

7836

Major coronary heart disease event excluding revascularizations

2504

7714

2.26

268.94

4.6

3.0

25.06

25.32

mmol/l

2.78

2440

7497

Asthma (only as main-diagnosis), excluding more controls

2353

5921

2.34

268.90

3.8

2.6

25.48

25.14

mmol/l

4.71

2284

5741

Obesity

2325

10386

2.24

267.17

4.1

3.3

25.41

25.21

mmol/l

1.97

2266

10059

Obesity and other hyperalimentation

2335

10433

2.24

267.14

4.1

3.3

25.42

25.21

mmol/l

1.95

2276

10103

Valvular heart disease excluding rheumatic fever

1905

5717

2.52

265.80

4.5

2.9

25.13

25.21

mmol/l

0.45

1850

5565

Non-rheumatic valve diseases

1895

5677

2.52

264.96

4.6

2.8

25.13

25.22

mmol/l

0.54

1840

5526

Intestinal infectious diseases

3577

14514

1.93

262.65

5.3

3.1

24.98

25.27

mmol/l

5.33

3473

14058

Symptoms and signs involving the circulatory and respiratory systems

3441

8792

2.01

261.72

4.1

3.0

25.24

25.09

mmol/l

1.72

3334

8504

Non-ischemic cardiomyopathy

1427

4259

2.88

259.96

4.8

2.8

25.52

25.17

mmol/l

2.36

1388

4150

Dialysis

368

521

8.97

258.03

18.3

2.9

23.52

25.37

mmol/l

16.41

360

505

Syncope and collapse

1844

6679

2.47

256.82

3.9

2.9

25.33

25.16

mmol/l

1.24

1787

6476

Intracranial trauma

2046

6242

2.38

255.23

3.8

3.3

25.20

25.13

mmol/l

0.42

1997

6050

Hypothyroidism, levothyroxine purchases

651

709

5.35

253.32

3.7

2.2

25.02

25.41

mmol/l

1.81

623

680

Hypothyroidism and >3 levothyroxin purchases

651

709

5.35

253.32

3.7

2.2

25.02

25.41

mmol/l

1.81

623

680

Glomerular disorders in diseases classified elsewhere

744

1971

4.27

252.96

11.6

3.1

23.88

25.21

mmol/l

18.81

729

1906

Asthma, unspecified (mode)

1978

6459

2.39

251.99

4.2

2.7

25.68

25.07

mmol/l

10.64

1911

6277

Diarrhoea and gastroenteritis of presumed infectious origin

2724

12325

2.06

248.61

5.2

3.1

24.94

25.27

mmol/l

5.20

2648

11924

Pure hypercholesterolaemia

2796

9049

2.09

248.04

4.1

2.9

25.14

25.34

mmol/l

2.12

2685

8801

Sub-endpoint used in defining T1D endpoints

1372

5137

2.78

247.51

6.3

3.4

24.80

25.13

mmol/l

2.35

1327

4966

COPD/asthma related infections

3590

9527

1.94

245.05

4.3

2.8

25.35

25.11

mmol/l

3.47

3486

9245

COPD/asthma/ILD related infections

3590

9527

1.94

245.05

4.3

2.8

25.35

25.11

mmol/l

3.47

3486

9245

Symptoms and signs involving the digestive system and abdomen

3654

9763

1.92

245.04

4.2

3.1

25.17

25.23

mmol/l

0.41

3535

9443

Substance abuse, excluding more controls

2178

8617

2.24

243.12

4.0

3.4

25.04

25.12

mmol/l

0.44

2107

8354

Aplastic and other anaemias

2149

9366

2.25

242.69

6.2

3.2

24.51

25.29

mmol/l

17.35

2085

9095

Secondary hypertension

402

636

6.89

242.56

12.2

2.2

24.17

25.11

mmol/l

5.22

393

617

Abdominal and pelvic pain

3633

9760

1.92

241.64

4.0

3.1

25.19

25.23

mmol/l

0.22

3521

9440

Diseases of oesophagus, stomach and duodenum

3886

12914

1.85

240.09

4.1

3.3

25.15

25.27

mmol/l

1.25

3786

12500

Oral corticosteroids

3927

12990

1.84

239.58

4.1

3.2

25.31

25.20

mmol/l

1.11

3805

12592

First line medication for Crohn's disease

3975

11957

1.84

237.98

5.1

2.9

25.12

25.24

mmol/l

1.19

3857

11582

Depression medications

708

753

4.85

236.62

3.6

2.0

25.22

25.49

mmol/l

1.01

684

721

Symptoms and signs involving cognition, perception, emotional state and behaviour

3568

13350

1.87

236.31

3.9

3.3

25.20

25.22

mmol/l

0.15

3465

12931

Asthma

2681

6839

2.11

234.70

3.8

2.7

25.53

25.07

mmol/l

8.51

2595

6639

Heart failure and bmi 25plus

1667

4657

2.57

234.12

5.2

2.8

25.49

25.10

mmol/l

3.13

1619

4513

Parasetamol

2507

5999

2.17

233.66

4.0

3.0

25.06

25.23

mmol/l

1.50

2415

5811

Bacterial pneumonia (organism specified)

2022

8481

2.27

232.56

5.4

3.2

25.73

25.05

mmol/l

11.45

1940

8240

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1200

2600

3.00

229.65

4.5

2.1

25.20

25.47

mmol/l

1.63

1162

2508

ILD medications: prednisolone, methylprednisolone, prednisone

3938

12443

1.81

226.69

5.2

2.9

25.12

25.24

mmol/l

1.29

3816

12048

Oxycodone

1797

7253

2.36

226.04

4.9

3.2

25.34

25.23

mmol/l

0.62

1729

7075

Asthma (only as main-diagnosis)

2450

6839

2.13

225.44

3.8

2.7

25.50

25.07

mmol/l

7.14

2379

6639

Other arrhythmias

2143

7626

2.19

222.84

3.6

2.8

25.36

25.25

mmol/l

0.84

2076

7399

Complications of procedures, not elsewhere classified

3031

13500

1.92

222.33

4.6

3.2

25.04

25.29

mmol/l

3.27

2947

13083

Any death

2584

9418

2.05

220.23

5.3

3.0

25.07

25.33

mmol/l

2.33

2500

9158

Hypothyroidism, drug reimbursement

405

432

6.90

219.97

3.5

2.0

25.47

25.41

mmol/l

0.11

384

416

Medical observation and evaluation for suspected diseases and conditions

2462

6081

2.13

218.52

4.5

2.9

25.16

25.25

mmol/l

0.59

2399

5881

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1068

1683

3.27

217.09

3.7

2.3

25.25

25.19

mmol/l

0.18

1033

1616

Other anaemias

1978

8930

2.21

215.47

5.6

3.2

24.54

25.27

mmol/l

14.60

1919

8668

Complications of medical and surgical care

2808

13794

1.93

215.12

4.9

3.2

25.16

25.26

mmol/l

0.73

2722

13380

Unstable angina pectoris

1661

5707

2.42

215.11

4.4

3.0

25.20

25.22

mmol/l

0.08

1612

5546

Glucagon-like peptide-1 (GLP-1) analogues

1134

4222

2.84

214.23

3.7

3.4

25.23

25.40

mmol/l

0.90

1109

4083

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1134

4222

2.84

214.23

3.7

3.4

25.23

25.40

mmol/l

0.90

1109

4083

Other and unspecified anaemias

1959

8883

2.21

212.51

5.6

3.2

24.53

25.27

mmol/l

14.43

1900

8622

Other neurological diseases

2888

12195

1.93

212.06

3.9

3.4

25.14

25.26

mmol/l

1.02

2812

11838

All influenza

1115

4154

2.84

210.61

5.5

2.9

25.49

25.01

mmol/l

4.08

1067

4032

ILD medications

4007

12586

1.77

209.92

5.2

2.9

25.13

25.23

mmol/l

1.07

3884

12188

Coronary atherosclerosis

2428

7697

2.07

208.57

4.5

2.9

25.15

25.34

mmol/l

1.73

2353

7486

Inflammatory bowel disease treatment related agents

4050

13220

1.75

208.43

4.4

3.2

25.25

25.19

mmol/l

0.51

3925

12811

Asthma (mode)

2572

6925

2.04

207.50

3.6

2.7

25.45

25.07

mmol/l

6.04

2483

6723

Other diseases of intestines

3611

11628

1.81

206.72

4.2

3.2

25.15

25.22

mmol/l

0.47

3513

11242

Dizziness and giddiness

2816

12041

1.91

203.66

3.8

3.4

25.25

25.23

mmol/l

0.14

2744

11681

Abnormalities of heart beat

1369

5581

2.51

203.66

3.8

2.9

25.39

25.09

mmol/l

2.57

1330

5406

Concussion

1689

6185

2.30

201.69

3.8

3.3

25.19

25.13

mmol/l

0.31

1644

5995

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

933

3210

3.02

200.76

3.5

3.1

25.26

25.22

mmol/l

0.10

895

3118

Autoimmune diseases excluding thyroid diseases

3725

11713

1.78

199.26

4.8

3.1

25.04

25.24

mmol/l

2.56

3622

11337

Poisoning by medicine

863

2882

3.17

198.96

3.8

3.5

25.34

25.21

mmol/l

0.43

832

2778

Poisoning by drugs, medicaments and biological substances

931

3251

3.02

198.00

3.7

3.5

25.32

25.20

mmol/l

0.42

897

3141

Asthma-related infections

2240

11283

2.01

194.38

4.3

3.4

25.66

25.12

mmol/l

9.87

2166

10948

Asthma, hospital admission 2, infections

2240

11283

2.01

194.38

4.3

3.4

25.66

25.12

mmol/l

9.87

2166

10948

Autoimmune diseases excluding thyroid diseases, strict definition

3600

11355

1.78

193.03

4.8

3.1

25.02

25.22

mmol/l

2.55

3502

11000

Mental and behavioural disorders due to psychoactive substance use

2240

10714

2.00

190.63

4.0

3.5

25.04

25.17

mmol/l

0.90

2169

10370

Myocardial infarction

1934

6546

2.17

190.38

4.6

3.0

24.98

25.28

mmol/l

2.97

1879

6369

Diseases of arteries, arterioles and capillaries

2716

10940

1.90

188.80

5.4

3.2

24.79

25.33

mmol/l

11.42

2629

10642

General examination and investigation of persons without complaint and reported diagnosis

2317

6057

2.05

187.89

4.4

2.9

25.09

25.25

mmol/l

1.27

2257

5857

Diseases of the digestive system

1948

9664

2.09

186.89

5.0

3.4

24.80

25.21

mmol/l

5.14

1894

9377

Hypokalaemia

631

1825

3.78

186.64

6.0

2.8

26.26

25.38

mmol/l

5.01

608

1767

Disorders of gallbladder, biliary tract and pancreas

3539

13067

1.75

185.45

4.2

3.3

25.11

25.27

mmol/l

1.85

3438

12669

Substance abuse

2178

10577

2.00

185.24

4.0

3.5

25.04

25.16

mmol/l

0.84

2107

10235

Pain, not elsewhere classified

1028

3923

2.74

183.92

4.8

2.8

25.33

25.15

mmol/l

0.91

991

3788

GASTRO-related operations

2578

6745

1.96

183.78

4.3

2.6

25.07

25.36

mmol/l

3.75

2492

6521

Any gastric operation

2578

6745

1.96

183.78

4.3

2.6

25.07

25.36

mmol/l

3.75

2492

6521

Diverticular disease of intestine

2716

9450

1.89

182.39

4.0

3.2

25.14

25.28

mmol/l

1.38

2659

9166

Unspecified kidney failure

625

1839

3.79

181.74

8.8

2.7

23.82

25.48

mmol/l

19.14

609

1775

Combinations of oral blood glucose lowering drugs

1187

4917

2.56

180.90

3.4

24.82

25.27

mmol/l

4.56

1170

4763

Fitting and adjustment of other devices

1517

6253

2.29

180.05

3.9

2.7

25.34

25.17

mmol/l

1.11

1497

6059

Cerebrovascular diseases

2877

11352

1.84

179.66

4.0

3.4

25.21

25.27

mmol/l

0.44

2805

11014

Convulsions, not elsewhere classified

887

3175

2.89

174.92

4.4

3.0

25.16

25.02

mmol/l

0.58

855

3072

GI-bleeding

1489

6905

2.27

174.27

4.9

3.4

24.77

25.17

mmol/l

3.84

1448

6698

Caries of dentine

1046

4037

2.67

173.67

6.6

3.2

25.00

25.23

mmol/l

1.18

1011

3930

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2534

12568

1.87

172.61

4.4

3.4

25.33

25.22

mmol/l

0.86

2474

12193

Other diseases of the digestive system

1471

6856

2.26

170.02

4.9

3.4

24.76

25.17

mmol/l

3.94

1430

6648

Neurological diseases, wide definition

828

1303

3.27

169.15

3.8

2.7

25.20

25.18

mmol/l

0.05

803

1254

Other functional intestinal disorders

1747

8008

2.10

168.76

4.5

3.2

25.34

25.22

mmol/l

0.73

1683

7760

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

640

1992

3.41

166.39

3.8

3.3

25.19

25.22

mmol/l

0.07

615

1926

Asthma-related pneumonia

1549

7406

2.18

165.90

4.9

3.4

25.82

25.07

mmol/l

11.52

1500

7186

Asthma-related pneumonia or sepsis

1550

7415

2.18

165.73

4.9

3.4

25.83

25.07

mmol/l

11.61

1501

7195

Asthma, hospital admissions 3, pneumonia

1550

7415

2.18

165.73

4.9

3.4

25.83

25.07

mmol/l

11.61

1501

7195

Dental caries

1134

4586

2.50

165.28

6.5

3.1

24.99

25.24

mmol/l

1.47

1097

4465

Diabetic maculopathy, excluding more controls

536

1510

3.86

164.57

6.8

3.0

24.60

25.32

mmol/l

3.85

516

1455

Personality disorders, excluding more controls

809

2884

2.92

164.37

3.6

3.1

25.35

25.25

mmol/l

0.31

790

2793

Oedema, not elsewhere classified

1211

5186

2.40

164.16

4.8

2.8

25.57

25.20

mmol/l

3.22

1182

5027

Mental and behavioural disorders due to alcohol

1909

9514

1.99

161.67

4.0

3.5

24.93

25.15

mmol/l

1.68

1849

9210

Other pulmonary diagnosis

2542

6909

1.88

161.50

4.1

2.7

25.39

25.07

mmol/l

4.22

2457

6707

Volume depletion

544

1577

3.80

160.96

6.1

2.9

24.54

25.21

mmol/l

2.85

519

1530

2140

10401

1.92

160.31

4.1

3.5

24.86

25.18

mmol/l

3.57

2072

10069

Other special examinations and investigations of persons without complaint or reported diagnosis

2285

6084

1.95

160.17

4.2

2.9

25.15

25.25

mmol/l

0.64

2205

5884

2212

10619

1.89

158.01

4.0

3.5

24.87

25.19

mmol/l

3.56

2141

10280

Stroke, including SAH

2457

9978

1.85

156.31

4.0

3.4

25.23

25.24

mmol/l

0.06

2391

9685

Any mental disorder

3697

11317

1.67

156.01

3.9

3.3

25.26

25.21

mmol/l

0.38

3581

10985

Polyarthropathies

2426

8781

1.85

154.76

4.9

3.3

24.98

25.21

mmol/l

2.20

2355

8521

Myocardial infarction, strict

1751

6273

2.07

153.38

4.5

3.0

24.98

25.27

mmol/l

2.54

1696

6110

Injuries to the head

3744

14359

1.64

152.72

3.7

3.5

25.17

25.22

mmol/l

0.33

3640

13898

Low back pain

2571

10509

1.80

152.43

3.7

3.4

25.46

25.14

mmol/l

4.95

2482

10204

Excluding asthma or asthma-COPD overlap

2506

6909

1.86

152.29

3.9

2.7

25.38

25.07

mmol/l

4.02

2424

6707

Symptoms and signs involving the urinary system

2791

12463

1.75

151.93

4.7

3.2

25.16

25.27

mmol/l

0.89

2692

12106

Nutritional anaemias

1943

10005

1.94

151.07

5.0

3.3

24.77

25.26

mmol/l

7.08

1878

9711

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1676

8494

2.04

150.85

4.1

3.5

24.95

25.17

mmol/l

1.53

1621

8228

3833

12347

1.64

150.83

4.2

3.1

25.33

25.14

mmol/l

2.44

3710

11971

Nerve, nerve root and plexus disorders

3644

13888

1.64

150.44

3.9

3.3

25.34

25.20

mmol/l

1.49

3506

13492

Alcohol use disorder, Swedish definition

2022

10004

1.91

150.39

4.1

3.5

24.88

25.18

mmol/l

3.00

1955

9687

COPD (mode)

1259

4462

2.32

149.56

4.7

2.7

26.16

24.91

mmol/l

20.06

1218

4356

Viral pneumonia

599

1921

3.35

149.45

6.7

2.8

25.41

25.03

mmol/l

1.52

569

1859

Iron deficiency anaemia

1692

8554

2.03

149.26

5.1

3.3

24.78

25.26

mmol/l

5.94

1634

8301

Insulin, fast-acting (human)

592

1881

3.35

149.10

7.8

3.0

25.00

25.22

mmol/l

0.76

575

1817

Dorsalgia

3331

10803

1.69

148.26

3.5

25.31

25.13

mmol/l

2.19

3222

10482

Other disorders of skin and subcutaneous tissue

2518

12938

1.78

147.87

5.3

3.2

25.11

25.27

mmol/l

1.42

2442

12566

Intestinal infectious diseases

3889

14049

1.61

147.72

4.7

3.1

25.03

25.28

mmol/l

4.33

3762

13620

ILD medications: immunosuppressive drugs

2114

10806

1.87

147.22

6.5

2.9

24.87

25.28

mmol/l

6.54

2055

10466

Alcohol use disorder, ICD-based

1557

7801

2.07

147.03

4.1

3.5

24.99

25.16

mmol/l

0.96

1507

7553

COPD differential diagnosis

2489

6927

1.84

146.80

3.9

2.7

25.37

25.06

mmol/l

3.75

2406

6725

Alcohol abuse, main dg, excluding more controls

623

2062

3.21

146.52

3.7

3.4

24.98

25.10

mmol/l

0.33

601

2003

ILD differential diagnosis

2487

6925

1.84

146.43

3.9

2.7

25.37

25.07

mmol/l

3.72

2404

6723

Other disorders of urethra and urinary system

2427

9950

1.81

145.54

4.6

3.2

25.17

25.20

mmol/l

0.17

2357

9644

Other soft tissue disorders, not elsewhere classified

3136

11071

1.70

145.49

4.3

3.3

25.38

25.13

mmol/l

3.73

3054

10718

Certain infectious and parasitic diseases

2396

6611

1.85

145.19

4.0

2.5

25.13

25.38

mmol/l

2.68

2319

6403

Statin medication

2046

6080

1.93

145.02

4.2

2.9

25.09

25.45

mmol/l

4.37

1984

5882

Lower back pain or/and sciatica

3546

14487

1.63

144.97

3.5

3.4

25.41

25.19

mmol/l

3.37

3437

14045

Hyperkalaemia

380

930

4.67

144.66

9.7

3.0

23.55

25.20

mmol/l

11.62

368

905

Liquid cancers, helper endpoint

1572

6903

2.07

143.79

4.0

3.4

25.08

25.32

mmol/l

1.88

1535

6689

L04AA Selective immunosuppressants

869

3465

2.64

143.34

9.9

3.2

24.31

25.33

mmol/l

14.99

845

3359

Unspecified mental disorder

1373

6632

2.14

142.52

3.6

3.5

25.63

25.17

mmol/l

4.73

1333

6428

Myocardial infarction, without ST-elevation

1772

8541

1.98

142.11

4.9

3.4

24.88

25.18

mmol/l

2.89

1714

8305

Paralytic ileus and intestinal obstruction

1110

4957

2.35

142.00

4.6

3.2

25.21

mmol/l

0.02

1070

4802

Chronic lower respiratory diseases

3974

13535

1.59

141.56

3.9

3.4

25.52

25.09

mmol/l

10.86

3841

13117

Stroke, excluding SAH

2324

9632

1.82

141.37

4.1

3.4

25.21

25.23

mmol/l

0.09

2263

9348

Diabetic nephropathy, excluding more controls

839

2703

2.80

141.30

9.6

2.9

24.13

25.19

mmol/l

13.34

817

2639

Examination and observation for other reasons

1961

5985

1.94

141.16

3.9

2.9

24.89

25.26

mmol/l

4.86

1915

5787

Other retinal disorders

2442

11003

1.78

140.71

5.1

3.3

24.98

25.29

mmol/l

4.09

2359

10696

Obesity related asthma

1267

5984

2.21

140.49

4.2

3.5

25.65

25.17

mmol/l

5.00

1231

5813

Used for control exclusion in common control thyroid runs

3483

10891

1.65

140.29

4.5

3.1

25.03

25.23

mmol/l

2.62

3367

10553

Schizophrenia or delusion, excluding more controls

1000

4227

2.43

140.27

3.4

3.3

25.78

25.22

mmol/l

4.64

963

4107

Pain in limb

2739

10832

1.73

140.24

4.3

3.3

25.41

25.14

mmol/l

3.90

2667

10490

Episodal and paroxysmal disorders

3575

11346

1.63

139.85

3.7

3.4

25.28

25.15

mmol/l

1.34

3470

10975

Disorders of thyroid, IBD co-morbidities

503

979

3.73

139.51

3.2

2.5

25.39

25.20

mmol/l

0.55

486

946

Bronchitis

3588

14288

1.61

139.19

4.5

3.2

25.36

25.18

mmol/l

2.16

3472

13845

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

410

702

4.38

137.87

4.7

2.6

25.65

25.17

mmol/l

1.37

384

681

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

933

3907

2.48

137.05

3.5

3.4

25.26

25.19

mmol/l

0.22

895

3780

1539

7802

2.02

136.46

4.4

3.5

25.63

25.12

mmol/l

6.94

1487

7569

Neurological diseases

2660

7758

1.76

135.50

3.7

3.4

25.22

25.09

mmol/l

1.02

2572

7528

Infections of the skin and subcutaneous tissue

1981

10929

1.85

134.26

5.4

3.3

25.08

25.19

mmol/l

0.70

1928

10593

Asthma (diagnoses ohter than nonallergic)

2925

14926

1.66

133.76

3.9

3.4

25.60

25.14

mmol/l

10.20

2828

14474

Suicide or other Intentional self-harm

850

3475

2.55

132.15

3.7

3.4

25.33

25.21

mmol/l

0.40

816

3364

Autoimmune diseases

3635

11761

1.60

131.06

4.6

3.1

25.04

25.24

mmol/l

2.71

3522

11384

Hydronephrosis

538

1756

3.31

130.70

6.1

2.6

24.02

25.58

mmol/l

17.00

527

1698

Substance use, excluding alcohol

707

2666

2.78

130.06

4.2

3.3

25.55

25.27

mmol/l

1.15

682

2573

Peripheral artery disease

1851

8076

1.90

129.46

6.1

3.2

24.58

25.28

mmol/l

12.20

1794

7849

Obesity, other/unspecified

1092

5015

2.25

129.21

3.9

3.4

25.38

25.23

mmol/l

0.71

1066

4862

Conduction disorders

1104

4074

2.29

128.85

4.0

2.8

24.95

25.15

mmol/l

1.00

1060

3969

Fall on same level

3668

12869

1.58

128.68

4.1

3.3

25.34

25.14

mmol/l

2.73

3568

12443

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

847

3544

2.55

127.40

3.8

3.3

24.99

25.23

mmol/l

1.04

826

3431

Status post-ami

1136

4004

2.28

127.12

4.2

2.9

24.95

25.19

mmol/l

1.36

1100

3904

Tramadol

2594

9489

1.72

127.05

4.4

3.1

25.11

25.29

mmol/l

1.73

2503

9221

Sulfonylureas

1400

5614

2.07

125.69

4.6

3.3

24.81

25.30

mmol/l

4.82

1371

5428

Transient ischemic attack

2021

9285

1.82

125.61

4.0

3.4

25.19

25.24

mmol/l

0.31

1970

9014

Disorders of choroid and retina

2866

12651

1.65

123.49

4.8

3.2

24.96

25.30

mmol/l

5.68

2775

12284

Gastroduodenal ulcer

1132

5394

2.20

122.63

4.7

3.3

24.65

25.11

mmol/l

3.50

1109

5224

Other acute lower respiratory infections

1910

10293

1.82

122.59

5.1

3.4

25.51

25.11

mmol/l

5.12

1848

9964

AV-block

784

2778

2.61

122.57

4.0

2.8

24.80

25.04

mmol/l

1.04

747

2706

Haemorrhage from respiratory passages

1273

5688

2.09

121.61

4.7

3.0

25.15

25.05

mmol/l

0.38

1237

5520

Early onset COPD, excluding more controls

762

3081

2.59

121.56

4.8

2.7

26.34

24.95

mmol/l

14.88

742

3006

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2128

12300

1.76

121.49

5.0

3.2

25.08

25.25

mmol/l

1.35

2061

11946

Cholelithiasis, broad definition with cholecystitis

2906

12217

1.64

120.62

3.8

3.3

25.21

25.27

mmol/l

0.39

2829

11850

Kela-code for severe mental illness

1224

6035

2.10

120.49

3.5

25.61

25.17

mmol/l

3.83

1185

5842

Problems related to lifestyle

446

1362

3.50

120.25

4.2

2.9

25.31

25.21

mmol/l

0.19

431

1315

Constipation

3009

13170

1.62

119.38

4.1

3.4

25.36

25.18

mmol/l

2.17

2908

12783

Pain (limb, back, neck, head abdominally)

2370

6921

1.75

119.15

3.9

3.2

25.22

25.09

mmol/l

0.95

2294

6683

Mood disorders, excluding more controls

2922

10887

1.63

118.25

3.9

3.3

25.36

25.23

mmol/l

1.08

2812

10566

Genitourinary diseases

1878

5128

1.88

118.24

5.0

2.3

24.92

25.40

mmol/l

6.45

1805

4969

Other antidepressants

3446

11375

1.58

118.07

3.8

3.4

25.23

25.15

mmol/l

0.68

3339

11036

Gastrointestinal diseases

1662

4365

1.94

116.77

3.9

2.5

25.20

25.22

mmol/l

0.05

1603

4196

Other or unspecified ileus, impaction or obstruction

815

3475

2.48

116.68

4.6

3.3

25.33

25.23

mmol/l

0.27

790

3374

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3680

13153

1.55

116.62

4.9

3.1

25.26

25.21

mmol/l

0.36

3566

12748

Disorders of lens

2285

8431

1.74

116.12

5.0

3.2

24.99

25.35

mmol/l

5.12

2217

8202

Other and unspecified iron deficiency

1291

6595

2.03

115.65

5.0

3.2

24.73

25.25

mmol/l

5.48

1247

6392

Asthma/COPD (KELA code 203)

3081

13515

1.59

115.59

3.8

3.3

25.61

25.09

mmol/l

12.67

2993

13097

Opioids

3058

10028

1.61

114.32

4.1

3.1

25.09

25.26

mmol/l

1.77

2945

9740

Diarrhoea and gastroenteritis of presumed infectious origin

3267

13979

1.57

114.17

4.7

3.1

24.97

25.28

mmol/l

5.48

3159

13554

Disorders of mineral metabolism

394

1161

3.69

113.29

8.6

2.9

25.45

mmol/l

0.00

382

1125

Intracranial injury

2024

11255

1.74

112.94

3.8

3.5

25.26

25.18

mmol/l

0.49

1973

10912

Sciatica+with lumbago

1692

8687

1.84

112.72

3.3

3.4

25.32

25.18

mmol/l

0.95

1649

8438

Gout

1221

5410

2.08

112.53

5.9

3.3

24.56

25.13

mmol/l

5.91

1187

5255

Ischaemic Stroke, excluding all haemorrhages

2130

9396

1.74

111.82

4.1

3.4

25.20

25.22

mmol/l

0.08

2072

9117

Vocal cord dysfunction

358

865

3.85

111.77

3.9

2.1

25.80

25.68

mmol/l

0.24

349

842

Implicit fungal Sepsis

349

963

4.00

111.44

6.9

2.7

25.26

25.33

mmol/l

0.10

337

931

Atherosclerosis, excluding cerebral and coronary sclerosis

1722

7658

1.85

111.21

5.8

3.2

24.57

25.27

mmol/l

11.35

1668

7446

Psychiatric diseases

3193

10256

1.59

110.92

3.9

3.4

25.22

25.23

mmol/l

0.10

3088

9956

Pacemaker

1441

7438

1.94

110.70

4.1

3.5

25.19

25.13

mmol/l

0.26

1390

7231

Glomerulonephritis

476

1603

3.22

110.10

11.3

3.3

24.13

25.24

mmol/l

9.81

469

1551

Other bacterial intestinal infections

762

3239

2.48

109.93

7.1

3.0

24.82

25.21

mmol/l

2.06

735

3138

Epilepsy

1113

5469

2.10

109.87

4.1

3.6

25.21

25.07

mmol/l

0.74

1078

5298

Hernia of abdominal wall, postoperative

706

2893

2.56

109.73

5.7

2.6

24.88

25.33

mmol/l

2.64

690

2811

Intestinal stricture

1234

6337

2.03

109.57

4.7

3.5

25.08

25.19

mmol/l

0.39

1192

6147

Disorders of calcium metabolism

330

888

4.11

109.24

8.6

2.8

25.45

25.48

mmol/l

0.03

322

856

Osteopathies and chondropathies

1914

10427

1.76

108.94

4.7

3.3

25.25

25.31

mmol/l

0.30

1852

10120

Dermatitis

2056

12241

1.72

108.93

4.2

3.4

25.12

25.26

mmol/l

1.06

2009

11866

Alcohol dependence

1013

4851

2.18

108.75

4.3

3.6

25.04

25.14

mmol/l

0.36

985

4698

Cholelithiasis

2754

12024

1.61

108.45

3.7

3.3

25.19

25.26

mmol/l

0.51

2682

11664

Alcohol abuse, main dg

623

2428

2.71

108.11

3.7

24.98

25.15

mmol/l

0.49

601

2346

Type 1 diabetes, strict (exclude DM2)

332

889

3.93

108.10

3.9

3.7

24.83

25.19

mmol/l

0.89

319

859

Codeine

2878

9895

1.61

107.77

3.8

3.1

25.16

25.27

mmol/l

0.88

2764

9609

Type 1 diabetes, definitions combined

332

897

3.89

106.68

3.9

3.6

24.83

25.21

mmol/l

0.94

319

866

Acute alcohol intoxication, ICD10

765

3314

2.42

105.26

3.8

24.96

25.13

mmol/l

0.61

741

3210

Persons encountering health services for examination and investigation

2083

6084

1.75

105.08

3.7

2.9

25.15

25.25

mmol/l

0.61

2015

5884

Autoimmune diseases related-to ILD

2714

14881

1.59

105.06

4.1

3.3

25.26

25.22

mmol/l

0.25

2639

14428

Unknown and unspecified causes of morbidity

320

861

4.01

104.89

5.1

2.8

24.71

25.01

mmol/l

0.88

313

835

Persons encountering health services in other circumstances, wide

3810

13272

1.50

104.20

4.7

3.1

25.22

25.21

mmol/l

0.05

3684

12864

Presence of other functional implants

2044

8429

1.73

104.17

4.8

2.9

25.20

25.30

mmol/l

0.63

2002

8172

Conductive and sensorineural hearing loss

2733

11783

1.60

103.62

3.5

25.26

mmol/l

0.00

2649

11447

Personality disorders

809

3597

2.33

103.61

3.6

3.5

25.35

25.18

mmol/l

0.61

790

3469

Disorders of adult personality and behaviour

842

3807

2.28

103.48

3.5

3.4

25.37

25.15

mmol/l

0.98

817

3675

Asthma, hospital admissions , main diagnosis only

2618

14752

1.60

103.38

3.9

3.4

25.51

25.17

mmol/l

5.57

2543

14293

Abnormal findings on diagnostic imaging of lung

1794

10065

1.76

102.96

4.3

3.4

25.39

25.18

mmol/l

1.61

1752

9771

Other reaction to severe stress, and adjustment disorders

1019

4986

2.10

101.85

4.5

3.2

25.34

25.30

mmol/l

0.12

986

4818

Anxiety disorders, excluding more controls

2414

9747

1.64

101.75

4.1

3.2

25.42

25.27

mmol/l

1.26

2348

9459

Fungal Sepsis

247

570

4.95

101.51

7.9

2.7

25.30

25.24

mmol/l

0.07

239

555

Pulmonary heart disease, diseases of pulmonary circulation

1263

6706

1.96

101.43

4.5

3.4

25.54

25.15

mmol/l

3.16

1215

6508

Other dorsopathies, not elsewhere classified

3160

10825

1.55

101.31

3.5

25.27

25.13

mmol/l

1.45

3050

10502

Other infectious diseases

457

1579

3.15

101.22

6.3

3.3

25.08

25.16

mmol/l

0.17

451

1529

Benign neoplasm of colon, rectum, anus and anal canal

2268

12250

1.65

101.10

4.4

3.4

25.09

25.29

mmol/l

1.96

2221

11901

Sensorineural hearing loss

2633

11406

1.60

100.64

3.5

25.27

25.26

mmol/l

0.05

2554

11087

Continuous positive airway pressure

492

1447

2.96

99.79

5.4

2.7

25.49

25.39

mmol/l

0.28

481

1420

COPD

1708

8089

1.78

99.34

4.8

3.3

26.04

25.00

mmol/l

20.49

1657

7868

Specific personality disorders

704

3008

2.42

99.02

3.6

3.5

25.41

25.16

mmol/l

1.03

683

2903

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

670

2829

2.52

98.84

3.6

3.3

25.25

25.19

mmol/l

0.19

661

2733

Viral and other specified intestinal infections

671

2736

2.48

98.72

7.0

3.1

24.92

25.13

mmol/l

0.82

648

2632

Acute alcohol intoxication

946

4591

2.14

97.92

3.7

3.6

25.01

25.11

mmol/l

0.33

919

4443

Viral hepatitis, IBD co-morbidity

173

296

6.17

97.38

4.5

2.6

24.96

25.19

mmol/l

0.33

167

286

Misadventures to patients during surgical and medical care

585

2334

2.66

97.08

5.2

3.1

25.21

25.23

mmol/l

0.05

568

2259

Schizophrenia or delusion

1000

4965

2.08

96.63

3.4

3.6

25.78

25.20

mmol/l

5.00

963

4808

Acute peritonitis

350

1066

3.64

96.56

12.2

3.3

23.90

25.11

mmol/l

6.81

344

1034

Unspecified acute lower respiratory infection

619

2544

2.57

96.25

5.9

3.4

25.73

25.17

mmol/l

2.94

600

2459

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1085

5563

2.02

96.13

4.4

3.5

25.33

25.15

mmol/l

0.91

1049

5394

Factors influencing health status and contact with health services

951

2182

2.24

96.03

3.7

2.3

25.14

25.13

mmol/l

0.02

917

2103

Schizophrenia, schizotypal and delusional disorders

1004

5009

2.07

95.73

3.4

3.6

25.78

25.20

mmol/l

4.99

967

4852

Falls/tendency to fall

3323

11121

1.52

95.72

4.0

3.2

25.28

25.13

mmol/l

1.47

3228

10745

Diabetic retinopathy, excluding more controls

1169

3340

2.07

95.41

6.2

2.9

24.70

25.23

mmol/l

4.77

1134

3251

Unspecified haematuria

1587

7564

1.80

94.88

5.2

3.3

24.97

25.14

mmol/l

1.04

1536

7360

Spondylopathies

2587

9896

1.59

94.61

3.4

25.35

25.16

mmol/l

1.92

2509

9612

DVT of lower extremities and pulmonary embolism

1557

8963

1.79

94.10

4.5

3.4

25.42

25.20

mmol/l

1.67

1509

8701

Gout, FINNGEN

1221

6567

1.94

93.94

5.9

3.3

24.56

25.10

mmol/l

5.55

1187

6387

Other chronic obstructive pulmonary disease

1638

7860

1.78

93.76

4.8

3.3

26.09

24.99

mmol/l

21.49

1588

7645

Other and unspecified dermatitis

1693

10006

1.74

93.71

4.0

3.4

25.11

25.25

mmol/l

0.98

1654

9696

Other diseases of pleura

1735

9028

1.74

93.53

5.3

3.3

26.08

25.00

mmol/l

22.66

1664

8767

Implicit fungal Sepsis

224

511

5.00

93.40

8.0

2.7

25.28

25.17

mmol/l

0.13

216

497

Disorders of other endocrine glands

1448

8060

1.82

93.39

6.0

3.3

25.01

25.26

mmol/l

1.96

1394

7824

Retention of urine

1368

6211

1.88

93.34

4.6

3.3

25.00

25.11

mmol/l

0.48

1314

6039

Bacterial intestinal infections, IBD co-morbidities

754

3426

2.32

93.15

7.2

3.3

24.80

25.22

mmol/l

2.27

728

3326

Venous thromboembolism

1922

11363

1.68

92.92

4.5

3.4

25.36

25.22

mmol/l

0.95

1865

11040

Calcific aortic valvular stenosis

1282

6867

1.89

91.11

4.5

3.4

25.04

25.13

mmol/l

0.41

1252

6663

Calcific aortic valvular stenosis, operated

1282

6867

1.89

91.11

4.5

3.4

25.04

25.13

mmol/l

0.41

1252

6663

Other bacterial intestinal infections

843

4034

2.18

90.73

6.7

3.1

24.88

25.22

mmol/l

1.87

813

3910

Streptococcal septicaemia

390

1308

3.21

90.58

5.9

2.8

25.14

25.19

mmol/l

0.08

377

1266

Calcific aortic valvular stenosis, diagnosis (helper)

1279

6858

1.89

90.57

4.6

3.4

25.04

25.13

mmol/l

0.40

1249

6654

Operations 2 for CAVS

1279

6858

1.89

90.57

4.6

3.4

25.04

25.13

mmol/l

0.40

1249

6654

Abnormal findings on examination of blood, without diagnosis

1709

9375

1.73

90.34

4.8

3.5

25.07

25.11

mmol/l

0.19

1652

9108

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

295

833

3.83

90.34

4.0

3.4

25.12

25.21

mmol/l

0.13

285

805

Asthma, including avohilmo

3707

14470

1.46

90.04

3.7

3.5

25.49

25.13

mmol/l

7.83

3581

14029

Benign neoplasm: Colon

1942

11477

1.66

89.89

4.5

3.4

25.03

25.28

mmol/l

2.52

1899

11147

Calcific aortic valvular stenosis, including rheumatic fever

1280

6880

1.88

89.63

4.6

3.4

25.03

25.13

mmol/l

0.43

1250

6675

Cough

1223

6292

1.89

89.02

4.6

3.1

25.21

25.11

mmol/l

0.47

1190

6103

Senile cataract

2060

7784

1.66

88.97

4.7

3.2

25.04

25.33

mmol/l

3.09

1996

7580

Pulmonary embolism

1130

6052

1.94

88.42

4.5

3.4

25.46

25.16

mmol/l

1.92

1089

5882

Explicit bacterial Sepsis

441

1600

2.93

88.41

5.9

2.8

25.06

25.15

mmol/l

0.21

425

1550

Mycoses

937

4724

2.06

87.47

4.8

3.4

25.22

25.17

mmol/l

0.16

907

4574

Enterocolitis due to Clostridium difficile

509

2005

2.72

87.45

8.1

3.1

24.88

25.14

mmol/l

0.74

489

1940

Pulmonary heart disease

1130

6084

1.93

86.99

4.5

3.4

25.46

25.17

mmol/l

1.83

1089

5910

Type 1 diabetes, strict definition, subgroup 1

236

580

4.27

86.61

3.5

4.1

24.60

25.17

mmol/l

1.31

225

561

Cholecystectomy

2289

12743

1.58

86.57

3.7

3.4

25.23

25.26

mmol/l

0.17

2230

12366

Non-allergic asthma (mode), excluding more controls

603

2541

2.44

85.60

3.6

2.5

25.46

25.00

mmol/l

2.59

587

2466

Enlarged lymph nodes

519

2067

2.62

85.50

3.7

2.9

25.20

25.09

mmol/l

0.32

506

2001

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1898

11849

1.64

84.47

4.9

3.3

25.06

25.27

mmol/l

1.75

1836

11511

Symptoms and signs concerning food and fluid intake

406

1445

2.97

83.85

4.8

3.0

24.91

25.01

mmol/l

0.20

388

1398

Disorders resulting from impaired renal tubular function

225

564

4.59

83.46

16.1

3.2

23.41

25.06

mmol/l

9.39

220

550

Benzodiazepine use

3136

14882

1.47

82.82

3.7

3.4

25.35

25.20

mmol/l

1.50

3044

14425

Other diseases of urinary system

3104

11913

1.49

82.80

4.3

3.3

25.14

25.19

mmol/l

0.33

3004

11545

Dysphagia

856

4275

2.08

81.93

4.1

3.0

25.75

25.19

mmol/l

4.46

826

4145

COPD related to multimorbidity

1517

7602

1.74

81.72

4.9

3.4

26.07

24.98

mmol/l

19.31

1468

7393

Cardiomyopathy

618

2730

2.37

81.27

4.6

2.9

24.98

25.06

mmol/l

0.22

596

2656

Viral and other specified intestinal infections

797

3729

2.12

81.24

6.5

3.0

24.91

25.15

mmol/l

1.11

770

3588

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

183

394

5.13

81.06

8.5

3.2

25.14

25.40

mmol/l

0.38

178

385

Type 1 diabetes, strict definition

243

640

3.98

81.01

3.6

3.9

24.59

25.21

mmol/l

1.55

232

617

Cervicobrachial syndrome

722

3399

2.20

80.75

3.4

25.32

25.14

mmol/l

0.81

705

3304

Other blood glucose lowering drugs, excl. Insulins

620

2758

2.37

80.68

4.3

3.3

25.23

25.28

mmol/l

0.11

604

2668

Other disorders of kidney and ureter

550

2332

2.51

80.52

10.3

3.4

24.30

25.21

mmol/l

7.47

536

2257

Chronic ulcer of skin, not elsewhere classified

357

1225

3.19

80.52

7.8

3.1

24.70

25.14

mmol/l

1.34

350

1187

Other intervertebral disc disorders

2563

10220

1.54

80.51

3.2

3.4

25.23

25.16

mmol/l

0.47

2455

9923

Depression

2810

12913

1.50

80.35

4.0

3.3

25.33

25.25

mmol/l

0.61

2712

12527

Emotionally unstable personality disorder

360

1227

3.06

79.98

3.6

3.4

25.23

25.24

mmol/l

0.02

351

1180

Functional dyspepsia

871

4418

2.04

79.61

4.0

3.1

25.56

25.28

mmol/l

1.92

842

4279

Cardiac arrest

240

529

4.11

79.43

6.2

2.2

25.22

25.13

mmol/l

0.13

223

516

Thiazolidinediones

478

1913

2.67

79.33

4.6

3.3

24.95

25.31

mmol/l

1.34

470

1849

Diseases of the skin and subcutaneous tissue

3104

10668

1.48

79.28

4.4

3.0

25.13

25.21

mmol/l

0.59

3021

10294

Codeine or tramadol medication

3495

13456

1.44

79.11

3.8

3.4

25.11

25.26

mmol/l

1.56

3366

13070

Cutaneous abscess, furuncle and carbuncle

838

4205

2.06

78.97

6.1

3.4

24.99

25.17

mmol/l

0.80

812

4071

Diseases of the respiratory system

1880

5777

1.66

78.51

3.7

2.7

25.34

25.05

mmol/l

2.73

1820

5609

Finngen Rheumatological endpoints

2848

10993

1.50

78.43

3.9

3.3

25.15

25.21

mmol/l

0.36

2755

10643

Acute upper respiratory infections of multiple and unspecified sites

2241

10835

1.56

78.39

4.6

3.3

25.25

25.20

mmol/l

0.32

2171

10479

Other disorders of glucose regulation and pancreatic internal secretion

376

1341

3.01

78.28

6.3

3.4

25.02

25.27

mmol/l

0.65

359

1291

Mood disorders

3076

13793

1.46

78.05

3.9

3.4

25.33

25.26

mmol/l

0.49

2961

13383

Diseases of liver

1163

6541

1.84

77.35

4.6

3.4

24.67

25.24

mmol/l

5.87

1125

6347

Elevated blood glucose level

368

1313

3.01

76.68

6.1

3.3

25.14

25.20

mmol/l

0.10

353

1263

Mood [affective] disorders

3060

13780

1.46

76.60

3.9

3.4

25.33

25.26

mmol/l

0.55

2946

13370

Other chronic obstructive pulmonary disease, including avohilmo

1900

10001

1.61

76.41

4.5

3.4

25.94

25.07

mmol/l

16.42

1846

9724

Other CVD

844

4329

2.05

75.95

4.9

3.4

25.12

25.17

mmol/l

0.15

813

4201

Gastric ulcer

724

3517

2.16

75.46

4.8

3.3

24.93

25.13

mmol/l

0.73

710

3406

Other cataract

1459

6579

1.72

75.23

4.9

3.3

25.03

25.33

mmol/l

2.50

1411

6403

Other disorders of ear

2866

12938

1.47

75.18

3.5

25.23

25.24

mmol/l

0.09

2777

12547

Ulcer of lower limb, not elsewhere classified

625

2890

2.29

74.62

7.4

3.3

24.72

25.18

mmol/l

2.16

608

2808

Acute bronchitis

1369

7988

1.72

73.85

4.9

3.4

25.47

25.11

mmol/l

3.27

1320

7740

Soft tissue disorders

3127

11215

1.46

73.75

4.0

3.3

25.22

25.13

mmol/l

0.80

3023

10855

Sequelae of external causes of morbidity and mortality

908

4814

1.96

73.34

4.7

3.4

25.09

25.21

mmol/l

0.41

880

4668

Hypoglycaemia, other or unspecified

313

1047

3.23

73.31

6.8

3.5

25.01

25.22

mmol/l

0.44

300

1009

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

249

719

3.67

73.28

3.7

3.6

25.39

25.09

mmol/l

0.57

236

704

Disorder of lipoprotein metabolism, unspecified

528

2294

2.43

72.81

4.8

2.9

25.15

25.21

mmol/l

0.16

522

2229

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

366

1339

2.91

72.46

5.5

3.0

25.51

25.33

mmol/l

0.37

352

1296

Focal epilepsy

754

3766

2.08

72.35

3.8

3.6

25.19

25.20

mmol/l

0.02

733

3643

Anxiety (asthma-related co-morbidities)

1531

7204

1.67

72.22

4.2

3.3

25.35

25.27

mmol/l

0.39

1489

6975

Neurotic, stress-related and somatoform disorders

2499

11864

1.50

71.66

4.2

3.3

25.41

25.27

mmol/l

1.24

2431

11480

Viral infections characterized by skin and mucous membrane lesions

1319

7840

1.72

71.48

5.0

3.5

25.12

25.21

mmol/l

0.44

1289

7596

Vascular disorders of the intestines

342

1226

3.03

71.04

5.3

3.1

24.54

25.18

mmol/l

1.84

329

1193

Cardiomyopathies, Primary/intrinsic

452

1851

2.57

70.89

4.6

2.9

24.68

25.02

mmol/l

1.15

432

1800

COPD, early/later onset

1646

8716

1.64

70.61

4.8

3.4

26.09

25.02

mmol/l

20.66

1596

8468

Dorsopathies

3061

10879

1.45

70.51

3.6

3.5

25.32

25.13

mmol/l

2.32

2956

10552

Non-selective monoamine reuptake inhibitors

1244

7044

1.75

70.31

4.0

3.3

25.58

25.25

mmol/l

2.54

1211

6846

Sleep apnoea

2834

12781

1.46

70.26

3.9

3.4

25.54

25.21

mmol/l

5.59

2757

12384

Diseases of peritoneum

429

1729

2.64

70.18

10.6

3.2

24.18

25.28

mmol/l

7.30

420

1670

Acute sinusitis

1431

8050

1.68

70.08

4.1

3.3

25.32

25.22

mmol/l

0.57

1396

7787

Non-allergic asthma (mode)

603

2769

2.23

69.89

3.6

2.7

25.46

24.93

mmol/l

3.28

587

2694

Osteoporosis

969

4968

1.89

69.80

4.3

3.2

25.55

25.35

mmol/l

0.95

935

4834

Diabetic nephropathy

846

4452

2.01

69.57

9.5

3.5

24.12

25.02

mmol/l

10.72

822

4340

Type of accident

950

5192

1.89

69.39

4.3

3.5

25.42

25.15

mmol/l

1.64

921

5033

Anxiety disorders

2519

12010

1.48

69.25

4.2

3.3

25.41

25.27

mmol/l

1.21

2450

11620

Other gastritis (incl. Duodenitis)

807

4195

2.00

69.18

4.5

3.3

24.96

25.16

mmol/l

0.82

792

4064

Anaemia in chronic diseases classified elsewhere

163

370

5.17

69.16

16.1

3.2

23.58

25.27

mmol/l

7.38

158

356

Hypotension

742

3774

2.07

68.64

5.0

3.4

25.03

25.14

mmol/l

0.37

718

3661

Other headache syndromes

1159

6718

1.76

68.41

3.4

3.3

25.40

25.22

mmol/l

1.14

1124

6504

ILD medications: azathioprine

481

2054

2.44

68.30

8.2

2.8

24.72

25.30

mmol/l

2.84

467

1988

Benign neoplasms

2942

11363

1.45

68.25

4.1

3.3

25.11

25.18

mmol/l

0.50

2862

10968

Cardiomyopathy (excluding other)

464

1958

2.49

68.15

4.6

2.9

24.66

25.07

mmol/l

1.52

444

1906

COPD, hospital admissions

1622

8661

1.63

68.11

4.8

3.4

26.10

25.02

mmol/l

21.12

1572

8414

Schizophrenia

520

2305

2.35

67.77

3.6

25.92

25.19

mmol/l

3.95

501

2232

Organic, including symptomatic, mental disorders

1833

8431

1.59

67.73

3.7

3.6

25.27

25.16

mmol/l

0.61

1779

8208

Coronary artery bypass grafting

970

3957

1.89

67.42

4.2

3.0

24.84

25.17

mmol/l

2.01

930

3854

Other and unspecified drugs and medicaments

351

1307

2.87

67.38

5.5

3.2

25.53

25.32

mmol/l

0.42

338

1268

Additional codes for the location of defect, injury or illness

264

843

3.40

67.15

3.6

3.2

25.17

25.28

mmol/l

0.22

258

812

Peripheral arterial reconstruction

739

3787

2.06

67.02

6.3

3.4

24.28

25.12

mmol/l

7.13

712

3673

Ascites

319

1138

3.01

66.51

6.8

2.8

24.37

25.24

mmol/l

3.41

310

1101

Amputation

465

2005

2.48

65.85

8.5

3.3

24.05

25.15

mmol/l

7.20

451

1938

Cytomegaloviral disease

142

298

5.50

65.81

10.3

3.2

24.11

25.17

mmol/l

2.45

132

291

Schizoaffective disorder

272

890

3.24

65.60

3.2

3.3

25.61

25.23

mmol/l

0.83

263

861

Other symptoms and signs involving cognitive functions and awareness

1530

8793

1.62

64.80

3.8

3.4

25.24

25.20

mmol/l

0.16

1483

8540

Peripheral artery operations in Hilmo

546

2530

2.28

64.63

7.7

3.1

24.20

25.21

mmol/l

7.52

535

2448

Iron deficiency anaemia secondary to blood loss (chronic)

627

3069

2.14

64.17

6.0

3.2

24.82

25.19

mmol/l

1.60

609

2986

External causes of morbidity and mortality

1872

6037

1.58

64.16

3.7

3.1

25.17

25.19

mmol/l

0.09

1813

5848

Cytomegalovirus infection, IBD co-morbidity

142

306

5.39

63.94

10.3

3.3

24.11

25.24

mmol/l

2.74

132

299

Unspecified dementia

542

2247

2.29

63.92

3.8

3.5

25.16

24.96

mmol/l

0.58

530

2184

Valvular operations

514

2331

2.31

63.76

4.4

2.9

24.96

25.01

mmol/l

0.11

497

2270

Other infectious diseases

348

1332

2.81

63.59

7.1

3.2

24.98

25.14

mmol/l

0.39

343

1291

Adjustment and management of implanted device

691

3512

2.05

63.57

5.0

2.7

25.33

25.11

mmol/l

0.94

674

3402

Azathioprine

481

2121

2.36

63.47

8.2

3.2

24.72

25.23

mmol/l

2.33

467

2051

Focal epilepsy, mode (most common among epilepsy diagnosis)

659

3299

2.08

63.00

3.7

3.6

25.21

25.19

mmol/l

0.05

642

3193

Other/unspecified dorsalgia

1145

6729

1.73

62.71

3.8

3.4

25.58

25.15

mmol/l

3.95

1111

6538

COPD, hospital admission 2, with asthma infections

1192

6112

1.73

62.60

5.3

3.4

26.26

24.95

mmol/l

21.48

1154

5935

Tobacco use

231

709

3.53

62.57

4.5

3.4

25.70

25.04

mmol/l

1.65

225

687

Early onset COPD

762

4025

1.97

62.40

4.8

3.5

26.34

25.02

mmol/l

13.82

742

3903

Later onset COPD, excluding more controls

800

3272

1.97

62.38

4.9

2.7

25.92

24.85

mmol/l

10.38

774

3194

Chronic pancreatitis

475

2112

2.37

62.20

5.1

3.4

24.71

25.20

mmol/l

2.02

459

2040

Other skin changes

678

3465

2.04

61.47

5.2

3.4

25.02

25.18

mmol/l

0.63

659

3357

Focal epilepsy, strict definition

686

3514

2.03

61.42

3.8

3.6

25.23

25.19

mmol/l

0.10

668

3401

Neoplasms

2080

7351

1.52

61.41

4.1

3.2

25.09

25.19

mmol/l

0.67

2011

7080

Other/unspecified cytomegaloviral diseases

123

243

5.92

61.32

11.3

3.5

24.00

25.06

mmol/l

2.22

117

236

Gout, idiopatic and unspecified

964

5517

1.82

61.30

5.9

3.4

24.63

25.14

mmol/l

4.10

939

5355

ILD, hospital admission 2, with pulmonary infections

394

1627

2.57

61.11

5.1

2.8

25.71

25.01

mmol/l

2.88

371

1573

Noninfective enteritis and colitis

1386

8683

1.63

60.77

4.9

3.5

24.93

25.22

mmol/l

2.26

1340

8415

Open wound of head

1732

11009

1.55

60.58

3.7

3.6

25.09

25.17

mmol/l

0.46

1683

10672

Gastro-oesophageal reflux disease

2011

11754

1.50

60.55

4.1

3.3

25.18

25.29

mmol/l

0.77

1948

11384

Bipolar affective disorders

504

2305

2.25

60.49

3.1

3.3

25.13

25.18

mmol/l

0.11

486

2233

All anxiety disorders

1555

7857

1.59

60.09

4.1

3.4

25.33

25.21

mmol/l

0.66

1513

7594

Undefined dementia

550

2424

2.20

59.38

3.8

3.3

25.17

25.03

mmol/l

0.38

538

2351

Carpal tunnel syndrome

1799

10562

1.53

59.16

3.7

3.3

25.40

25.30

mmol/l

0.64

1741

10283

Malignant neoplasm

2486

10294

1.45

59.14

3.9

3.3

25.19

25.33

mmol/l

1.12

2426

9958

Superficial injury of head

784

4254

1.90

58.70

3.8

3.5

25.29

25.18

mmol/l

0.42

761

4117

Nonorganic sleeping disorders, excluding more controls

507

2353

2.22

58.63

3.7

3.2

25.07

25.15

mmol/l

0.20

486

2280

Other respiratory disorders and diseases

778

4239

1.91

58.12

5.6

3.5

27.25

24.94

mmol/l

33.47

734

4116

Other diseases of the respiratory system

778

4239

1.91

58.12

5.6

3.5

27.25

24.94

mmol/l

33.47

734

4116

All influenza (not pneumonia)

468

2126

2.28

57.47

5.2

2.8

25.51

25.11

mmol/l

1.42

448

2055

Sleep apnoea, including avohilmo

2894

12968

1.40

57.45

3.8

3.4

25.52

25.20

mmol/l

5.39

2799

12571

Hernia of abdominal wall

1457

9406

1.59

56.85

4.8

3.4

25.19

mmol/l

0.01

1423

9123

Allergic asthma (mode), excluding more controls

536

2515

2.13

56.42

3.0

2.6

25.40

25.07

mmol/l

1.63

519

2439

Disorders of parathyroid gland

753

4045

1.91

56.41

6.9

3.2

25.00

25.32

mmol/l

1.66

728

3939

Injuries to the thorax

1478

9584

1.58

56.34

4.1

3.5

25.39

25.15

mmol/l

1.86

1438

9305

Candidiasis

454

2066

2.29

55.87

5.4

3.2

25.34

25.30

mmol/l

0.06

441

2001

Acute upper respiratory infections

3093

13995

1.38

55.83

4.0

3.3

25.28

25.21

mmol/l

0.52

2995

13563

Symptoms and signs involving the skin and subcutaneous tissue

2063

14016

1.46

55.72

4.3

3.4

25.19

25.25

mmol/l

0.32

2006

13593

Shoulder lesions

2344

9963

1.45

55.45

3.6

3.2

25.24

25.19

mmol/l

0.32

2260

9654

Intestinal adhesions without obstruction

343

1394

2.61

55.17

4.6

3.2

24.99

25.26

mmol/l

0.53

331

1354

Other external causes of accidental injury

2368

8277

1.45

55.14

3.9

3.2

25.26

25.15

mmol/l

0.77

2287

8014

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

551

2726

2.12

55.01

5.3

3.7

24.30

25.16

mmol/l

5.21

533

2636

Malignant neoplasm, wide definition for exclusion

2515

10479

1.43

54.93

3.9

3.3

25.20

25.32

mmol/l

0.94

2452

10135

Hernia

2780

13531

1.40

54.76

4.1

3.3

25.18

25.28

mmol/l

0.92

2696

13115

Cellulitis

707

3799

1.92

54.75

6.0

3.4

24.92

25.19

mmol/l

1.09

688

3681

Post-traumatic stress disorder

211

657

3.33

54.75

5.3

3.2

25.17

24.99

mmol/l

0.32

202

633

Other complications of surgical and medical care, not elsewhere classified

345

1407

2.58

54.72

5.1

2.9

25.32

25.36

mmol/l

0.06

329

1361

Accidents

2363

8277

1.45

54.41

3.8

3.2

25.25

25.15

mmol/l

0.61

2283

8014

Other and unspecified nonorganic psychotic disorders

510

2453

2.14

53.89

3.3

3.6

25.78

25.16

mmol/l

2.76

487

2367

Gout, strict definition

722

3949

1.91

53.74

6.1

3.5

24.63

25.08

mmol/l

2.46

700

3825

Hyperparathyroidism

673

3549

1.95

53.65

7.2

3.1

24.93

25.34

mmol/l

2.22

649

3464

Ventral hernia

813

4595

1.83

53.56

4.4

3.4

25.26

25.20

mmol/l

0.17

793

4462

Pain in thoracic spine

469

2197

2.21

53.38

3.4

3.3

25.32

25.14

mmol/l

0.59

452

2129

Sequelae of cerebrovascular disease

1273

6963

1.62

52.91

4.3

3.4

25.23

25.16

mmol/l

0.29

1237

6753

COPD, hospital admissions 3, with asthma pneumonia sepsis

1019

5228

1.72

52.88

5.5

3.4

26.28

24.87

mmol/l

20.03

986

5071

Abnormal findings on diagnostic imaging of other body structures

472

2236

2.21

52.67

5.0

3.3

25.35

25.27

mmol/l

0.17

463

2170

Other metabolic disorders

371

1586

2.42

52.56

4.2

2.7

25.94

25.46

mmol/l

1.86

358

1533

Other anxiety disorders

1099

5811

1.67

52.45

4.1

3.3

25.18

25.23

mmol/l

0.15

1066

5618

ILD, hospital admissions 3, with pneumonia sepsis

349

1468

2.53

52.24

5.4

2.8

25.81

24.96

mmol/l

3.53

328

1418

Exclusions for E4_PCOS_BROAD

529

2615

2.09

52.22

5.2

3.7

25.00

25.26

mmol/l

0.96

505

2526

Traumatic subdural haemorrhage

507

2371

2.14

52.12

4.0

3.2

25.27

24.88

mmol/l

1.75

495

2301

Somatoform disorder

470

2228

2.18

51.85

3.9

3.2

25.57

25.25

mmol/l

1.31

456

2161

Injuries to the hip and thigh

1573

9519

1.53

51.56

4.0

3.4

25.34

25.17

mmol/l

1.05

1533

9229

Impacted teeth

434

1756

2.25

51.46

4.4

3.6

25.20

24.90

mmol/l

1.23

423

1691

Amputation of toe

327

1351

2.60

51.35

9.0

3.3

23.93

25.15

mmol/l

6.15

319

1309

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

839

4793

1.79

51.12

3.6

3.3

25.16

25.26

mmol/l

0.36

817

4643

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

309

1246

2.64

50.68

5.8

3.2

25.06

25.37

mmol/l

0.84

303

1205

Postprocedural endocrine and metabolic disorders, not elsewhere classified

344

1447

2.47

50.58

4.0

2.7

26.11

25.50

mmol/l

2.66

331

1400

Use of hypnotics and sedatives

3124

13376

1.36

50.53

4.1

3.4

25.28

25.21

mmol/l

0.55

3030

12965

Certain disorders involving the immune mechanism

600

3145

1.98

50.30

5.7

3.5

24.86

25.27

mmol/l

2.25

575

3046

Other noninfective gastroenteritis and colitis

760

4284

1.82

50.14

5.6

3.5

24.92

25.18

mmol/l

1.20

733

4149

Undetermined asthma, excluding more controls

369

1605

2.38

50.13

5.0

2.5

25.97

25.00

mmol/l

4.64

354

1558

Fentanyl

429

1997

2.25

50.08

4.7

3.2

25.51

25.16

mmol/l

1.09

418

1945

Candidiasis

812

4671

1.78

49.95

4.6

3.2

25.30

25.23

mmol/l

0.21

789

4524

Unspecified fall

1555

10300

1.52

49.94

4.3

3.5

25.16

25.21

mmol/l

0.24

1509

9993

Delirium, not induced by alcohol and other psychoactive substances

491

2414

2.14

49.79

4.8

3.5

25.14

25.09

mmol/l

0.11

471

2340

Spinal stenosis

1635

8375

1.51

49.78

3.5

3.4

25.29

25.15

mmol/l

0.83

1591

8156

Noninfectious colitis NAS

460

2204

2.17

49.71

5.3

3.3

24.69

25.28

mmol/l

3.10

445

2134

Other viral diseases

772

4365

1.80

49.65

6.5

3.5

25.07

25.13

mmol/l

0.22

736

4213

Leisure time condition

586

3067

1.98

49.34

4.1

3.4

25.48

25.21

mmol/l

1.10

569

2974

Other disorders of skin and subcutaneous tissue, not elsewhere classified

512

2564

2.08

49.27

6.6

3.2

24.97

25.24

mmol/l

0.89

500

2490

Toxic effects of substances chiefly nonmedicinal as to source

374

1660

2.35

48.93

3.6

3.5

25.17

25.25

mmol/l

0.17

366

1605

Sequelae with surgical and medical care as external cause

686

3796

1.87

48.72

4.8

3.4

25.14

25.21

mmol/l

0.17

664

3678

Systemic connective tissue disorders

1081

6759

1.64

48.53

4.2

3.3

25.35

25.26

mmol/l

0.39

1047

6559

Coxarthrosis [arthrosis of hip](FG)

1739

8380

1.49

48.39

3.4

3.3

25.32

25.24

mmol/l

0.44

1693

8141

Amiodarone users

418

1969

2.26

48.08

4.2

3.5

25.17

25.10

mmol/l

0.16

407

1901

Respiratory insufficiency

318

1325

2.52

48.04

5.9

2.8

28.76

24.70

mmol/l

30.23

298

1281

Depression or dysthymia

1954

7486

1.46

48.01

3.9

3.4

25.34

25.22

mmol/l

0.81

1891

7274

Panic disorder

358

1565

2.35

47.94

4.0

3.1

25.27

25.20

mmol/l

0.13

350

1504

Allergic asthma (mode)

536

2672

2.00

47.89

3.0

2.8

25.40

25.05

mmol/l

1.73

519

2589

Congenital malformations of the urinary system

222

778

3.05

47.87

11.0

3.5

23.48

25.14

mmol/l

11.67

215

750

Polyneuropathies and other disorders of the peripheral nervous system

756

4346

1.80

47.27

5.7

3.5

25.54

25.13

mmol/l

2.40

736

4207

Spondylosis

1624

9029

1.49

47.18

3.2

3.4

25.55

25.19

mmol/l

4.00

1576

8779

Nonischemic cardiomyopathy

347

1517

2.40

47.18

4.1

3.1

25.00

25.26

mmol/l

0.58

334

1472

Other and unspecified effects of external causes

727

4129

1.80

46.64

4.3

3.5

25.06

25.17

mmol/l

0.40

704

3993

Decubitus ulcer and pressure area

285

1156

2.65

46.57

7.5

3.2

25.06

25.08

mmol/l

0.02

276

1116

Injury, poisoning and certain other consequences of external causes

1477

4861

1.54

46.53

3.6

3.1

25.11

25.24

mmol/l

0.69

1428

4697

Other ulcerative colitis

210

725

3.08

46.39

5.6

3.5

25.06

25.23

mmol/l

0.26

203

699

Myocarditis

138

364

3.98

46.33

4.5

2.3

25.38

25.34

mmol/l

0.03

131

352

Diseases of the ear and mastoid process

3271

12440

1.33

46.25

3.7

3.4

25.19

25.21

mmol/l

0.15

3182

12035

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

488

2373

2.06

46.06

7.3

3.7

24.56

25.20

mmol/l

3.92

475

2289

Diagnoses used for exclusion with ILD

848

5062

1.72

45.97

4.5

3.5

25.48

25.08

mmol/l

2.80

809

4906

Cirrhosis of liver, NAS

244

925

2.86

45.93

6.0

3.2

24.28

25.20

mmol/l

2.57

239

890

Injuries to the abdomen, lower back, lumbar spine and pelvis

1240

8010

1.56

45.91

4.1

3.5

25.40

25.17

mmol/l

1.41

1201

7762

Solid cancers, helper endpoint

2376

10187

1.40

45.88

3.8

3.3

25.21

25.33

mmol/l

0.90

2315

9856

Duodenal ulcer

431

2090

2.16

45.53

4.4

3.3

24.23

25.10

mmol/l

4.41

418

2015

Recurrent or chronic depression

982

4212

1.67

45.35

3.7

3.3

25.32

25.36

mmol/l

0.14

958

4091

Extreme obesity with alveolar hypoventilation

179

575

3.39

45.31

5.0

3.2

28.57

25.22

mmol/l

12.69

168

558

Congenital malformations of the urinary system

230

846

2.89

45.30

10.7

3.5

23.53

25.15

mmol/l

11.64

223

816

Type1 diabetes, definitions combined, early onset

183

587

3.24

45.11

4.6

24.75

24.92

mmol/l

0.24

176

565

Other and unspecified local infections of skin and subcutaneous tissue

337

1485

2.38

45.09

6.3

3.4

25.17

25.24

mmol/l

0.13

330

1434

Mental and behavioural disorders due to sedatives or hypnotics

227

830

2.88

44.96

4.0

3.3

25.43

25.21

mmol/l

0.37

219

804

Viral pneumonia (unknown virus, not influenza)

253

983

2.72

44.66

7.7

3.5

25.16

25.08

mmol/l

0.15

247

946

COPD, hospital admissions 1, only main diagnosis

1197

6666

1.58

44.58

5.2

3.4

26.20

24.98

mmol/l

20.13

1163

6477

Gout, unspecified

755

4421

1.77

44.45

6.0

3.4

24.61

25.13

mmol/l

3.41

735

4281

Mental and behavioural disorders due to opioids

132

351

4.01

44.16

3.9

3.5

25.36

25.05

mmol/l

0.45

124

342

Other and unspecified polyneuropathies, also in other diseases

669

3792

1.83

44.05

5.7

3.5

25.44

25.13

mmol/l

1.49

652

3672

Other diseases of pancreas

311

1343

2.45

43.92

5.6

3.2

24.94

25.31

mmol/l

1.14

306

1301

Migraine

1105

5708

1.59

43.71

3.1

3.4

25.13

25.23

mmol/l

0.50

1070

5511

Other obstructive and reflux uropathy

162

498

3.47

43.61

8.7

2.5

23.84

25.50

mmol/l

6.36

157

481

Periapical abscess

1250

8269

1.54

43.53

4.3

3.5

25.18

25.26

mmol/l

0.33

1215

8006

Diseases of the eye and adnexa

2122

7592

1.42

43.48

4.2

3.1

25.05

25.24

mmol/l

1.71

2049

7347

Cystitis

2382

10391

1.38

43.20

4.1

3.2

25.17

25.20

mmol/l

0.13

2298

10069

Other viral diseases

920

5634

1.65

43.11

5.9

3.5

25.04

25.17

mmol/l

0.53

875

5449

Any event in cancer register

2547

11122

1.36

43.07

3.8

3.4

25.17

25.31

mmol/l

1.21

2479

10766

Acute pancreatitis

634

3556

1.84

42.97

4.9

3.4

24.75

25.20

mmol/l

2.57

613

3438

Irritable bowel syndrome

714

4138

1.76

42.69

3.8

3.1

25.38

25.29

mmol/l

0.35

704

4002

Disorders of the thyroid gland

2713

13281

1.35

42.66

3.5

3.4

25.24

25.18

mmol/l

0.47

2618

12896

Fibrosis and cirrhosis of liver

300

1294

2.46

42.60

6.0

3.1

24.38

25.25

mmol/l

2.86

290

1249

Undetermined asthma

369

1721

2.21

42.45

5.0

2.6

25.97

24.96

mmol/l

4.98

354

1670

Other degenerative diseases of the nervous system

828

3692

1.71

42.43

3.3

3.1

25.47

25.06

mmol/l

2.73

796

3598

Other local infections of skin and subcutaneous tissue

347

1589

2.28

42.31

6.3

3.4

25.12

25.22

mmol/l

0.20

340

1534

Familial hypercholesterolemia

521

2766

1.96

42.30

4.3

3.0

24.92

25.18

mmol/l

0.89

504

2688

Caries of enamel

1234

13274

0.66

42.26

3.6

3.5

25.11

25.25

mmol/l

0.88

1197

12852

Vitreous haemorrhage

373

1765

2.22

42.11

8.5

3.3

24.33

25.24

mmol/l

5.35

363

1709

Zoster [herpes zoster]

613

3429

1.85

42.08

4.4

3.3

25.28

25.21

mmol/l

0.20

602

3325

Symptoms and signs involving the nervous and musculoskeletal systems

1689

11922

1.44

42.00

3.7

3.5

25.46

25.18

mmol/l

2.83

1632

11585

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

935

5844

1.64

41.99

3.8

3.4

25.47

25.29

mmol/l

0.89

886

5676

Pneumonitis due to solids and liquids

349

1616

2.28

41.82

5.1

3.4

25.73

24.95

mmol/l

3.93

333

1565

Malignant neoplasm of digestive organs

1262

6630

1.54

41.64

3.5

3.3

24.62

25.31

mmol/l

8.61

1216

6425

Transport accidents

1232

7015

1.53

41.59

3.4

3.2

25.23

25.15

mmol/l

0.37

1194

6795

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

352

1636

2.26

41.56

5.8

3.3

25.22

25.26

mmol/l

0.07

342

1586

Dermatitis and eczema

3168

15133

1.31

41.33

4.0

3.4

25.19

25.22

mmol/l

0.20

3088

14643

Other and unspecified myopathies

345

1602

2.28

41.05

4.3

3.4

25.02

25.20

mmol/l

0.38

336

1552

Primary_lymphoid and hematopoietic malignant neoplasms

807

4907

1.70

40.99

4.3

3.5

24.95

25.14

mmol/l

0.83

789

4761

Congenital malformations, deformations and chromosomal abnormalities

1458

9572

1.47

40.72

5.1

3.4

25.12

25.19

mmol/l

0.35

1414

9265

Lumbar disc prolapse

1747

9502

1.43

40.66

3.3

3.4

25.23

25.20

mmol/l

0.15

1672

9229

Other viral diseases, not elsewhere classified

515

2743

1.93

40.61

6.2

3.4

25.38

25.13

mmol/l

0.93

493

2644

Coxarthrosis

1600

7356

1.46

40.51

3.5

3.2

25.30

25.23

mmol/l

0.32

1555

7157

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

500

2567

1.95

40.51

7.2

3.7

24.57

25.20

mmol/l

3.95

487

2478

Disorders of skin appendages

1231

8230

1.52

40.38

4.6

3.4

25.08

25.20

mmol/l

0.59

1204

7967

Viral pneumonia (known virus, not influenza)

138

410

3.75

40.04

8.2

3.6

25.48

25.04

mmol/l

0.56

130

400

Diabetic neuropathy

553

3065

1.91

39.83

6.7

4.1

24.98

24.99

mmol/l

0.02

538

2988

Other symptoms and signs involving the digestive system and abdomen

454

2343

1.99

39.69

4.9

2.9

25.28

25.33

mmol/l

0.11

439

2279

Diseases of the myoneural junction and muscle

429

2185

2.05

39.58

4.2

3.5

25.16

25.26

mmol/l

0.22

416

2115

Infective dermatitis

378

1837

2.14

39.56

4.3

3.4

25.19

25.25

mmol/l

0.12

371

1772

Hypothyroidism, strict autoimmune

1982

9456

1.40

39.31

3.6

3.0

25.18

25.21

mmol/l

0.15

1915

9180

Injuries to the shoulder and upper arm

2450

14886

1.34

39.12

3.9

3.5

25.20

25.25

mmol/l

0.31

2381

14431

Abnormal findings on examination of urine, without diagnosis

186

664

3.02

39.12

6.3

3.4

24.27

25.09

mmol/l

2.31

181

642

Diseases of the musculoskeletal system and connective tissue

1430

4854

1.49

39.08

3.8

3.2

25.16

25.09

mmol/l

0.27

1377

4694

Fracture of rib(s), sternum and thoracic spine

971

6243

1.59

38.97

4.1

3.5

25.41

25.12

mmol/l

1.88

944

6054

Other specified and unspecified personality disorders

255

1058

2.51

38.88

3.3

25.26

25.21

mmol/l

0.07

248

1022

Other diseases of anus and rectum

904

5704

1.62

38.75

3.8

3.2

25.19

25.23

mmol/l

0.13

886

5530

Cholangitis (primary sclerosing, PSC)

244

1002

2.58

38.61

5.3

3.2

24.34

25.12

mmol/l

2.80

237

969

Osteomyelitis

253

1060

2.54

38.38

8.9

3.3

24.59

25.04

mmol/l

1.16

247

1027

Diabetic retinopathy

1467

6363

1.49

38.28

5.9

3.6

24.69

25.09

mmol/l

3.73

1420

6203

Selective serotonin reuptake inhibitors

2862

11430

1.32

38.23

3.6

3.4

25.37

25.15

mmol/l

2.67

2768

11087

Phobic anxiety disorders

292

1296

2.31

37.67

4.7

3.2

25.61

25.20

mmol/l

1.16

281

1249

Gonarthrosis [arthrosis of knee](FG)

2211

9528

1.37

37.65

3.2

25.33

25.27

mmol/l

0.39

2143

9242

Acute gastritis

276

1214

2.39

37.29

4.6

3.0

25.10

25.27

mmol/l

0.36

265

1173

Other pleural conditions

394

1996

2.07

37.13

6.3

3.3

25.42

24.88

mmol/l

2.07

379

1929

Sleep disorders (combined)

3218

13190

1.29

36.84

3.6

3.4

25.34

25.19

mmol/l

1.56

3110

12779

Other respiratory diseases principally affecting the interstitium

635

3740

1.76

36.64

5.2

3.5

25.56

25.13

mmol/l

2.02

604

3627

Other symptoms and signs involving the nervous and musculoskeletal systems

1158

7819

1.51

36.60

3.6

3.5

25.57

25.17

mmol/l

3.47

1119

7587

Cholecystitis

482

2625

1.90

36.20

4.7

3.3

25.10

25.17

mmol/l

0.14

469

2538

Vascular syndromes of brain in cerebrovascular disorders

209

829

2.73

36.06

3.5

3.4

25.60

25.08

mmol/l

1.35

199

801

Hypothyroidism, other/unspecified

2464

12346

1.33

35.47

3.6

3.5

25.28

25.19

mmol/l

0.63

2370

12001

Rotator cuff syndrome

1796

9395

1.39

35.33

3.6

3.2

25.23

25.21

mmol/l

0.10

1735

9121

Use of disulfiram, acamprosate or naltrexone

274

1229

2.33

35.19

4.0

3.6

25.42

25.25

mmol/l

0.28

264

1189

Visual disturbances

1357

9522

1.45

35.14

4.5

3.4

25.24

mmol/l

0.01

1308

9247

Hypothyreosis and Thyroxine purchase for inclusion criteria

2549

12816

1.32

35.13

3.6

3.5

25.30

25.19

mmol/l

0.91

2452

12457

Diabetic retinopathy, strict definition

746

4094

1.68

35.08

7.8

3.6

24.61

25.05

mmol/l

2.50

717

3993

Endocarditis

144

473

3.27

35.06

8.9

2.8

24.40

24.85

mmol/l

0.70

139

456

Special screening examination for other diseases and disorders

314

1491

2.17

34.60

6.7

2.9

24.28

25.15

mmol/l

4.48

302

1441

Disorders of eyelid, lacrimal system and orbit

2425

14115

1.32

34.26

3.7

3.4

25.32

25.22

mmol/l

0.73

2357

13684

Other systemic involvement of connective tissue (FG)

750

4614

1.64

34.19

3.6

3.2

25.54

25.25

mmol/l

1.44

727

4482

Vascular diseases of the intestine

179

676

2.86

34.01

5.3

2.8

24.01

25.12

mmol/l

2.48

171

656

Maltreatment syndromes

148

499

3.10

33.97

3.6

3.4

24.90

25.16

mmol/l

0.41

142

485

Dermatophytosis

424

2267

1.94

33.85

4.2

3.4

25.11

25.20

mmol/l

0.21

413

2193

Acute pancreatitis (for exclusion)

634

3812

1.71

33.68

4.9

3.4

24.75

25.19

mmol/l

2.49

613

3688

Thyroiditis, ILD-related definition

313

1506

2.15

33.49

3.7

3.2

25.38

25.31

mmol/l

0.15

304

1455

Embedded and impacted teeth

537

2519

1.79

33.22

4.3

3.5

25.14

25.02

mmol/l

0.36

523

2420

Other viral diseases, not elsewhere classified

647

3892

1.69

33.10

5.6

3.5

25.25

25.14

mmol/l

0.37

617

3767

Unspecified misadventure during surgical and medical care

213

886

2.56

32.97

4.8

3.3

25.26

25.25

mmol/l

0.01

203

853

Nonorganic sleeping disorders

507

2875

1.80

32.95

3.7

3.5

25.07

25.20

mmol/l

0.37

486

2775

Visual disturbances and blindness

1465

10535

1.41

32.90

4.6

3.4

25.19

25.24

mmol/l

0.22

1415

10229

Pleural effusion

540

3139

1.78

32.75

5.2

3.3

25.51

24.98

mmol/l

2.69

526

3035

Other problems related to primary support group, including family circumstances

269

1194

2.25

32.63

6.7

3.4

24.97

25.13

mmol/l

0.37

264

1149

Assault

329

1627

2.08

32.55

4.3

3.7

24.93

25.10

mmol/l

0.36

318

1580

COPD-related respiratory insufficiency

427

2328

1.91

32.29

6.4

3.4

27.55

24.95

mmol/l

20.46

405

2257

Other diseases of pericardium

162

595

2.89

32.17

5.0

2.9

25.23

25.01

mmol/l

0.30

157

576

Myalgia

596

3558

1.71

32.16

3.6

3.1

25.57

25.16

mmol/l

2.29

580

3459

Status epilepticus

151

537

3.01

32.00

6.1

3.3

24.90

25.05

mmol/l

0.24

146

518

Psoriatic and enteropathic arthropathies

340

1719

2.04

31.85

4.3

3.3

25.55

25.28

mmol/l

0.77

335

1667

Cervicalgia

576

3424

1.72

31.74

3.7

3.3

25.42

25.13

mmol/l

1.43

553

3321

Lung diseases due to external agents

491

2808

1.81

31.52

4.7

3.5

25.72

25.07

mmol/l

3.93

471

2713

Parkinson's disease, excluding more controls

426

2195

1.89

31.23

3.6

3.2

25.56

24.95

mmol/l

3.10

404

2138

Fracture of femur

922

5579

1.53

30.95

4.1

3.4

25.37

25.16

mmol/l

0.85

901

5408

Migraine with aura

496

2841

1.77

30.90

3.0

3.2

25.20

mmol/l

0.00

479

2752

Other arthritis (FG)

838

5493

1.55

30.70

4.3

3.3

25.33

25.19

mmol/l

0.52

813

5336

Arthrosis

2042

8452

1.34

30.69

3.5

3.2

25.31

25.23

mmol/l

0.52

1971

8206

Any dementia, excluding more controls

1202

5781

1.46

30.56

3.5

3.3

25.36

25.11

mmol/l

1.64

1164

5627

Allergic contact dermatitis

346

1786

1.99

30.41

3.7

3.1

25.75

25.38

mmol/l

1.48

339

1726

Other diseases of biliary tract

304

1515

2.10

30.02

5.0

3.2

24.40

25.29

mmol/l

3.87

299

1471

Second line medication for Crohn's disease

1480

10819

1.39

30.01

4.7

3.4

25.22

25.26

mmol/l

0.20

1437

10481

Inflammatory bowel disease

812

5317

1.55

29.87

4.3

3.5

24.95

25.21

mmol/l

1.24

784

5150

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2719

13741

1.28

29.86

4.2

3.3

25.20

25.24

mmol/l

0.21

2649

13314

Aneurysms, operations, SAH

496

2888

1.77

29.75

3.6

3.3

25.26

25.24

mmol/l

0.06

484

2796

Idiopathic gout

352

1858

1.99

29.66

5.9

3.4

24.64

25.07

mmol/l

1.24

346

1799

L04AX Other immunosuppressants

1447

10571

1.39

29.49

4.8

3.4

25.24

25.25

mmol/l

0.04

1404

10241

Other diseases of liver

502

2939

1.75

29.42

4.0

3.3

24.71

25.31

mmol/l

3.28

491

2842

Benign neoplasm: Colon, unspecified

795

5217

1.56

29.40

5.1

3.4

25.02

25.15

mmol/l

0.49

775

5065

Benign neoplasm: Skin of other and unspecified parts of face

355

1880

1.96

29.33

4.3

3.3

25.30

25.25

mmol/l

0.08

346

1816

Cardiodefibrillation

1161

8190

1.45

29.33

4.1

3.6

25.37

25.12

mmol/l

1.86

1131

7956

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

592

3566

1.67

29.32

5.3

3.3

25.16

mmol/l

0.00

570

3440

Migraine without aura

375

2018

1.89

28.76

2.8

3.3

24.93

25.19

mmol/l

0.89

359

1949

Somnolence, stupor and coma

163

637

2.71

28.72

6.3

3.3

25.73

25.14

mmol/l

1.00

155

616

Agranulocytosis

338

1773

1.98

28.66

5.2

3.2

25.13

25.36

mmol/l

0.57

324

1713

Purpura and other haemorrhagic conditions

412

2301

1.85

28.62

5.5

3.5

24.80

25.21

mmol/l

1.70

402

2226

Hypopituitarism

217

964

2.35

28.61

4.9

4.1

24.82

25.14

mmol/l

0.69

204

937

Disorders of vitreous body and globe

1440

10154

1.38

28.58

4.9

3.3

25.19

25.30

mmol/l

0.60

1406

9872

Alcohol-induced chronic pancreatitis

223

1007

2.33

28.53

5.6

3.8

24.88

25.22

mmol/l

0.62

214

976

Nontraumatic intracranial haemmorrhage

651

4113

1.62

28.42

3.7

3.4

25.33

25.14

mmol/l

0.80

635

3993

Congenital malformations, deformations and chromosomal abnormalities

1541

10514

1.36

28.41

4.9

3.4

25.16

25.22

mmol/l

0.29

1493

10171

Arthropathies

2411

9501

1.30

28.40

3.9

3.3

25.19

25.18

mmol/l

0.05

2310

9208

Parkinson's disease, strict definition, excluding more controls

395

2077

1.87

28.21

3.6

3.2

25.62

24.93

mmol/l

3.67

374

2023

Intentional self-harm by sharp object

233

3.93

28.18

3.6

3.2

24.38

24.74

mmol/l

0.39

224

Familial hypercholesterolemia, with ischemic heart disease

328

1721

1.99

28.03

4.4

3.0

24.82

25.27

mmol/l

1.35

316

1672

Viral warts

273

1337

2.11

28.02

6.8

3.3

24.82

25.26

mmol/l

1.48

266

1294

Papulosquamous disorders

1066

7481

1.45

27.78

3.8

3.5

25.36

25.25

mmol/l

0.44

1049

7260

Urolithiasis

968

6681

1.48

27.76

4.0

3.6

24.96

25.10

mmol/l

0.62

947

6474

Other symptoms and signs involving the circulatory and respiratory systems

189

801

2.45

27.69

5.0

2.5

25.55

25.07

mmol/l

1.07

177

767

Polycystic ovarian syndrome, consortium definition

1578

6904

1.37

27.63

3.3

3.0

25.72

25.36

mmol/l

3.93

1541

6688

Corns and callosities

228

1052

2.27

27.63

6.1

3.1

25.03

25.29

mmol/l

0.47

218

1021

Disorders of vitreous body

1393

9887

1.38

27.54

4.7

3.4

25.22

25.31

mmol/l

0.43

1361

9613

755

4670

1.56

27.50

3.7

3.3

25.25

25.24

mmol/l

0.02

738

4540

Alzheimer’s disease (Atypical or mixed), excluding more controls

324

1342

2.00

27.19

3.0

3.2

25.42

24.91

mmol/l

1.98

308

1308

Benign neoplasm of other and ill-defined parts of digestive system

533

3250

1.69

26.99

3.8

3.4

25.23

25.26

mmol/l

0.07

519

3139

Coxarthrosis, primary

1806

11682

1.33

26.98

3.4

3.5

25.36

25.25

mmol/l

0.75

1763

11353

Acute and transient psychotic disorders

303

1560

2.00

26.96

3.5

3.4

25.79

25.24

mmol/l

1.55

289

1512

Other and unspecified nerve root and plexus disorders, also in other diseases

515

3111

1.69

26.80

3.7

3.5

25.61

25.25

mmol/l

1.49

477

3015

Special screening examination for infectious and parasitic diseases

1949

0.32

26.74

3.2

2.8

25.60

25.28

mmol/l

0.55

1876

Tubulo-interstitial nephritis, not specified as acute or chronic

218

1000

2.27

26.65

5.7

2.5

24.92

25.61

mmol/l

1.98

209

968

Dilated cardiomyopathy

401

2279

1.83

26.53

4.3

3.7

24.74

25.11

mmol/l

1.18

384

2202

Gonarthrosis

1859

8067

1.33

26.41

3.2

25.37

25.24

mmol/l

0.89

1801

7834

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

858

5042

1.50

26.41

3.3

3.0

25.27

25.45

mmol/l

0.77

828

4889

severe traumatic brain injury, does not include concussion

720

4739

1.56

26.28

3.9

3.6

25.30

25.06

mmol/l

1.07

702

4590

Psoriasis

757

5029

1.53

26.22

3.8

3.6

25.42

25.21

mmol/l

0.88

745

4871

Hyperkinetic disorders, excluding more controls

180

726

2.41

26.08

3.6

3.5

25.04

25.06

mmol/l

0.02

172

695

Paralytic ileus

151

600

2.68

25.87

6.0

3.0

25.17

25.14

mmol/l

0.02

145

583

Non-Hodgkin lymphoma, all, including Hilmo

429

2502

1.77

25.82

3.9

3.2

25.03

25.23

mmol/l

0.64

420

2410

Malignant neoplasm of bladder

278

1420

2.05

25.79

5.1

3.2

24.50

25.00

mmol/l

1.31

273

1367

Other viral hepatitis

170

711

2.48

25.70

4.5

3.5

24.90

25.27

mmol/l

0.71

164

692

Vitamin deficiency

163

672

2.55

25.67

4.2

3.2

24.67

25.18

mmol/l

0.99

155

647

Vitamin deficiency, wide

163

672

2.55

25.67

4.2

3.3

24.67

25.18

mmol/l

0.99

155

647

Dementia, including avohilmo

1479

7578

1.37

25.66

3.3

3.6

25.21

25.13

mmol/l

0.45

1439

7372

Other diseases of blood and blood-forming organs, wide

617

3942

1.60

25.66

4.9

3.5

25.06

25.22

mmol/l

0.55

595

3816

Mental retardation, excluding more controls

112

368

3.11

25.62

6.2

4.6

25.53

25.00

mmol/l

0.86

107

358

Degeneration of macula and posterior pole

1479

8802

1.36

25.55

4.0

3.4

25.08

25.26

mmol/l

1.17

1432

8560

Calculus of kidney and ureter

881

6073

1.48

25.49

4.0

3.6

25.02

25.10

mmol/l

0.32

863

5881

Other necrotizing vasculopathies

255

1269

2.11

25.49

6.8

3.1

24.96

25.31

mmol/l

0.95

247

1228

Total colectomy

143

560

2.70

25.14

6.5

3.2

24.35

25.24

mmol/l

1.81

138

545

Total colectomy operation

143

560

2.70

25.14

6.5

3.2

24.35

25.24

mmol/l

1.81

138

545

Arthropod-borne viral fevers and viral haemorrhagic fevers

295

1548

1.98

25.12

3.6

3.5

24.49

25.30

mmol/l

4.08

283

1495

Malignant neoplasm of bladder, including Hilmo

436

2562

1.75

25.02

4.6

3.3

24.51

25.07

mmol/l

2.38

425

2462

Other diseases of intestine

421

2461

1.76

24.98

5.7

3.4

24.48

25.21

mmol/l

3.45

403

2386

Oesophagitis

189

844

2.35

24.87

5.7

3.1

25.31

25.25

mmol/l

0.08

183

813

1003

6186

1.44

24.77

3.8

3.3

25.10

25.21

mmol/l

0.38

974

6017

Disorders of synovium and tendon

1351

8771

1.36

24.76

3.6

3.2

25.42

25.21

mmol/l

1.52

1299

8506

Any dementia

1308

6705

1.38

24.35

3.4

25.31

25.10

mmol/l

1.37

1267

6520

Soft tissue disorders related to use, overuse and pressure

734

4922

1.52

24.34

4.1

3.1

25.43

25.19

mmol/l

1.06

711

4787

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

252

1267

2.08

24.32

3.4

3.3

25.49

25.19

mmol/l

0.74

245

1221

Injuries to the ankle and foot

1685

11490

1.32

24.27

4.4

3.4

25.27

25.20

mmol/l

0.40

1635

11110

Disturbances of skin sensation

645

4208

1.56

24.23

3.6

3.2

25.44

25.27

mmol/l

0.64

623

4067

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

367

1832

1.81

24.21

4.0

4.3

24.95

24.86

mmol/l

0.20

355

1765

Immunodeficiencies

154

636

2.55

24.19

5.6

3.5

25.10

25.26

mmol/l

0.21

148

613

Hepatic failure, not elsewhere classified

147

597

2.63

24.16

5.9

3.0

23.97

25.13

mmol/l

3.23

137

575

Other specified/unspecified arthritis

717

4796

1.52

24.03

4.3

3.3

25.35

25.19

mmol/l

0.53

695

4670

Chronic gastritis

802

5493

1.49

24.01

4.0

3.2

25.19

25.22

mmol/l

0.07

779

5317

Other necrotizing vasculopathies (FG)

219

1054

2.18

24.00

6.1

3.1

24.93

25.26

mmol/l

0.76

213

1025

Other condition

391

2266

1.77

23.90

4.5

3.4

25.35

25.25

mmol/l

0.21

378

2185

Viral haemorrhagic fevers, not elsewhere classified/unspecified

243

1214

2.08

23.89

3.6

3.4

24.38

25.25

mmol/l

3.98

237

1170

Other systemic involvement of connective tissue

760

5160

1.50

23.77

3.6

3.3

25.54

25.26

mmol/l

1.43

737

5002

Left ventricular outflow tract obstruction (LVOTO), broad definition

286

1512

1.96

23.75

6.6

3.9

25.05

25.23

mmol/l

0.38

281

1465

DVT of lower extremities

583

3749

1.59

23.71

4.6

3.3

25.28

25.17

mmol/l

0.31

573

3642

Ulcerative colitis

613

3979

1.57

23.64

4.4

3.4

24.83

25.20

mmol/l

1.78

588

3852

Exclusions for E4_PCOS_CONSORTIUM

1676

8023

1.32

23.58

3.6

3.3

25.32

25.34

mmol/l

0.06

1626

7772

ILD, hospital admissions

495

3077

1.66

23.44

4.6

3.4

25.62

25.14

mmol/l

1.98

470

2985

Cervical disc disorders

951

6744

1.43

23.44

3.4

25.34

25.15

mmol/l

1.04

918

6558

Crohn disease

326

1803

1.85

23.31

4.8

3.4

25.16

25.27

mmol/l

0.24

319

1743

Other interstitial pulmonary diseases

504

3152

1.65

23.28

4.7

3.4

25.62

25.13

mmol/l

2.12

479

3060

Diabetic maculopathy

527

3151

1.65

23.18

6.6

3.6

24.59

25.05

mmol/l

1.92

507

3077

Interstitial lung disease endpoints

504

3156

1.65

23.16

4.7

3.4

25.62

25.14

mmol/l

2.10

479

3063

Interstitial lung disease

504

3156

1.65

23.16

4.7

3.4

25.62

25.14

mmol/l

2.10

479

3063

Pregnancy hypertension

743

4499

1.50

23.03

3.3

2.9

25.26

25.43

mmol/l

0.71

718

4354

Injuries to the knee and lower leg

3230

14799

1.22

22.99

3.7

3.4

25.36

25.19

mmol/l

2.06

3120

14347

Other diseases of arteries and capillaries

279

1482

1.95

22.93

5.7

3.1

24.87

25.29

mmol/l

1.22

271

1436

Other mental disorders due to brain damage and dysfunction and to physical disease

389

2291

1.76

22.75

3.3

3.5

25.26

25.14

mmol/l

0.27

378

2223

Disorders of psychological development

263

1261

1.98

22.75

4.4

4.3

24.88

24.87

mmol/l

0.01

255

1208

Benign neoplasm of other and unspecified endocrine glands

373

2169

1.77

22.66

4.9

3.3

25.16

25.30

mmol/l

0.36

358

2102

Fracture of lower leg, including ankle

1462

11036

1.33

22.52

3.9

3.4

25.58

25.25

mmol/l

2.75

1407

10711

Cardiac murmurs and other cardiac sounds

220

1065

2.09

22.49

5.9

3.1

24.94

25.02

mmol/l

0.13

202

1024

Coagulation defects, purpura and other haemorrhagic conditions

527

3356

1.61

22.30

5.5

3.4

24.88

25.22

mmol/l

1.58

511

3249

Arterial embolism and thrombosis

214

1050

2.13

22.24

6.3

3.0

24.75

25.06

mmol/l

0.61

205

1016

Colectomy operation

518

3296

1.61

22.18

4.8

3.5

24.70

25.18

mmol/l

2.13

503

3196

Fracture of lumbar spine and pelvis

686

4630

1.51

22.11

3.9

3.4

25.40

25.23

mmol/l

0.63

662

4489

Primary hyperparathyroidism

326

1842

1.83

22.01

4.9

3.1

25.10

25.46

mmol/l

0.97

312

1799

Secondary uncertain malignant neoplasm

413

2492

1.71

21.96

3.7

3.2

25.19

25.20

mmol/l

0.01

406

2402

Benign neoplasm: Sigmoid colon

572

3732

1.57

21.92

4.4

3.6

24.96

25.19

mmol/l

0.83

563

3625

Disorders of sclera, cornea, iris and ciliary body

1409

10736

1.33

21.91

4.6

3.3

25.17

25.24

mmol/l

0.32

1366

10412

Irregular menses

890

4947

1.44

21.90

3.7

2.9

25.50

25.27

mmol/l

1.36

872

4783

Pruritus

300

1652

1.87

21.89

5.4

3.0

25.26

25.35

mmol/l

0.18

294

1595

Alcohol withdrawal state with delirium

227

1145

2.07

21.87

4.9

3.8

25.27

25.18

mmol/l

0.11

217

1115

Outcome of delivery

950

0.20

21.82

1.9

3.1

26.05

25.18

mmol/l

0.63

916

ILD, hospital admissions 1, main diag only

445

2745

1.67

21.82

4.4

3.4

25.59

25.17

mmol/l

1.51

427

2656

Ovarian cyst

802

3166

1.48

21.80

3.4

3.0

25.31

25.37

mmol/l

0.22

775

3079

Mixed and other personality disorders

188

880

2.20

21.77

3.5

25.57

25.24

mmol/l

0.60

183

851

Asthma and allergy, excluding more controls

228

1127

2.03

21.72

2.6

2.7

25.46

25.12

mmol/l

0.94

223

1087

Alzheimer disease, excluding more controls

529

2203

1.62

21.63

3.1

3.2

25.51

24.93

mmol/l

3.32

510

2149

Viral hepatitis

188

885

2.20

21.54

4.6

3.5

24.87

25.21

mmol/l

0.69

182

856

Herpesviral [herpes simplex] infections

306

1704

1.85

21.52

4.9

3.2

25.04

25.21

mmol/l

0.38

298

1646

Gonarthrosis,primary

2552

12809

1.24

21.28

3.1

3.5

25.39

25.24

mmol/l

1.45

2482

12426

Heartburn

272

1464

1.91

21.27

4.1

3.0

25.37

25.28

mmol/l

0.18

266

1417

Superficial injury of hip and thigh

447

2772

1.65

21.22

4.5

3.4

25.44

25.15

mmol/l

0.93

437

2684

Hypothyroidism, strict autoimmune, 3 medication purchases required

2175

11779

1.26

21.19

3.4

25.23

25.21

mmol/l

0.11

2102

11445

Pyogenic arthritis

225

1145

2.05

21.09

5.5

3.5

25.00

25.10

mmol/l

0.15

216

1113

Emphysema

242

1265

1.99

21.00

4.7

3.4

25.39

24.85

mmol/l

1.24

235

1228

Secondary right heart disease

162

732

2.35

21.00

5.2

3.1

26.02

25.08

mmol/l

1.78

155

709

Superficial injury of lower leg

626

4193

1.52

20.92

4.1

3.4

25.40

25.17

mmol/l

0.88

614

4080

Viral infections characterized by skin and mucous membrane lesions

2246

15531

1.25

20.90

4.0

3.4

25.12

25.24

mmol/l

1.00

2196

15036

Other sleep disorders

301

1684

1.84

20.85

4.4

3.4

25.45

25.00

mmol/l

1.54

286

1625

Myocardial infarction, with ST-elevation

576

3811

1.55

20.74

4.5

3.6

25.07

25.04

mmol/l

0.07

561

3687

Dementia

1371

7182

1.33

20.68

3.3

3.5

25.27

25.13

mmol/l

0.79

1334

6985

Haemorrhoids and perianal venous thrombosis

863

6143

1.42

20.64

3.5

3.1

25.17

25.26

mmol/l

0.34

836

5959

Cerebral aneurysm, nonruptured

251

1335

1.95

20.58

3.7

3.2

25.26

25.40

mmol/l

0.35

246

1285

Other pulmonary heart/vessel disease

174

819

2.24

20.37

5.2

3.2

25.94

25.04

mmol/l

1.71

167

795

Chronic viral hepatitis

135

567

2.47

20.33

4.8

3.7

24.87

25.23

mmol/l

0.54

129

552

Nail disorders

227

1173

2.00

20.24

5.6

3.3

25.19

25.30

mmol/l

0.19

221

1132

Other symptoms and signs involving general sensations and perceptions

139

596

2.45

20.22

4.2

3.2

25.42

25.29

mmol/l

0.15

133

576

Migraine with aura and triptan purchases

293

1639

1.82

20.08

3.0

3.3

25.24

25.26

mmol/l

0.04

284

1575

Gastrojejunal ulcer

177

3.94

20.05

4.5

2.9

24.06

25.07

mmol/l

1.26

172

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

664

9324

0.69

20.02

3.1

3.3

25.33

25.30

mmol/l

0.10

650

9026

Alcoholic liver disease

310

1778

1.80

19.96

4.4

3.5

24.12

25.16

mmol/l

4.35

296

1726

Asthma and allergy

228

1162

1.97

19.95

2.6

2.8

25.46

25.12

mmol/l

0.94

223

1119

Other embolism and thrombosis

383

2327

1.69

19.84

5.0

3.3

24.88

25.17

mmol/l

0.87

368

2259

Superficial injury of abdomen, lower back and pelvis

393

2406

1.67

19.61

4.2

3.4

25.32

25.20

mmol/l

0.28

381

2328

Benign neoplasm: Ascending colon

421

2633

1.65

19.53

4.4

3.4

24.89

25.21

mmol/l

1.17

413

2551

Adverse effects, not elsewhere classified

444

2801

1.61

19.50

4.5

3.3

25.13

25.25

mmol/l

0.37

434

2707

Examination and encounter for administrative purposes

150

674

2.32

19.48

3.3

3.1

24.95

24.94

mmol/l

0.01

141

651

Injuries to the neck

543

3585

1.54

19.48

3.7

3.5

25.45

25.16

mmol/l

1.40

525

3463

Seborrhoeic keratosis

644

4416

1.49

19.39

4.1

3.2

25.17

25.23

mmol/l

0.18

623

4294

Follow-up examination after treatment for conditions other than malignant neoplasms

1000

4843

1.38

19.16

3.7

2.9

25.20

25.26

mmol/l

0.20

976

4695

Other factor of the environment

178

3.86

19.13

7.4

3.3

25.35

24.83

mmol/l

0.61

173

Deforming dorsopathies

676

4680

1.47

19.12

3.8

3.4

25.58

25.17

mmol/l

2.19

651

4548

Iridocyclitis

582

3921

1.51

19.03

5.0

3.3

25.08

25.23

mmol/l

0.48

561

3800

Lesion of ulnar nerve

361

2182

1.69

19.00

4.1

3.4

25.16

25.18

mmol/l

0.04

347

2108

Other disorders of nervous system

203

1036

2.04

18.94

4.2

3.4

25.51

25.28

mmol/l

0.33

197

1004

Abnormal serum enzyme levels

911

6496

1.39

18.92

4.3

3.6

24.98

25.08

mmol/l

0.34

882

6304

Contact with and exposure to communicable diseases

220

4040

0.54

18.89

3.9

3.5

24.65

25.11

mmol/l

0.84

176

3896

Superficial injury of thorax

408

2550

1.64

18.81

4.3

3.5

25.47

25.17

mmol/l

1.12

397

2469

Injuries to the wrist and hand

2591

14856

1.22

18.76

3.9

3.4

25.21

25.22

mmol/l

0.09

2516

14391

Psoriasis vulgaris

480

3116

1.57

18.75

3.8

3.5

25.55

25.22

mmol/l

1.20

472

3005

Osteoporosis with pathological fracture (FG)

246

1347

1.90

18.66

4.4

2.9

26.12

25.39

mmol/l

2.30

239

1316

Anterior Iridocyclitis

518

3425

1.54

18.58

5.1

3.3

25.11

25.24

mmol/l

0.34

501

3316

Intracerebral haemorrhage

404

2535

1.64

18.46

3.8

3.3

25.49

25.17

mmol/l

1.32

395

2461

Excessive, frequent and irregular menstruation

846

3302

1.42

18.44

3.5

3.0

25.62

25.35

mmol/l

1.49

826

3205

Allergic conjunctivitis

722

9864

0.71

18.40

3.1

3.4

25.31

25.30

mmol/l

0.04

707

9552

Suppurative and necrotic conditions of lower respiratory tract

188

947

2.08

18.32

5.2

3.4

25.61

25.11

mmol/l

0.97

183

912

Polyuria

629

4345

1.48

18.22

4.2

3.3

25.45

25.17

mmol/l

1.36

614

4222

Other spirochaetal diseases

340

5509

0.61

18.11

2.6

3.5

25.20

25.27

mmol/l

0.18

335

5341

Complications of internal orthopaedic prosthetic devices, implants and grafts

653

4552

1.46

18.06

3.9

3.2

25.25

mmol/l

0.02

634

4410

Malnutrition

316

2.97

18.05

5.1

4.0

25.34

25.16

mmol/l

0.17

308

Artificial opening status

171

836

2.14

18.04

5.7

2.8

24.63

25.07

mmol/l

0.71

163

803

Other and unspecified tonsillitis

661

3851

1.46

18.01

4.1

3.4

25.04

25.13

mmol/l

0.30

633

3709

Spirochaetal infections, other/unspecified

340

5498

0.61

17.97

2.5

3.5

25.16

25.27

mmol/l

0.32

335

5329

Seborrhoeic dermatitis

273

1556

1.81

17.94

4.0

3.4

25.27

25.23

mmol/l

0.06

266

1503

Persistent mood disorders

452

2923

1.57

17.89

4.2

3.2

25.30

25.25

mmol/l

0.09

431

2844

Diseases of male genital organs

1473

5779

1.30

17.84

4.6

3.6

25.06

25.04

mmol/l

0.09

1411

5611

Assault by bodily force

177

876

2.07

17.78

4.4

3.6

24.66

25.28

mmol/l

1.56

169

852

Umbilical hernia

720

5118

1.43

17.76

5.3

3.4

25.31

25.17

mmol/l

0.53

706

4965

Disorders of ocular muscles, binocular movement, accommodation and refraction

1076

8071

1.34

17.63

4.5

3.5

25.28

25.20

mmol/l

0.39

1048

7814

Use of biperiden

158

756

2.18

17.61

3.4

3.3

25.94

25.33

mmol/l

1.06

153

732

Lifestyle-related condition

169

3.81

17.56

7.1

3.3

25.49

24.85

mmol/l

0.73

164

Phlebitis and thrombophlebitis (not including DVT)

605

4177

1.48

17.55

4.9

3.3

25.28

25.22

mmol/l

0.17

593

4054

Other arthrosis

1427

7726

1.29

17.53

3.5

3.2

25.36

25.26

mmol/l

0.50

1380

7510

Other spirochaetal diseases

351

5584

0.62

17.30

2.6

3.5

25.20

25.27

mmol/l

0.19

345

5411

Superficial injury of wrist and hand

443

2874

1.57

17.26

4.1

3.4

25.23

25.22

mmol/l

0.03

429

2777

Fracture of skull and facial bones

521

3501

1.51

17.26

4.3

3.6

25.27

25.18

mmol/l

0.22

505

3383

Other noninflammatory disorders of uterus, except cervix

572

2614

1.50

17.09

3.3

3.1

25.69

25.53

mmol/l

0.49

557

2555

Acute and subacute iridocyclitis

483

3208

1.53

17.01

5.1

3.2

25.18

25.23

mmol/l

0.11

468

3109

Generalized anxiety disorder

284

1655

1.74

16.96

3.0

3.1

25.17

25.24

mmol/l

0.12

279

1591

Pulmonary oedema

306

2.94

16.81

7.2

3.2

24.57

25.03

mmol/l

0.41

297

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

759

5459

1.40

16.79

3.7

3.5

25.37

25.21

mmol/l

0.71

739

5267

Orchitis and epididymitis

282

1655

1.76

16.77

5.1

3.6

25.18

24.97

mmol/l

0.41

270

1604

Appendectomy

1508

11466

1.27

16.71

3.4

25.16

25.24

mmol/l

0.44

1469

11094

Diplopia

356

2221

1.64

16.65

4.8

3.3

25.18

25.28

mmol/l

0.25

342

2152

Disorders of vestibular function (Vertigo)

1253

9605

1.30

16.64

3.5

3.4

25.58

25.29

mmol/l

2.55

1227

9323

Other follicular disorders

175

888

2.03

16.49

4.9

3.5

24.90

25.16

mmol/l

0.50

175

859

Drug-induced neutropenia

204

1096

1.93

16.39

4.3

3.2

25.16

25.39

mmol/l

0.40

199

1065

Congenital malformations of heart and great arteries

308

1799

1.70

16.37

4.8

3.9

25.50

25.12

mmol/l

1.11

301

1740

Diaphragmatic hernia

980

7415

1.34

16.33

3.8

3.3

25.00

25.30

mmol/l

2.12

955

7207

Other disorders of bone

453

2995

1.54

16.26

3.8

3.2

25.10

25.27

mmol/l

0.54

433

2897

Urticaria and erythema

807

5926

1.38

16.25

3.8

3.5

25.41

25.20

mmol/l

1.04

787

5747

Retinal vascular occlusion

380

2428

1.61

16.23

4.2

3.3

25.11

25.18

mmol/l

0.15

367

2356

Disorders of muscles

263

1526

1.77

16.20

4.9

3.3

24.95

25.15

mmol/l

0.46

256

1480

Redundant prepuce, phimosis and paraphimosis

541

3675

1.48

16.19

5.0

3.7

25.07

25.06

mmol/l

0.05

525

3562

Open wound of lower leg

407

2636

1.58

16.18

4.5

3.4

25.31

25.19

mmol/l

0.25

394

2562

Pre-eclampsia

350

2184

1.63

16.11

3.9

3.0

25.18

25.48

mmol/l

0.88

341

2109

Hyperplasia of prostate

1091

4712

1.33

16.08

4.4

3.6

25.11

24.98

mmol/l

0.57

1042

4589

Colorectal cancer

691

4861

1.42

16.02

3.5

3.3

24.58

25.25

mmol/l

4.69

667

4710

Radiculopathy

440

2907

1.54

15.96

3.4

25.31

25.05

mmol/l

0.87

429

2820

Sarcoidosis

342

2135

1.64

15.96

4.0

3.3

25.10

25.34

mmol/l

0.66

324

2070

Benign neoplasm: Adrenal gland

226

1265

1.85

15.96

3.7

3.2

25.41

25.36

mmol/l

0.08

219

1227

Reimbursement for rheumatic diseases

1424

11279

1.27

15.95

3.9

3.4

25.39

25.27

mmol/l

0.67

1377

10943

Foreign body in alimentary tract

165

834

2.06

15.91

3.4

3.7

25.23

25.01

mmol/l

0.32

160

805

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

720

5221

1.40

15.80

3.7

3.6

25.14

25.19

mmol/l

0.17

696

5050

Non-follicular lymphoma

291

1754

1.71

15.79

4.0

3.5

25.07

25.19

mmol/l

0.25

285

1699

Injuries to the elbow and forearm

1756

12559

1.24

15.74

3.8

3.4

25.36

25.26

mmol/l

0.71

1704

12175

Malignant neoplasm of pancreas, including Hilmo

272

1616

1.74

15.60

3.6

3.0

24.89

25.21

mmol/l

0.68

262

1557

Pure hyperglyceridaemia

301

2.82

15.47

4.3

2.5

25.14

25.21

mmol/l

0.06

290

Childhood asthma (age<16), excluding more controls

182

739

1.96

15.46

3.2

2.8

24.81

24.94

mmol/l

0.24

177

710

Retinal vascular disorders

383

2481

1.59

15.41

4.2

3.3

25.10

25.17

mmol/l

0.15

370

2408

Vascular dementia

326

1962

1.65

15.33

4.3

3.5

25.37

24.92

mmol/l

1.53

314

1902

Periodontitis

2545

14344

1.19

15.22

4.0

3.4

25.05

25.31

mmol/l

3.39

2456

13924

Acute suppurative otitis media

489

3098

1.49

15.16

5.7

3.4

24.86

25.08

mmol/l

0.83

476

2976

Ulcerative colitis, NAS

329

2063

1.63

15.02

4.9

3.4

24.51

25.28

mmol/l

3.26

316

1996

Pedal cyclist injured in other and unspecified transport accidents

279

1681

1.70

15.00

4.5

3.4

25.49

25.22

mmol/l

0.61

271

1624

Chronic periodontitis, including avohilmo

2536

14341

1.19

14.98

4.0

3.4

25.05

25.31

mmol/l

3.52

2447

13924

Diseases of inner ear

1442

11196

1.26

14.94

3.5

3.4

25.50

25.27

mmol/l

1.87

1409

10870

Fracture of shoulder and upper arm

942

7170

1.33

14.91

4.2

3.5

25.36

25.28

mmol/l

0.29

914

6956

Mental retardation

112

497

2.33

14.85

6.2

5.0

25.53

24.80

mmol/l

1.44

107

480

Pyothorax

145

722

2.10

14.73

5.4

3.4

25.75

25.14

mmol/l

1.20

140

698

Follicular cysts of skin and subcutaneous tissue

452

3059

1.50

14.62

4.6

3.4

25.19

25.22

mmol/l

0.07

440

2958

Nontoxic multinodular goitre

514

3572

1.47

14.54

3.4

3.1

25.76

25.37

mmol/l

2.06

493

3476

Other and unspecified mood [affective] disorders

135

652

2.11

14.52

3.5

3.0

24.73

25.20

mmol/l

0.84

129

635

Extrapyramidal and movement disorders

1031

7988

1.31

14.52

4.0

3.4

25.44

25.20

mmol/l

1.55

990

7753

Pre-eclampsia or eclampsia

370

2402

1.56

14.42

3.9

3.0

25.23

25.49

mmol/l

0.77

359

2326

Subarachnoid haemorrhage

295

1825

1.66

14.41

3.4

3.3

25.33

25.24

mmol/l

0.18

288

1764

Childhood asthma (age<16)

182

758

1.91

14.41

3.2

2.9

24.81

24.95

mmol/l

0.26

177

729

Rheumatoid arthritis

824

5548

1.35

14.30

3.8

3.2

25.32

25.24

mmol/l

0.26

801

5404

Car occupant injured in other and unspecified transport accidents

416

2780

1.52

14.25

3.0

3.5

25.39

25.21

mmol/l

0.52

402

2681

Other and unspecified visual disturbances

266

1607

1.70

14.24

4.7

3.3

25.42

25.35

mmol/l

0.15

259

1554

malignant neoplasm of female genital organs

389

2555

1.55

14.21

3.1

3.0

25.36

25.64

mmol/l

0.88

381

2481

Speech disturbances, not elsewhere classified

267

1620

1.70

14.15

4.4

3.3

25.25

25.24

mmol/l

0.01

258

1567

Dislocation, sprain and strain of joints and ligaments at neck level

308

1929

1.62

14.11

3.4

3.3

25.37

25.25

mmol/l

0.30

299

1861

Abnormal results of function studies

223

1290

1.77

14.00

6.3

3.5

25.07

25.23

mmol/l

0.25

217

1247

Idiopathic pulmonary fibrosis

258

1560

1.71

13.98

4.6

3.3

25.75

25.02

mmol/l

2.21

245

1515

Disorders of lacrimal system

1047

8142

1.30

13.97

4.0

3.3

25.29

25.31

mmol/l

0.06

1016

7889

Nontoxic goitre/thyroid nodule

735

5463

1.37

13.93

3.4

3.2

25.55

25.36

mmol/l

0.90

712

5310

Vascular dementia (undefined)

157

813

1.99

13.81

4.6

3.3

25.43

25.05

mmol/l

0.76

148

782

Strabismus

598

4293

1.41

13.78

4.4

3.6

25.25

25.14

mmol/l

0.32

582

4156

Cyst of kidney

220

1279

1.78

13.76

5.7

3.3

24.97

25.20

mmol/l

0.48

214

1241

Amputation of thigh

117

553

2.24

13.76

6.5

3.2

24.18

25.14

mmol/l

2.13

112

537

Zoster [herpes zoster]

1297

10236

1.26

13.69

3.7

3.3

25.29

25.28

mmol/l

0.04

1265

9933

Open wound of forearm

252

1518

1.70

13.65

3.5

3.3

25.20

25.18

mmol/l

0.03

240

1470

Attention to artificial openings

126

613

2.15

13.61

5.6

2.6

25.30

25.03

mmol/l

0.37

117

589

Open wound of wrist and hand

1052

8045

1.29

13.56

3.9

3.5

25.04

25.16

mmol/l

0.55

1027

7786

Trigger finger

338

2189

1.57

13.49

3.8

3.2

25.41

25.24

mmol/l

0.45

329

2131

!Aliquae complicationes praecoces traumatis

128

629

2.12

13.42

5.1

3.4

25.32

25.14

mmol/l

0.21

122

607

Early complications of trauma

128

629

2.12

13.42

5.1

3.4

25.32

25.14

mmol/l

0.21

122

607

Malignant neoplasm of pancreas

218

1277

1.77

13.28

3.6

2.9

24.55

25.22

mmol/l

1.89

208

1227

Dental operations

1830

7759

1.22

13.26

3.8

3.3

25.24

25.22

mmol/l

0.09

1765

7542

Conjunctivitis (acute, non atopic)

631

4598

1.38

13.20

4.0

3.6

25.34

25.16

mmol/l

0.63

616

4456

Coxarthrosis, primary, with hip surgery

1332

10070

1.25

13.16

3.3

3.5

25.28

25.24

mmol/l

0.17

1296

9793

Pain associated with micturition

289

1818

1.62

13.15

4.2

3.1

25.83

25.24

mmol/l

2.11

279

1764

IBD patients in KELA-register

492

3451

1.44

13.15

4.2

3.5

24.74

25.24

mmol/l

2.34

476

3338

Other aneurysm

174

957

1.89

13.15

4.8

2.9

24.77

25.04

mmol/l

0.48

167

925

Gestational [pregnancy-induced] hypertension

397

2663

1.50

13.13

2.9

3.0

25.20

25.37

mmol/l

0.42

380

2568

Other disorders of conjunctiva

389

2618

1.52

13.11

4.4

3.4

25.48

25.22

mmol/l

0.84

373

2543

Neuromuscular dysfunction of bladder

245

1483

1.70

13.08

3.9

3.1

25.77

25.21

mmol/l

1.55

229

1433

Spondyloarthritis

432

2965

1.48

13.02

4.4

3.4

25.56

25.20

mmol/l

1.25

420

2862

Other benign neoplasms of skin

966

7530

1.30

13.02

4.1

3.4

25.25

25.21

mmol/l

0.13

938

7299

Mental retardation, wide definition

117

564

2.14

12.69

6.0

4.8

25.51

24.91

mmol/l

1.10

112

546

Crohn's disease NAS

156

836

1.92

12.65

4.6

3.4

24.84

25.32

mmol/l

0.87

150

807

Suppurative and unspecified otitis media

714

4732

1.35

12.65

4.9

3.4

24.98

25.10

mmol/l

0.43

694

4565

Arthropathies in other diseases classified elsewhere

113

544

2.17

12.58

10.0

3.3

24.85

25.08

mmol/l

0.26

108

534

Aortic aneurysm

663

4841

1.37

12.54

4.1

3.3

24.95

25.15

mmol/l

0.75

644

4700

Later onset COPD

896

5532

1.31

12.45

4.8

3.4

25.87

24.91

mmol/l

10.21

864

5376

Malignant neoplasm of urinary organs

291

1866

1.60

12.38

5.2

3.1

24.21

25.22

mmol/l

5.60

284

1795

Diabetes mellitus in pregnancy

434

1898

1.48

12.33

3.6

3.0

24.91

25.27

mmol/l

1.36

414

1823

Abnormal involuntary movements

339

2245

1.54

12.33

4.0

3.5

25.31

25.18

mmol/l

0.32

327

2173

Lung cancer and mesothelioma

492

2986

1.43

12.29

4.0

2.8

25.94

24.80

mmol/l

9.89

485

2911

Congenital malformations of the circulatory system

322

2049

1.55

12.12

4.8

3.9

25.38

25.12

mmol/l

0.69

316

1979

Oesophageal varices

131

676

2.02

12.11

6.3

3.3

23.60

25.06

mmol/l

4.06

125

651

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

304

1979

1.58

12.10

5.0

3.2

24.48

25.23

mmol/l

3.42

296

1904

Malignant neoplasm of colon

434

3033

1.46

12.09

3.6

3.2

24.56

25.21

mmol/l

3.17

424

2932

Other diseases of oesophagus

262

1647

1.63

12.06

4.0

3.2

25.51

25.20

mmol/l

0.80

253

1590

Artrosis, including avohilmo

2194

10176

1.19

12.05

3.2

3.6

25.33

25.20

mmol/l

1.00

2117

9865

Use of pramipexole

576

4229

1.38

11.96

4.6

3.4

25.34

25.21

mmol/l

0.40

553

4109

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

160

886

1.88

11.94

4.9

2.9

25.83

25.20

mmol/l

1.07

155

851

Pre-eclampsia or poor fetal growth

469

3305

1.43

11.93

3.6

2.9

25.24

25.36

mmol/l

0.32

453

3195

Migraine without aura and triptan purchases

265

1669

1.61

11.88

2.7

3.4

25.04

25.32

mmol/l

0.89

255

1613

Pain in joint

1245

6392

1.25

11.85

4.0

3.2

25.17

25.14

mmol/l

0.12

1200

6173

Superficial injury of forearm

222

1343

1.69

11.84

4.8

3.2

25.31

25.22

mmol/l

0.15

214

1296

Non-Hodgkin lymphoma, all

146

788

1.93

11.82

4.6

2.8

25.00

25.13

mmol/l

0.17

141

759

Polyarthrosis

541

3651

1.40

11.82

3.6

3.3

25.72

25.31

mmol/l

2.08

532

3562

Other bursopathies

331

2202

1.53

11.79

4.2

3.3

25.33

25.16

mmol/l

0.39

323

2141

Benign paroxysmal vertigo

744

5683

1.33

11.78

3.4

25.67

25.28

mmol/l

2.78

731

5512

Missing teeth due to accident, extraction or parodontitis

1563

12230

1.21

11.75

3.8

3.5

25.39

25.27

mmol/l

0.73

1509

11896

Melanocytic naevi

655

4912

1.35

11.72

4.7

3.4

25.07

25.22

mmol/l

0.60

634

4754

Coeliac disease

277

1774

1.59

11.71

4.9

3.2

25.24

25.33

mmol/l

0.17

268

1707

Other and unspecified follicular disorders

106

513

2.14

11.61

5.0

3.1

24.85

25.18

mmol/l

0.50

106

495

Other joint disorders

2121

9479

1.19

11.55

3.7

3.3

25.16

25.18

mmol/l

0.09

2034

9186

Persons with potential health hazards related to communicable diseases

379

5414

0.69

11.55

9.1

3.5

24.44

25.15

mmol/l

2.83

321

5238

Fracture of foot, except ankle

516

3739

1.40

11.51

4.9

3.5

25.18

25.23

mmol/l

0.13

495

3615

Cervicocranial syndrome

246

1539

1.63

11.49

2.9

3.3

25.58

25.20

mmol/l

1.22

240

1489

Adhesive capsulitis of shoulder

401

2785

1.46

11.47

4.1

3.2

25.15

25.20

mmol/l

0.10

386

2709

Need for immunization against other single infectious diseases

16.36

11.47

31.9

3.2

23.27

23.45

mmol/l

0.07

ILD-related respiratory insufficiency

120

615

2.06

11.45

7.1

3.1

26.36

25.16

mmol/l

1.86

107

595

Inflammatory bowel disease, strict (require KELA)

492

3545

1.41

11.37

4.2

3.5

24.74

25.21

mmol/l

2.11

476

3429

Olecranon bursitis

178

1030

1.78

11.35

5.3

3.5

25.22

25.12

mmol/l

0.13

173

1000

Cerebral palsy and other paralytic syndromes

279

1805

1.58

11.33

4.8

3.6

25.65

25.22

mmol/l

1.17

270

1748

Generalized epilepsy

103

498

2.13

11.28

4.3

4.0

24.85

25.20

mmol/l

0.44

484

Hydrocephalus

225

1390

1.67

11.25

3.1

3.3

24.93

25.18

mmol/l

0.54

220

1346

Benign neoplasm: Stomach

268

1726

1.59

11.22

3.3

3.2

25.05

25.35

mmol/l

0.87

261

1674

Spondylolisthesis/Spondylolysis

421

2965

1.44

11.16

3.4

25.38

25.14

mmol/l

0.73

404

2881

Keratitis

834

6515

1.29

11.09

4.4

3.4

25.15

25.23

mmol/l

0.27

813

6327

Fall on same level involving ice and snow

1387

11462

1.22

11.07

3.7

3.4

25.42

25.25

mmol/l

1.25

1348

11116

Paracetamol or NSAID medication

437

1529

1.45

11.00

3.7

3.5

25.14

25.08

mmol/l

0.11

422

1486

Oxicams

767

3337

1.32

10.98

3.1

4.2

25.14

24.96

mmol/l

0.71

747

3235

Appendicitis, broad definition

1740

13267

1.19

10.98

3.4

3.5

25.20

25.21

mmol/l

0.05

1689

12849

Mandibular retrognathia

134

714

1.91

10.97

2.7

3.9

25.43

25.29

mmol/l

0.25

129

685

Nondiabetic hypoglycaemic coma

5.97

10.95

7.0

4.0

25.13

24.36

mmol/l

0.39

Rheumatism, unspecified

299

1978

1.54

10.93

3.9

3.0

25.88

25.31

mmol/l

2.25

288

1936

Effects of foreign body entering through natural orifice

568

4218

1.36

10.93

3.5

3.8

25.28

25.10

mmol/l

0.63

549

4077

Sulfasalazine

637

4808

1.34

10.93

3.6

3.1

25.31

25.19

mmol/l

0.41

616

4670

Bell's palsy

283

1852

1.56

10.93

3.5

3.3

25.37

25.24

mmol/l

0.26

273

1792

Acquired absence of organs, not elsewhere classified

173

3.05

10.87

9.3

2.8

24.09

24.75

mmol/l

0.67

166

Acute appendicitis

1624

12735

1.20

10.86

3.3

3.5

25.23

25.21

mmol/l

0.06

1575

12337

Acute appendicitis, no complications

1214

9877

1.23

10.77

3.3

3.5

25.28

25.20

mmol/l

0.36

1181

9559

Glaucoma

1550

11154

1.21

10.76

3.8

3.4

25.13

25.26

mmol/l

0.75

1496

10843

Neuralgia and neuritis, unspecified

131

702

1.92

10.74

4.6

3.1

25.64

25.22

mmol/l

0.81

123

682

Other disorders of eyelid

1200

9346

1.23

10.64

3.6

3.4

25.46

25.27

mmol/l

1.29

1176

9080

Malignant neoplasm of colon, including Hilmo

534

3949

1.37

10.63

3.7

3.2

24.56

25.20

mmol/l

3.71

521

3819

5-aminosalicylic acid

441

3157

1.41

10.61

4.1

3.2

24.91

25.19

mmol/l

0.90

425

3057

Disorders of optic nerve and visual pathways

217

1346

1.65

10.57

4.5

3.5

24.54

25.21

mmol/l

1.94

212

1300

Diseases of appendix

1751

13363

1.19

10.52

3.4

3.5

25.21

mmol/l

0.01

1700

12943

Weight loss

263

1713

1.57

10.47

3.5

25.16

25.22

mmol/l

0.10

250

1661

Hypertrophic disorders of skin

125

665

1.93

10.44

3.0

2.9

25.16

25.27

mmol/l

0.15

120

640

Postmenopausal osteoporosis with pathological fracture

195

1189

1.70

10.38

4.0

2.8

26.39

25.51

mmol/l

2.63

189

1163

Malignant neoplasm of kidney, except renal pelvis

259

1687

1.58

10.37

5.3

3.1

24.34

25.22

mmol/l

4.13

253

1618

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

391

2757

1.45

10.36

4.5

3.1

24.97

25.20

mmol/l

0.60

383

2660

Wet age-related macular degeneration

554

4018

1.36

10.36

3.5

3.3

24.86

25.25

mmol/l

1.58

535

3918

Other renal tubulo-interstitial diseases

265

2.52

10.22

5.7

2.5

24.04

25.46

mmol/l

2.24

259

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

195

1194

1.68

10.17

3.7

3.0

23.94

25.17

mmol/l

4.37

189

1144

Arterial embolism and thrombosis of lower extremity artery

117

619

1.97

10.11

6.2

3.1

24.85

25.05

mmol/l

0.23

112

601

Injuries involving multiple body regions

101

507

2.06

10.09

5.4

3.2

24.63

25.17

mmol/l

1.11

489

Inflammatory diseases of the central nervous system

201

1240

1.66

10.06

3.5

3.3

25.48

25.31

mmol/l

0.28

193

1200

Benign neoplasm: Duodenum

450

2.16

10.05

4.2

3.3

24.86

25.22

mmol/l

0.42

438

Disorders of continuity of bone

213

1332

1.63

10.05

5.3

3.3

25.29

25.35

mmol/l

0.08

206

1286

Persistent delusional disorders

191

1167

1.68

9.96

2.8

3.4

26.18

25.27

mmol/l

2.23

181

1132

Early lumbar disc prolapse, operated

164

959

1.73

9.93

3.2

3.4

25.09

25.19

mmol/l

0.14

150

928

Burns and corrosions

309

2103

1.49

9.90

4.1

3.6

25.04

25.18

mmol/l

0.29

302

2033

Thyrotoxicosis

558

4198

1.35

9.89

3.7

3.3

25.53

25.31

mmol/l

0.88

535

4078

Paralytic strabismus

198

1226

1.66

9.87

4.3

3.3

25.20

25.19

mmol/l

0.01

192

1184

Acute posthaemorrhagic anaemia

109

568

2.00

9.86

5.7

2.9

24.62

25.32

mmol/l

1.21

104

546

Benign neoplasm: Rectum

481

3548

1.38

9.85

3.9

3.6

25.24

25.16

mmol/l

0.19

473

3444

Anomalies of dental arch relationship, including avohilmo

368

2327

1.44

9.83

3.7

3.5

25.15

25.13

mmol/l

0.03

360

2247

Disturbance of activity and attention

175

1025

1.69

9.73

3.7

4.3

24.99

24.82

mmol/l

0.31

167

984

Sequelae of injuries, of poisoning and of other consequences of external causes

522

3899

1.36

9.72

3.4

3.7

25.46

25.22

mmol/l

0.75

501

3782

Autoimmune thyroiditis

194

2.75

9.72

3.3

3.4

25.89

25.07

mmol/l

1.03

188

Primary gonarthrosis, bilateral

1379

9872

1.21

9.71

3.1

3.6

25.45

25.25

mmol/l

1.39

1339

9608

Other shoulder lesions

207

1304

1.62

9.49

3.5

3.2

25.40

25.19

mmol/l

0.47

199

1266

Otitis media, unspecified

217

1273

1.59

9.32

5.4

3.4

24.91

24.89

mmol/l

0.03

206

1223

Diseases of pulp and periapical tissues, including avohilmo

2776

12646

1.14

9.30

3.8

3.4

25.04

25.26

mmol/l

2.78

2679

12267

Thyrotoxicosis, other and/or unspecified

425

3100

1.39

9.25

3.3

3.2

25.27

25.33

mmol/l

0.14

405

3019

Collagenous colitis

218

1402

1.59

9.22

5.3

3.3

24.83

25.44

mmol/l

1.55

209

1360

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1285

7257

1.21

9.18

4.1

3.3

25.09

25.36

mmol/l

2.22

1252

7035

Haemangioma and lymphangioma, any site

213

1364

1.59

9.17

3.4

25.55

25.31

mmol/l

0.56

208

1321

1179

8971

1.22

9.14

4.1

3.4

25.23

25.20

mmol/l

0.12

1153

8713

Injuries to unspecified part of trunk, limb or body region

253

1686

1.53

9.09

5.1

3.5

25.35

25.28

mmol/l

0.12

245

1629

Pedal cyclist injured in transport accident

477

3553

1.36

9.08

3.8

3.5

25.44

25.20

mmol/l

0.77

464

3440

Haemorrhage in early pregnancy

428

3049

1.38

9.01

2.8

3.0

25.17

25.49

mmol/l

1.37

415

2952

Biological medication for rheuma

324

2268

1.45

8.95

3.7

3.5

25.41

25.26

mmol/l

0.34

311

2191

Temporomandibular joint disorders, including avohilmo

812

6398

1.26

8.94

3.1

3.3

25.32

25.26

mmol/l

0.20

786

6201

Disease of hard tissues of teeth, NOS

1137

7194

0.82

8.90

3.0

3.2

25.13

25.29

mmol/l

1.02

1098

7009

Malignant neoplasm of thyroid gland, including Hilmo

170

1040

1.67

8.86

3.1

2.9

26.08

25.41

mmol/l

1.58

163

1003

Urticaria

595

4587

1.31

8.85

3.6

3.4

25.41

25.23

mmol/l

0.68

583

4438

Maternal care for known or suspected fetal abnormality and damage

1230

0.48

8.79

2.9

3.2

25.24

25.15

mmol/l

0.08

1178

Malignant neoplasm of endocrine gland

163

991

1.68

8.72

3.2

3.1

25.84

25.38

mmol/l

0.84

155

955

264

1787

1.50

8.72

4.8

2.9

25.18

25.29

mmol/l

0.20

248

1727

Hypertrophic scar

110

598

1.88

8.67

3.2

2.9

25.40

25.26

mmol/l

0.17

105

575

Stomatitis and related lesions

418

3077

1.38

8.64

4.0

3.4

25.18

25.28

mmol/l

0.21

407

2980

Other other unspecified disorders of the circulatory system

107

581

1.91

8.60

5.1

3.2

25.62

25.18

mmol/l

0.49

100

564

Pilonidal cyst

163

993

1.67

8.58

3.1

3.3

25.18

25.13

mmol/l

0.08

158

960

Rare circulating lymphoid malignancy, including Hilmo

469

2.02

8.57

4.3

3.3

25.15

25.08

mmol/l

0.08

454

Abscess of lung

214

2.57

8.57

3.9

3.7

25.74

24.84

mmol/l

0.64

207

Menorrhagia

709

3081

1.29

8.57

3.4

3.0

25.64

25.44

mmol/l

0.79

693

2996

Hypogonadotropic hypogonadism

353

2.17

8.55

3.2

3.9

25.17

25.08

mmol/l

0.09

342

Other enthesopathies

637

4980

1.29

8.54

3.5

3.1

25.54

25.21

mmol/l

1.82

615

4854

Chondropathies

324

2291

1.43

8.53

3.4

24.93

25.24

mmol/l

0.97

310

2210

Abnormal weight loss

238

1591

1.53

8.51

3.6

3.5

25.22

25.18

mmol/l

0.05

226

1540

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

161

981

1.67

8.49

4.0

2.9

25.35

25.47

mmol/l

0.16

155

951

Benign neoplasm: Rectum, anus and anal canal

527

4032

1.33

8.47

4.0

3.6

25.21

25.18

mmol/l

0.07

518

3907

Alzheimer’s disease (Atypical or mixed)

341

2428

1.43

8.45

3.0

3.5

25.41

25.01

mmol/l

1.58

325

2356

Adalimumab

185

1169

1.61

8.42

3.7

3.4

25.35

25.21

mmol/l

0.23

175

1131

Unspecified event, undetermined intent

310

2.24

8.37

4.7

3.5

25.45

25.20

mmol/l

0.19

300

Parkinson's disease, including avohilmo

448

3359

1.36

8.36

3.6

3.4

25.57

25.10

mmol/l

2.25

426

3260

Hyperkinetic disorders

183

1129

1.60

8.32

3.7

4.2

25.01

24.79

mmol/l

0.43

175

1085

Malignant neoplasm of thyroid gland

151

912

1.69

8.31

3.3

3.0

26.08

25.39

mmol/l

1.49

144

878

Chronic apical periodontitis

2853

14440

1.13

8.28

4.0

3.4

25.04

25.27

mmol/l

3.19

2758

14002

Other disorders of lacrimal gland

797

6427

1.25

8.26

4.4

3.3

25.17

25.30

mmol/l

0.50

774

6239

Budesonide

289

2014

1.45

8.25

3.4

3.1

24.66

25.25

mmol/l

1.96

276

1946

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

148

895

1.71

8.22

3.8

3.0

23.78

25.16

mmol/l

4.00

142

861

Bronchitis, not specified as acute or chronic

206

1345

1.56

8.18

4.4

3.3

25.45

25.05

mmol/l

0.80

199

1305

Abdominal aortic aneurysm (AAA)

299

2089

1.45

8.15

4.8

3.3

24.36

24.98

mmol/l

2.14

288

2024

Mouth breathing

923

7566

1.23

8.10

4.2

3.6

25.27

25.18

mmol/l

0.38

897

7328

Other fall from one level to another

502

3835

1.32

8.07

3.8

25.26

25.08

mmol/l

0.59

485

3706

Subjective visual disturbances

560

4344

1.30

8.06

4.0

3.3

25.22

25.24

mmol/l

0.07

535

4216

Haemangioma, any site

198

1288

1.57

8.03

3.5

3.4

25.67

25.29

mmol/l

1.00

193

1247

Gonarthrosis, primary, with knee surgery

1551

10599

1.17

8.01

3.2

3.6

25.26

25.25

mmol/l

0.04

1517

10306

Special screening examination for neoplasms

134

792

1.73

8.00

4.1

2.9

25.46

25.06

mmol/l

0.55

127

766

Bacterial, viral and other infectious agents

194

1256

1.57

8.00

4.4

3.5

25.35

25.23

mmol/l

0.24

189

1212

Viral warts

423

3158

1.35

7.99

5.4

3.4

24.81

25.24

mmol/l

2.19

413

3047

Mycoses

2056

15665

1.15

7.97

3.8

3.5

25.21

25.24

mmol/l

0.12

1986

15189

Diseases of salivary glands

704

5630

1.26

7.88

3.7

3.4

25.56

25.24

mmol/l

1.64

687

5461

conjunctival haemorrhage

205

1354

1.55

7.83

4.5

3.2

25.72

25.30

mmol/l

0.92

198

1312

Other maternal disorders predominantly related to pregnancy

916

4690

1.23

7.83

3.1

3.0

25.18

25.48

mmol/l

2.01

879

4552

Benign lipomatous neoplasm

691

5522

1.26

7.82

3.8

3.5

25.35

25.25

mmol/l

0.34

669

5358

Polymyalgia rheumatica

377

2785

1.38

7.81

3.8

3.3

25.84

25.21

mmol/l

3.03

365

2712

Parkinson's disease

426

3208

1.35

7.76

3.6

3.4

25.56

25.11

mmol/l

1.95

404

3112

Inflammatory diseases of female pelvic organs

1158

7137

1.20

7.74

3.3

3.0

25.40

25.43

mmol/l

0.14

1123

6927

Exposure to unspecified factor

2486

15871

1.13

7.73

4.0

3.5

25.40

25.19

mmol/l

2.14

2394

15389

Alkalosis

7.44

7.72

14.3

1.7

27.34

25.01

mmol/l

0.49

Necrosis of pulp, including avohilmo

1226

10348

1.19

7.67

3.9

3.4

25.05

25.25

mmol/l

1.35

1179

10027

Otitis externa, unspecified

238

1624

1.49

7.66

4.0

3.6

25.05

25.20

mmol/l

0.26

229

1570

Suggestive for eosinophilic asthma

217

1456

1.52

7.64

4.2

3.3

25.80

25.19

mmol/l

2.05

211

1407

Perineal laceration during delivery

215

1194

1.52

7.59

2.1

3.2

24.91

25.09

mmol/l

0.35

209

1147

Colorectal adenocarcinoma

532

4131

1.30

7.56

3.3

24.48

25.22

mmol/l

4.43

510

4001

Other and unspecified disorders of vitreous body

990

8129

1.21

7.53

3.5

3.4

25.52

25.31

mmol/l

1.20

971

7906

Symptoms and signs involving speech and voice

778

6327

1.24

7.53

3.7

3.4

25.44

25.23

mmol/l

0.94

756

6140

Acute nasopharyngitis (common cold)

243

1659

1.48

7.51

3.7

3.3

25.30

25.34

mmol/l

0.06

234

1597

Impingement syndrome of shoulder

539

4203

1.30

7.49

3.4

3.2

25.43

25.23

mmol/l

0.72

517

4091

Puerperal sepsis

225

1526

1.49

7.45

3.6

3.0

25.95

25.56

mmol/l

1.17

219

1479

Other and unspecified vascular occlusions

265

1864

1.45

7.39

4.7

3.3

25.26

25.23

mmol/l

0.04

255

1805

Other diseases of lip and oral mucosa

892

7370

1.22

7.36

3.7

3.5

25.38

25.26

mmol/l

0.51

870

7158

Atypical facial pain

118

691

1.75

7.35

3.0

2.9

25.66

25.36

mmol/l

0.53

112

672

Acute pharyngitis

259

1792

1.45

7.35

4.0

3.4

25.20

25.11

mmol/l

0.20

245

1735

Disorders of refraction and accommodation

510

3940

1.30

7.35

5.3

3.6

25.22

25.20

mmol/l

0.04

497

3807

Somnolence

163

2.65

7.30

5.4

4.1

25.97

24.53

mmol/l

1.40

156

Carbimazole or st.post thyroidectomy, condition for graves disease

418

3163

1.34

7.27

2.9

3.3

26.00

25.34

mmol/l

3.88

391

3068

Persons encountering health services in circumstances related to reproduction

827

6784

0.82

7.26

3.7

25.57

25.27

mmol/l

1.96

787

6568

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1198

6953

1.19

7.25

4.1

3.3

25.09

25.37

mmol/l

2.32

1165

6740

Diseases of middle ear and mastoid

1208

8380

1.19

7.22

4.5

3.5

25.12

25.13

mmol/l

0.06

1173

8096

Ocular pain

170

1099

1.57

7.11

4.3

3.3

25.24

25.27

mmol/l

0.04

164

1062

Perforation of tympanic membrane

231

1594

1.47

7.09

5.1

3.4

25.37

25.23

mmol/l

0.21

225

1541

Glaucoma suspect

919

7651

1.21

7.08

3.7

3.4

25.20

25.28

mmol/l

0.29

888

7436

Fracture at wrist and hand level

742

6029

1.24

7.08

4.8

3.6

25.24

25.20

mmol/l

0.13

723

5835

Mantle cell lymphoma, including Hilmo

235

2.35

7.07

4.0

2.8

25.27

25.18

mmol/l

0.07

230

Other diseases of gallbladder

114

671

1.75

7.03

4.6

3.1

25.60

25.30

mmol/l

0.40

109

651

Retinal detachments and breaks

894

7432

1.21

7.00

4.1

3.3

25.03

25.26

mmol/l

1.22

871

7219

Trochanteric bursitis

311

2266

1.39

6.98

3.8

3.0

25.46

25.26

mmol/l

0.50

300

2216

Pneumothorax

181

1196

1.55

6.94

4.1

3.3

25.77

24.80

mmol/l

2.92

170

1156

Other strabismus

422

3207

1.32

6.93

4.4

3.6

25.23

25.19

mmol/l

0.09

412

3100

Tumor necrosis factor alpha inhibitors

277

1982

1.41

6.89

3.6

3.4

25.41

25.22

mmol/l

0.43

265

1915

Other/unspecified synovitis and tenosynovitis

246

1726

1.45

6.88

3.3

25.66

25.25

mmol/l

1.23

241

1674

Spondylopathies (FG)

275

1967

1.42

6.87

3.6

3.3

25.48

25.22

mmol/l

0.62

268

1908

Assault by blunt object

156

2.61

6.83

5.5

3.7

26.11

25.01

mmol/l

0.56

151

Parkinson's disease, strict definition

395

3006

1.34

6.76

3.6

3.4

25.62

25.13

mmol/l

2.21

374

2914

Malignant neoplasm of stomach, including Hilmo

167

1092

1.57

6.74

3.1

2.9

25.41

25.14

mmol/l

0.46

161

1045

Degenerative macular diseases

328

2431

1.37

6.72

3.8

3.2

25.14

25.24

mmol/l

0.22

315

2368

Herpesviral [herpes simplex] infections

463

3593

1.30

6.70

4.1

3.2

25.01

25.27

mmol/l

1.02

455

3472

Skin changes due to chronic exposure to nonionizing radiation

1097

8597

1.19

6.69

4.2

3.4

25.20

25.19

mmol/l

0.04

1071

8348

Postprocedural musculoskeletal disorders, not elsewhere classified

181

1207

1.53

6.68

2.8

3.3

25.55

25.29

mmol/l

0.36

173

1171

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

324

2396

1.37

6.63

4.4

3.5

24.79

25.22

mmol/l

1.28

311

2315

Fissure and fistula of anal and rectal regions

511

4025

1.28

6.60

3.4

3.3

25.56

25.24

mmol/l

1.36

491

3903

Other specified/unspecified necrotizing vasculopathies

216

2.35

6.59

7.9

3.6

24.27

25.04

mmol/l

0.83

209

Ulcerative colitis (strict definition, require KELA)

335

2492

1.36

6.59

4.4

3.6

24.79

25.20

mmol/l

1.24

321

2408

Abnormal spermatozoa

344

2579

1.36

6.58

4.0

25.18

24.90

mmol/l

0.85

338

2495

Panhypopituitarism

268

2.19

6.58

3.5

3.4

25.22

24.86

mmol/l

0.37

261

Recurrent aphthous stomatitis , including avohilmo

308

2266

1.38

6.55

3.9

3.3

25.30

25.26

mmol/l

0.07

299

2195

Amyloidosis

316

2.07

6.51

5.5

2.5

24.88

25.36

mmol/l

0.43

303

Nonsuppurative otitis media

412

2730

1.32

6.46

5.8

3.5

25.08

25.01

mmol/l

0.14

399

2634

Superficial injury of ankle and foot

221

1539

1.45

6.44

4.5

3.4

25.12

25.18

mmol/l

0.11

214

1480

Accidental poisoning by and exposure to alcohol

211

2.31

6.40

8.3

3.7

26.01

24.69

mmol/l

1.71

199

Pain and other conditions associated with female genital organs and menstrual cycle

311

2106

1.37

6.39

2.8

2.9

25.42

25.19

mmol/l

0.63

301

2039

Malignant neoplasm of corpus uteri, including Hilmo

228

1606

1.45

6.35

2.9

3.0

25.45

25.59

mmol/l

0.24

223

1563

Actinic keratosis

1070

8441

1.18

6.35

4.3

3.4

25.20

25.19

mmol/l

0.03

1046

8199

Melanocytic naevi of trunk

253

1813

1.42

6.34

5.2

3.4

24.81

25.22

mmol/l

1.30

242

1750

Superficial injury of shoulder and upper arm

252

1805

1.42

6.33

4.3

3.4

25.55

25.29

mmol/l

0.60

246

1738

Localized swelling, mass and lump of skin and subcutaneous tissue

712

5849

1.23

6.32

4.3

3.3

25.17

25.21

mmol/l

0.11

694

5669

Arthropod-borne viral fevers and viral haemorrhagic fevers

401

3088

1.31

6.23

3.3

3.6

24.59

25.19

mmol/l

3.39

386

2984

Visual field defects

210

1463

1.46

6.22

4.2

3.3

25.10

25.31

mmol/l

0.42

200

1416

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

358

2714

1.33

6.22

4.2

3.6

24.75

25.21

mmol/l

1.54

343

2625

Other specific joint derangements/joint disorders

1599

9039

1.15

6.21

3.8

3.3

25.20

25.21

mmol/l

0.05

1538

8763

Complications predominantly related to the puerperium

384

2937

1.32

6.21

3.0

25.53

25.38

mmol/l

0.43

374

2847

Primary coxarthrosis, bilateral

763

6332

1.22

6.19

3.4

3.5

25.35

25.18

mmol/l

0.65

741

6147

Chronic sinusitis

934

7878

1.19

6.16

3.5

3.4

25.38

25.22

mmol/l

0.77

900

7626

Conjunctivitis

1281

12344

0.86

6.15

3.5

25.29

25.26

mmol/l

0.14

1251

11943

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1202

10062

1.17

6.13

3.9

3.5

25.45

25.20

mmol/l

1.93

1170

9750

Abrasion of teeth

455

5766

0.78

6.10

2.9

3.4

25.42

25.33

mmol/l

0.25

439

5598

Need for immunization against other single viral diseases

276

2.12

6.10

34.4

3.4

23.66

25.08

mmol/l

2.75

271

Acute laryngitis and tracheitis

188

1262

1.48

6.07

4.2

3.3

24.96

25.14

mmol/l

0.35

181

1216

Common variable immunodeficiency

3.42

6.05

3.2

3.5

24.84

25.08

mmol/l

0.13

Thoracic aortic aneurysm

358

2732

1.33

6.04

3.8

3.3

25.34

25.18

mmol/l

0.41

351

2652

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

544

4363

1.26

6.04

3.9

3.5

25.44

25.23

mmol/l

0.79

528

4215

Malignant neoplasm of rectum, including Hilmo

320

2403

1.35

6.04

3.3

3.2

24.71

25.22

mmol/l

1.45

305

2321

Congenital malformations and deformations of the musculoskeletal system

155

1014

1.54

6.03

4.5

4.3

25.16

25.01

mmol/l

0.20

149

979

Preterm labour and delivery

388

2985

1.31

6.02

3.2

25.29

25.55

mmol/l

0.94

379

2896

Scabies

563

1.74

6.02

5.3

3.3

25.38

25.14

mmol/l

0.22

545

Prolonged pregnancy

1222

0.57

6.00

1.7

3.1

24.42

25.11

mmol/l

1.18

1172

Other menopausal disorders

328

2452

0.75

5.97

2.7

3.0

25.85

25.52

mmol/l

1.24

314

2395

Squamous cell neoplasms and carcinomas of the skin

247

1786

1.41

5.97

4.6

3.1

24.88

25.18

mmol/l

0.66

240

1720

Congenital malformations and deformations of the musculoskeletal system

192

1315

1.47

5.96

4.3

3.9

25.19

25.10

mmol/l

0.13

185

1266

Viral infections of the central nervous system

154

1017

1.54

5.95

3.6

3.2

25.41

25.24

mmol/l

0.33

144

985

Other keratitis

232

1657

1.42

5.94

4.5

3.1

25.56

25.30

mmol/l

0.52

226

1602

Vitamin B12 deficiency anaemia

274

2017

1.38

5.90

4.7

3.1

24.68

25.17

mmol/l

1.42

266

1959

Other and unspecified urticaria

372

2860

1.31

5.86

3.7

3.4

25.51

25.24

mmol/l

0.87

366

2767

Burn and corrosion of hip and lower limb, except ankle and foot

301

2.03

5.82

5.6

3.6

25.10

25.08

mmol/l

0.01

290

Injury of muscle and tendon at wrist and hand level

291

2166

1.36

5.80

2.8

3.4

25.30

25.23

mmol/l

0.13

282

2090

Otitis externa

463

3667

1.27

5.79

4.2

3.5

25.13

25.18

mmol/l

0.11

448

3553

Spondylopathies in diseases classified elsewhere

183

2.37

5.78

7.5

3.3

25.67

25.22

mmol/l

0.33

176

Hidradenitis suppurativa

357

1.92

5.76

4.7

3.4

25.12

25.13

mmol/l

0.01

345

Short Achilles tendon (acquired)

337

1.95

5.75

3.6

3.3

26.66

25.44

mmol/l

0.97

329

Abscess of anal and rectal regions

172

1170

1.49

5.75

4.8

3.4

24.83

25.29

mmol/l

0.86

164

1132

Other abnormal uterine and vaginal bleeding

481

2730

1.27

5.72

3.0

26.04

25.49

mmol/l

2.86

468

2659

Vulvovaginal ulceration/inflammation in other diseases

578

1.70

5.71

4.3

2.6

25.29

mmol/l

0.00

561

Brachial plexus disorders

161

1082

1.51

5.69

3.3

3.1

25.17

25.18

mmol/l

0.02

149

1045

Lichen planus

288

2149

1.36

5.68

3.9

3.3

25.34

mmol/l

0.00

282

2083

Right bundle-branch block

506

1.76

5.67

3.9

2.4

25.09

24.92

mmol/l

0.17

485

Colon adenocarcinoma

316

2395

1.34

5.64

3.4

3.2

24.46

25.23

mmol/l

3.45

307

2310

Excessive vomiting in pregnancy

119

749

1.61

5.64

3.2

3.1

25.28

25.36

mmol/l

0.10

113

726

413

1.86

5.64

4.9

3.3

27.25

24.88

mmol/l

3.43

398

Papillary adenocarcinoma of thyroid gland

108

667

1.65

5.61

3.1

2.8

26.23

25.51

mmol/l

1.20

103

641

Injury of unspecified body region

180

1244

1.47

5.60

4.8

3.4

25.38

25.21

mmol/l

0.25

174

1202

Inflammatory diseases of prostate (prostatitis)

319

2424

1.34

5.58

3.5

25.21

25.01

mmol/l

0.50

305

2352

Sequelae of injuries of lower limb

189

1323

1.45

5.47

3.7

3.5

25.36

25.33

mmol/l

0.05

182

1282

Blepharochalasis

714

5962

1.21

5.47

3.5

3.4

25.65

25.28

mmol/l

2.57

697

5783

Other extrapyramidal and movement disorders in other diseases

547

4449

1.24

5.46

4.0

3.5

25.32

25.18

mmol/l

0.44

531

4323

Fall on and from stairs and steps

580

4745

1.23

5.46

3.5

25.10

25.20

mmol/l

0.31

559

4604

Chronic periodontitis, complicated

1311

11376

1.15

5.45

4.2

3.5

24.95

25.28

mmol/l

2.75

1262

11054

Fibroblastic disorders

560

4569

1.24

5.42

3.4

3.2

25.13

25.12

mmol/l

0.02

543

4436

Pediculosis, acariasis and other infestations

122

783

1.59

5.40

5.8

3.4

25.30

25.12

mmol/l

0.18

117

754

Fracture of neck

159

1083

1.50

5.40

3.7

3.3

25.73

25.03

mmol/l

1.58

153

1049

Other symptoms and signs involving the urinary system

245

1801

1.38

5.36

4.5

3.3

25.18

25.09

mmol/l

0.17

217

1743

Viral infections of the central nervous system

160

1090

1.49

5.36

3.5

3.3

25.50

25.25

mmol/l

0.54

150

1054

Mixed connective tissue disease

133

873

1.55

5.34

3.7

3.1

25.61

25.42

mmol/l

0.22

128

849

Amyloidosis, other/unspecified

256

2.07

5.34

5.8

2.7

24.62

25.45

mmol/l

0.73

246

Malignant neoplasm of skin

1254

7491

1.15

5.33

3.9

3.3

25.12

25.35

mmol/l

1.78

1220

7264

Hypoplasia of dental enamel, prenatal

6.01

5.30

34.8

6.3

23.79

23.36

mmol/l

0.15

Corneal ulcer

377

2950

1.29

5.26

4.9

3.3

25.10

25.25

mmol/l

0.40

371

2854

Other and unspecified injuries of lower leg

146

980

1.51

5.25

5.3

3.6

24.97

25.17

mmol/l

0.39

141

941

Early lumbar disc prolapse operation

167

1151

1.47

5.22

3.2

3.5

25.10

25.25

mmol/l

0.22

153

1110

Inflammatory disease of uterus

217

1568

1.40

5.21

3.1

3.0

25.37

25.34

mmol/l

0.05

211

1516

Inguinal hernia

1514

8947

1.14

5.18

3.8

3.5

25.09

25.14

mmol/l

0.23

1460

8674

Seropositive rheumatoid arthritis

564

4610

1.23

5.17

3.7

3.2

25.19

25.25

mmol/l

0.15

547

4478

Endometriosis of rectovaginal septum and vagina

156

1066

1.49

5.16

3.3

3.0

25.69

25.43

mmol/l

0.49

150

1039

Noninflammatory disorders of female genital tract

795

3348

1.20

5.15

3.1

3.0

25.39

25.33

mmol/l

0.17

763

3248

Lateral epicondylitis

244

1802

1.37

5.15

3.1

3.2

25.49

25.23

mmol/l

0.62

237

1751

Rheumatoid arthritis, including avohilmo

879

7515

1.18

5.11

3.7

3.4

25.32

25.29

mmol/l

0.07

854

7296

Fracture of forearm

1247

10008

1.15

5.09

3.8

3.4

25.48

25.32

mmol/l

1.00

1216

9711

Renal agenesis and other reduction defects of kidney

3.37

5.08

10.3

3.7

23.63

24.28

mmol/l

0.36

Mixed conductive and sensorineural hearing loss

292

2225

1.33

5.05

3.9

3.4

25.23

25.25

mmol/l

0.04

286

2159

Other autoimmune haemolytic anaemias

201

2.20

5.05

6.2

3.1

24.29

25.04

mmol/l

0.77

196

Secondary systemic amyloidosis

4.94

4.97

9.8

2.7

24.40

24.77

mmol/l

0.13

Dementia in Alzheimer disease

522

3606

1.24

4.92

2.7

3.5

25.29

25.02

mmol/l

1.07

509

3502

Histrionic personality disorder

3.03

4.92

3.1

2.4

25.65

24.97

mmol/l

0.38

Immunodeficiency associated with other major defects

4.87

4.89

4.1

5.0

26.41

24.33

mmol/l

2.01

156

2.29

4.87

4.9

2.8

24.43

25.03

mmol/l

0.43

151

Calcinosis cutis

6.40

4.87

17.6

2.7

23.74

24.40

mmol/l

0.37

Viral haemorrhagic fevers, not elsewhere classified/unspecified

345

2701

1.29

4.83

3.3

3.7

24.50

25.22

mmol/l

4.05

336

2612

Pediculosis, acariasis and other infestations

293

2247

1.32

4.80

4.0

3.4

25.08

25.23

mmol/l

0.29

279

2168

Crowding of teeth, including avohilmo

136

754

1.51

4.78

7.5

3.9

24.61

24.83

mmol/l

0.31

129

727

Other peripheral vertigo

217

1599

1.38

4.75

3.6

3.2

25.51

25.38

mmol/l

0.21

210

1548

Impotence

139

950

1.50

4.70

5.9

3.8

25.03

24.92

mmol/l

0.10

130

925

Syndrome of inappropriate secretion of antidiuretic hormone

2.81

4.68

5.0

3.5

25.53

24.91

mmol/l

0.49

Occupational exposure to risk-factors

521

1.68

4.67

3.5

3.4

25.71

25.08

mmol/l

0.83

503

Stenosis and insufficiency of lacrimal passages

216

1595

1.37

4.66

3.6

3.1

25.66

25.35

mmol/l

0.70

210

1541

Drug-induced systemic lupus erythematosus

2.82

4.64

2.2

3.7

25.90

24.86

mmol/l

0.82

Flat foot [pes planus] (acquired)

197

1434

1.39

4.63

3.3

3.2

25.71

25.28

mmol/l

0.94

192

1400

Hypersensitivity angiitis

2.91

4.61

15.0

3.8

24.50

25.10

mmol/l

0.33

Conotruncal defects

148

2.32

4.61

6.8

7.3

24.89

24.60

mmol/l

0.25

143

Abnormal findings on diagnostic imaging of breast

189

2.15

4.53

3.9

2.5

25.44

25.41

mmol/l

0.02

184

Conductive hearing loss, unspecified

176

1263

1.41

4.53

4.2

3.5

25.38

25.30

mmol/l

0.12

169

1224

Injury of eye and orbit

269

2061

1.32

4.48

4.4

3.6

25.23

25.19

mmol/l

0.05

263

1993

Open wound of shoulder and upper arm

273

1.93

4.47

6.0

3.1

24.59

24.98

mmol/l

0.42

261

Thyrotoxicosis with diffuse goitre

248

1880

1.33

4.45

3.4

3.1

25.59

25.42

mmol/l

0.34

237

1830

Autoimmune polyglandular failure

10.23

4.45

8.1

8.6

24.00

23.26

mmol/l

—

Giant cell arteritis

111

734

1.55

4.45

4.5

3.2

25.40

25.26

mmol/l

0.19

105

712

Intentional self-harm by jumping from a high place

3.38

4.43

3.2

3.8

25.97

24.40

mmol/l

1.16

Other disorders of the musculoskeletal system and connective tissue

325

2563

1.28

4.38

3.0

3.4

25.39

25.24

mmol/l

0.30

309

2488

Injury of heart

4.96

4.36

4.8

3.2

24.13

24.05

mmol/l

0.04

Intentional self-harm by smoke, fire and flames

5.99

4.35

6.9

4.7

25.10

24.59

mmol/l

0.18

Magnesium deficiency

3.77

4.35

5.8

4.8

26.79

24.60

mmol/l

1.14

Methotrexate

283

2194

1.30

4.34

3.8

3.0

25.01

25.27

mmol/l

0.67

275

2127

Faecal incontinence

182

1324

1.39

4.32

3.5

2.8

25.31

25.37

mmol/l

0.09

173

1291

Other specified/unspecified systemic involvement of connective tissue

116

777

1.52

4.32

3.7

2.9

25.79

25.44

mmol/l

0.42

111

756

Maternal care for other conditions predominantly related to pregnancy

248

1850

1.32

4.30

2.8

3.0

25.11

25.35

mmol/l

0.56

238

1788

Other disorders of eye and adnexa

273

2110

1.31

4.29

3.9

3.4

25.36

25.25

mmol/l

0.23

261

2037

UC patients in KELA-register (code 208), prior to 1994

101

659

1.57

4.29

3.4

24.73

25.21

mmol/l

0.50

637

Use of levodopa decarboxylase inhibitor

365

2930

1.26

4.28

3.5

3.4

25.54

25.13

mmol/l

1.58

348

2843

Deep endometriosis

174

1259

1.40

4.27

3.1

2.9

25.63

25.47

mmol/l

0.31

168

1227

Vasomotor and allergic rhinitis

712

5969

1.18

4.22

3.1

3.6

25.45

25.18

mmol/l

1.46

689

5777

Other and unspecified vasculitis limited to skin

361

1.77

4.17

5.8

3.1

25.29

25.21

mmol/l

0.06

353

Myopia

205

1528

1.35

4.15

5.0

3.4

25.24

25.22

mmol/l

0.04

198

1469

Abnormal findings in secretions and smears from cervix uteri vagina vulva

578

5187

0.84

4.13

2.9

3.0

25.22

25.39

mmol/l

0.61

553

5035

Spontaneous rupture of synovium and tendon

179

1311

1.38

4.11

3.9

3.3

25.43

25.30

mmol/l

0.19

170

1271

Injury of muscle and tendon at shoulder and upper arm level

837

7266

1.16

4.10

3.5

25.11

25.19

mmol/l

0.27

815

7056

MS-disease / Multiple Sclerosis

123

843

1.48

4.08

3.3

26.03

25.24

mmol/l

2.15

115

813

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

4.20

4.08

14.2

3.0

25.09

24.97

mmol/l

0.05

Malignant neoplasm of vulva, including Hilmo

212

2.02

4.05

4.2

2.5

25.56

25.68

mmol/l

0.09

203

Enteropathogenic Escherichia coli infection

3.56

4.05

6.1

3.6

24.26

24.57

mmol/l

0.12

ILD medications: acetylcysteine

118

2.39

4.05

3.7

2.8

25.00

25.08

mmol/l

0.04

113

Vasculitis limited to skin, not elsewhere classified

402

1.71

4.05

5.8

3.2

25.39

25.23

mmol/l

0.15

392

Other or unspecified common variable immunodeficiency

3.55

4.05

2.7

3.5

25.16

24.99

mmol/l

0.07

Other (seronegative) rheumatoid arthritis, wide

418

3424

1.23

4.03

3.7

3.3

25.29

25.23

mmol/l

0.11

407

3330

Hypertrophy of breast in women and men

324

2581

1.26

4.00

3.5

3.1

25.24

25.41

mmol/l

0.44

310

2493

Varicose veins

1535

10441

1.11

3.98

3.4

3.3

25.39

25.25

mmol/l

0.83

1490

10138

Demyelinating diseases of the central nervous system

145

1030

1.42

3.98

3.3

3.2

25.81

25.30

mmol/l

1.21

137

995

Polyp of the female genital tract

610

2955

1.19

3.97

2.9

3.0

25.73

25.48

mmol/l

1.13

591

2876

Female genital prolapse

601

2864

1.19

3.92

2.8

3.0

25.42

25.50

mmol/l

0.21

583

2791

Tetralogy of Fallot, a congenital heart defect.

3.41

3.89

6.9

5.7

25.44

24.54

mmol/l

0.83

Peritonsillar abscess

381

3102

1.24

3.87

3.5

3.6

24.96

25.11

mmol/l

0.42

372

2993

Allergic rhinitis

515

4271

1.20

3.83

3.2

3.7

25.46

25.18

mmol/l

1.23

498

4129

Diseases of oral cavity, salivary glands and jaws

1687

7850

1.11

3.82

3.8

3.2

25.15

25.24

mmol/l

0.52

1626

7641

Personal history of other diseases and conditions

161

1168

1.38

3.80

7.3

2.6

24.92

25.07

mmol/l

0.23

156

1123

Degeneration of nervous system due to alcohol

372

1.72

3.80

4.6

3.3

24.47

24.87

mmol/l

0.43

359

Selective deficiency of immunoglobulin M [IgM]

13.76

3.78

10.8

12.2

25.25

26.12

mmol/l

—

Other abnormalities of plasma proteins

239

1.91

3.77

4.6

3.3

24.69

25.15

mmol/l

0.45

231

Degeneration of the brain due to alcohol

373

1.72

3.76

4.6

3.4

24.47

24.93

mmol/l

0.52

360

Hereditary hypogammaglobulinemia

3.79

3.74

3.6

3.2

25.66

24.93

mmol/l

0.38

Other and unspecified iridocyclitis

648

1.52

3.73

5.0

3.1

25.11

25.31

mmol/l

0.25

625

Human immunodeficiency virus [HIV] disease resulting in other conditions

216

0.27

3.70

2.7

3.2

24.90

24.76

mmol/l

—

210

Transepidermal elimination disorders

6.12

3.69

9.4

2.8

26.26

24.97

mmol/l

—

Multiple sites

9.62

3.68

5.7

6.3

24.56

25.16

mmol/l

—

Other/unspecified rheumatoid arthritis

283

2251

1.27

3.64

4.1

3.2

25.21

25.32

mmol/l

0.19

276

2184

L02BB Anti-androgens

255

2009

1.29

3.60

3.5

3.7

25.04

24.89

mmol/l

0.23

249

1941

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

246

1923

1.29

3.59

3.3

3.0

25.41

25.28

mmol/l

0.29

240

1861

Ulcerative colitis (strict definition, all Crohn cases excluded)

268

2121

1.27

3.56

3.9

3.5

24.73

25.22

mmol/l

1.37

258

2048

Malignant neoplasm of rectum

233

1818

1.30

3.53

3.3

3.1

24.60

25.22

mmol/l

1.43

220

1751

Basal cell carcinoma

1099

6775

1.13

3.52

3.9

3.3

25.07

25.37

mmol/l

2.54

1067

6567

Other and unspecified haemorrhagic conditions

230

1.89

3.52

4.9

3.6

24.88

25.09

mmol/l

0.15

225

Other diseases of upper respiratory tract

2834

13725

1.08

3.50

3.5

25.29

25.19

mmol/l

0.80

2747

13297

Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]

10.88

3.47

7.5

3.0

26.08

24.06

mmol/l

—

Other female pelvic inflammatory diseases

275

2192

1.26

3.45

3.5

2.8

25.53

25.49

mmol/l

0.07

264

2133

Other osteochondropathies

133

959

1.40

3.43

3.0

3.6

24.58

25.20

mmol/l

1.14

124

924

Abnormalities of gait and mobility

287

2306

1.26

3.42

4.1

3.5

25.34

25.12

mmol/l

0.50

277

2232

Motor disorders

153

2.07

3.41

5.1

8.4

24.18

24.21

mmol/l

0.02

145

Acute appendicitis, with complications

410

3414

1.21

3.41

3.5

3.6

25.05

25.17

mmol/l

0.26

394

3303

Victim of lightning

9.84

3.38

5.5

1.9

24.47

26.50

mmol/l

—

Allergic urticaria

145

1063

1.38

3.37

3.4

3.3

25.02

25.23

mmol/l

0.36

140

1027

Basal cell carcinoma, including avohilmo

1132

6979

1.12

3.37

3.9

3.3

25.10

25.37

mmol/l

2.03

1100

6766

Artificial joint operation, meniscal resection

2324

13960

1.08

3.36

3.3

3.5

25.32

25.25

mmol/l

0.49

2263

13539

Malignant otitis externa

4.71

3.35

5.2

2.6

23.45

25.02

mmol/l

—

Use of levodopa decarbox-comt-inhibitor

601

1.52

3.35

3.7

3.4

25.60

25.15

mmol/l

0.78

581

Metatarsalgia

173

1305

1.34

3.34

3.6

3.2

25.59

25.24

mmol/l

0.88

167

1268

Endometriosis ASRM stages 3,4

383

3174

1.21

3.34

3.1

3.0

25.54

25.43

mmol/l

0.29

372

3079

Chorioretinal inflammation

377

1.65

3.33

3.4

3.1

24.52

25.32

mmol/l

1.01

367

Benign lipomatous neoplasm of other sites/unspecified

202

1561

1.31

3.32

3.6

3.3

25.63

25.34

mmol/l

0.57

195

1515

Scabies

227

1777

1.29

3.32

3.9

3.5

24.91

25.24

mmol/l

0.66

215

1714

Digeorge syndrome

7.83

3.30

7.0

8.2

25.77

24.19

mmol/l

—

Salpingitis and oophoritis

295

2384

1.25

3.30

3.6

2.9

25.60

25.53

mmol/l

0.14

287

2323

Fenamates

260

2207

0.79

3.27

3.4

4.2

25.57

25.02

mmol/l

2.07

252

2142

Other disorders of the genitourinary system

268

2148

1.26

3.27

4.3

3.1

25.27

25.42

mmol/l

0.31

261

2094

Specific developmental disorder of motor function

153

2.03

3.26

5.1

8.2

24.18

24.12

mmol/l

0.03

143

Congenital malformation of biliary tract

3.76

3.24

11.9

8.9

24.84

24.49

mmol/l

0.09

Other diseases of hard tissues of teeth

1350

7716

0.90

3.23

3.7

3.3

25.15

25.25

mmol/l

0.56

1301

7512

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

269

2160

1.26

3.22

4.3

3.4

25.25

25.36

mmol/l

0.20

264

2085

Colonic or urogenital fistula

569

4900

1.17

3.20

3.4

3.5

25.50

25.20

mmol/l

1.31

548

4748

Alzheimer’s disease (Late onset)

510

5011

0.85

3.20

2.5

3.5

25.24

25.09

mmol/l

0.47

490

4875

Malignant neoplasm of testis, including Hilmo

237

1.82

3.20

4.5

3.0

23.98

25.08

mmol/l

1.39

229

Toxic effect of other noxious substances eaten as food

3.64

3.19

2.3

3.5

23.82

23.96

mmol/l

0.06

Food allergy

4.30

3.17

4.3

2.4

24.57

23.82

mmol/l

—

Meniscus derangement

1310

7984

1.11

3.17

3.3

3.2

25.44

25.24

mmol/l

1.44

1269

7759

Persons encountering health services in other circumstances

806

7077

1.14

3.16

4.8

3.0

24.88

25.15

mmol/l

1.41

763

6864

Other enthesopathy of foot (+metatarsalgia)

182

1395

1.32

3.16

3.6

3.2

25.60

25.23

mmol/l

0.98

174

1357

Idiopathic progressive neuropathy

4.89

3.15

3.9

4.1

26.96

23.20

mmol/l

—

Dentofacial anomalies [including malocclusion]

1334

9713

1.11

3.14

3.4

3.5

25.22

25.27

mmol/l

0.20

1300

9406

Rapidly progressive nephritic syndrome

3.90

3.12

7.9

5.1

24.57

24.42

mmol/l

0.03

Juvenile rheumatoid arthirtis

202

1.87

3.11

6.1

3.8

24.22

25.27

mmol/l

0.75

197

Alzheimer’s disease, strict definition

553

5274

0.86

3.10

2.6

3.4

25.21

25.12

mmol/l

0.27

532

5129

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

235

1874

1.27

3.04

3.1

24.54

25.22

mmol/l

1.74

222

1803

Benign neoplasm of urinary organs

107

763

1.43

3.02

4.8

3.1

25.38

25.30

mmol/l

0.09

102

740

Exposure to other specified factors

1667

14066

1.09

2.99

3.9

3.5

25.14

25.22

mmol/l

0.42

1607

13633

Myocardial infarction, unclassifiable

626

4872

1.16

2.99

4.7

3.5

25.03

25.07

mmol/l

0.10

599

4722

Excessive and redundant skin and subcutaneous tissue

6.08

2.98

1.9

2.0

26.27

26.13

mmol/l

—

Atopic dermatitis

851

7838

0.89

2.98

3.4

25.26

25.21

mmol/l

0.18

826

7570

Other and unspecified acne

121

2.12

2.97

6.8

2.9

24.78

25.00

mmol/l

0.16

115

Single spontaneous delivery

624

3799

0.87

2.97

2.6

3.3

25.60

25.41

mmol/l

0.69

602

3707

Donors of organs and tissues

142

2.02

2.95

2.6

25.68

24.87

mmol/l

0.90

137

Supervision of normal pregnancy

173

1285

0.77

2.94

2.3

3.0

25.63

25.18

mmol/l

1.26

166

1243

Disorders of optic nerve, not elsewhere classified

338

1.64

2.88

5.6

3.4

24.77

25.13

mmol/l

0.26

331

Malignant neoplasm of cervix uteri, including Hilmo

307

1.66

2.85

5.3

2.8

25.60

25.56

mmol/l

0.02

297

Certain conditions originating in the perinatal period

116

748

1.39

2.84

6.1

3.9

24.95

24.74

mmol/l

0.28

111

720

Bartonellosis

7.12

2.84

3.3

2.3

22.07

25.37

mmol/l

—

Benign neoplasm of meninges

220

1757

1.27

2.83

3.9

3.1

25.20

25.42

mmol/l

0.49

213

1706

Other and unspecified corneal deformities and disorders

434

1.55

2.83

3.3

3.1

25.06

25.38

mmol/l

0.29

421

Other specified and unspecified disorders of eye and adnexa

554

0.55

2.82

2.6

3.3

25.60

25.05

mmol/l

0.47

535

Other peripheral vascular diseases

157

1202

1.32

2.81

4.4

2.9

25.15

25.31

mmol/l

0.17

152

1164

Rash and other nonspecific skin eruption

191

1501

1.29

2.80

4.5

3.2

25.18

25.33

mmol/l

0.27

185

1456

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

3.75

2.79

2.5

2.8

24.74

24.42

mmol/l

—

Exposure to other and unspecified inanimate mechanical forces

136

1022

1.35

2.78

3.5

3.6

25.21

25.18

mmol/l

0.03

130

984

Tonsillectomy and adenotomy

939

5855

1.12

2.78

3.7

25.16

25.20

mmol/l

0.15

907

5642

Atopic dermatitis, strict definition with reimbursement

468

3878

1.17

2.77

3.6

3.5

25.04

25.15

mmol/l

0.33

453

3736

Testicular dysfunction

485

1.51

2.76

3.8

3.9

25.81

25.03

mmol/l

1.15

469

Glycosuria

6.46

2.76

3.0

1.6

25.13

24.17

mmol/l

—

Tooth eruption problems

187

1430

1.28

2.74

5.1

3.9

24.76

24.94

mmol/l

0.30

177

1382

Malignant neoplasm of vulva

162

1.94

2.72

3.6

2.5

25.52

mmol/l

0.00

156

Postmenopausal bleeding

575

2664

1.16

2.72

3.3

3.0

25.53

25.55

mmol/l

0.03

557

2601

Radial styloid tenosynovitis [de Quervain]

634

1.44

2.72

2.8

3.0

25.62

25.32

mmol/l

0.35

620

Syndactyly

3.33

2.71

3.5

2.8

26.20

24.42

mmol/l

0.74

Ganglion

365

3078

1.19

2.71

3.5

3.1

25.26

25.22

mmol/l

0.10

349

2992

Ulcerative rectosigmoiditis

148

1130

1.32

2.71

4.8

3.4

25.06

25.35

mmol/l

0.45

142

1094

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

3.13

2.71

9.7

3.3

25.13

24.76

mmol/l

0.14

Kyphoscoliotic heart disease

5.25

2.70

3.9

3.3

26.57

25.30

mmol/l

—

Drug phototoxic response

6.46

2.68

1.2

5.7

25.88

24.20

mmol/l

—

Medullary cystic kidney disease, nephronophthisis

4.44

2.67

7.9

2.9

22.73

24.82

mmol/l

—

Bullous disorders

135

1022

1.34

2.67

4.3

3.3

25.53

25.22

mmol/l

0.53

135

988

Malignant neoplasm of testis

199

1.80

2.65

4.1

3.1

23.71

24.96

mmol/l

1.54

191

Benign neoplasm: Liver/bile ducts (ICD-9)

8.14

2.64

2.6

1.9

24.66

26.24

mmol/l

—

Enthesopathies of lower limb, excluding foot

403

3437

1.18

2.63

4.6

3.4

25.49

25.15

mmol/l

1.33

391

3341

Labyrinthitis

2.79

2.63

7.5

3.2

24.38

24.80

mmol/l

0.18

Palmar fascial fibromatosis [Dupuytren]

373

3167

1.19

2.61

3.5

3.3

25.05

25.07

mmol/l

0.04

362

3069

Female infertility, associated with anovulation

563

1.45

2.61

3.4

3.0

24.33

24.95

mmol/l

1.24

537

Malignant neoplasm of breast, HER2-negative, including Hilmo

788

4544

1.13

2.61

2.7

3.0

25.66

mmol/l

0.02

771

4404

Contact with machinery

237

1929

1.24

2.60

4.0

3.7

24.60

25.08

mmol/l

1.39

229

1863

Malignant neoplasm of breast, including Hilmo

788

4544

1.13

2.60

2.7

3.0

25.66

mmol/l

0.02

771

4404

Q fever

8.91

2.60

3.4

7.9

26.34

23.76

mmol/l

—

Drug-induced dystonia

3.43

2.59

4.0

2.8

25.19

23.61

mmol/l

—

Polyglandular dysfunction

3.73

2.56

7.9

6.2

23.22

24.60

mmol/l

—

Bullous pemphigoid

390

1.56

2.54

3.5

3.2

25.73

25.15

mmol/l

0.64

377

Benign neoplasm: Liver/bile ducts

318

1.60

2.51

4.4

3.3

25.32

25.38

mmol/l

0.04

308

Other and unspecified rosacea

159

1241

1.29

2.51

4.4

3.2

24.78

25.36

mmol/l

1.38

152

1200

Delivery

638

3814

0.88

2.50

2.7

3.3

25.57

25.41

mmol/l

0.57

615

3721

Maternal care related to the fetus and amniotic cavity and possible delivery problems

477

3232

0.86

2.50

2.9

3.2

25.28

25.35

mmol/l

0.17

464

3120

Unspecified urinary incontinence

180

1428

1.27

2.50

3.7

2.8

25.75

25.45

mmol/l

0.46

172

1386

Need for other prophylactic measures

875

0.67

2.49

3.3

3.4

24.21

25.27

mmol/l

1.01

845

3.08

2.49

17.5

3.4

23.49

24.42

mmol/l

0.50

Progressive external ophthalmoplegia

7.25

2.47

2.2

2.4

24.72

22.31

mmol/l

—

Nanophthalmos, microphthalmos and macrophthalmos

5.98

2.47

5.3

3.5

24.92

23.37

mmol/l

—

Seronegative juvenile rheumatoid arthritis

152

1.87

2.46

2.1

4.5

24.78

24.93

mmol/l

0.07

146

Pemphigoid

483

1.48

2.45

3.7

3.3

25.75

25.27

mmol/l

0.54

466

Bilateral sagittal split ramus osteotomy operation

328

1.58

2.43

2.5

3.2

25.31

25.39

mmol/l

0.07

316

Other disorders of choroid

236

1.70

2.43

4.1

3.2

23.42

25.29

mmol/l

2.39

229

Other congenital musculoskeletal deformities

3.81

2.41

5.9

4.4

27.11

23.69

mmol/l

—

Alzheimer’s disease (Late onset), excluding more controls

348

1932

1.19

2.40

2.7

3.2

25.33

24.92

mmol/l

1.42

339

1886

Nasal polyp

423

3656

1.16

2.39

3.4

3.7

25.40

25.07

mmol/l

1.39

411

3534

Bacterial agents resistant to antibiotics

4.56

2.39

4.6

3.6

27.99

25.39

mmol/l

—

Malignant neoplasm of oesophagus, including Hilmo

628

1.41

2.38

3.2

3.0

25.61

25.06

mmol/l

0.80

604

Adenocarcinoma and papilloma adenocarcinoma of rectum

220

1797

1.24

2.38

3.1

24.52

25.20

mmol/l

1.58

207

1730

Ventricular septal defect, a heart condition

259

1.65

2.37

8.2

6.1

24.91

24.29

mmol/l

0.60

253

Vestibular neuronitis

184

1474

1.26

2.37

3.6

3.4

25.26

25.31

mmol/l

0.07

177

1426

Other bullous disorders

412

1.51

2.37

4.6

3.5

25.25

25.15

mmol/l

0.11

398

Oter anti-inflammatory and antirheumatic agents, non-steroids

651

3183

1.14

2.37

3.2

4.1

25.05

24.98

mmol/l

0.21

632

3087

Q fever

7.06

2.37

3.4

7.1

26.34

23.78

mmol/l

—

Hallux valgus (acquired)

713

4578

1.12

2.35

3.0

3.2

25.41

25.32

mmol/l

0.30

687

4457

Endometriosis

604

3125

1.14

2.33

3.0

25.43

25.39

mmol/l

0.09

589

3037

Malignant neoplasm of breast, HER2-negative

765

4489

1.12

2.30

2.8

3.0

25.71

25.66

mmol/l

0.15

749

4356

Malignant immunoproliferative diseases

172

1.81

2.29

4.1

3.4

25.04

24.79

mmol/l

0.12

167

Unspecific neurodegenerative disorder

1166

7308

1.10

2.29

2.9

3.6

25.33

25.12

mmol/l

1.35

1128

7110

Other obstetric conditions, not elsewhere classified

346

1868

1.18

2.29

2.8

2.9

24.47

25.19

mmol/l

4.04

332

1796

Absence of one kidney

2.86

2.28

10.5

3.8

25.51

24.04

mmol/l

0.94

Lichen planus, including avohilmo

377

3245

1.17

2.27

3.6

3.4

25.40

25.27

mmol/l

0.32

368

3153

Fall on and from ladder

171

1368

1.27

2.26

3.5

3.7

25.26

25.10

mmol/l

0.24

165

1325

Toxic colitis

2.66

2.26

7.7

4.2

24.17

24.61

mmol/l

0.24

Other and unspecified hypertrophic disorders of skin

2.27

2.26

1.9

2.6

23.39

24.33

mmol/l

0.85

Proteinuria and renal glomerular damage; focal glomerulonephritis

4.20

2.26

4.9

2.9

26.44

24.24

mmol/l

—

Benign mammary dysplasia

266

2227

1.20

2.24

3.9

3.0

25.56

25.48

mmol/l

0.17

259

2168

Whooping cough

107

2.00

2.23

4.2

3.0

24.27

24.92

mmol/l

0.43

101

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

550

4869

1.14

2.22

3.7

3.4

25.13

25.29

mmol/l

0.50

533

4723

Disorders of tooth development and eruption

207

2044

0.82

2.21

5.7

3.1

24.96

25.26

mmol/l

0.70

199

1991

Other maltreatment syndromes

329

1.54

2.19

6.1

3.7

24.99

25.15

mmol/l

0.12

318

Pleural plaque

251

2099

1.21

2.19

3.5

3.4

25.81

24.74

mmol/l

4.36

240

2033

Hydrocele

273

2300

1.20

2.16

4.9

3.6

24.92

24.94

mmol/l

0.03

261

2235

Sexual assault by bodily force

3.40

2.15

5.8

2.7

25.18

24.56

mmol/l

—

Human immunodeficiency virus [HIV] disease

237

0.41

2.14

2.7

3.2

25.02

24.77

mmol/l

—

231

Recurrent dislocation of patella

445

1.45

2.14

3.7

3.1

25.05

25.12

mmol/l

0.05

433

LeFortI or BSSO operation

396

1.48

2.14

2.5

3.4

25.59

25.40

mmol/l

0.18

382

Malignant neoplasm of vagina, including Hilmo

2.49

2.13

6.5

2.1

24.78

25.66

mmol/l

0.62

Systemic atrophies primarily affecting the central nervous system

710

1.36

2.13

3.7

3.3

26.07

25.18

mmol/l

1.35

685

Glaucoma-related operations

1110

0.73

2.13

3.2

24.88

25.28

mmol/l

0.31

1074

Other congenital musculoskeletal deformities

3.03

2.11

5.4

3.5

26.90

23.95

mmol/l

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

333

1804

1.18

2.10

2.9

24.46

25.18

mmol/l

3.87

320

1733

Benign neoplasm: Cerebral meninges

194

1588

1.23

2.10

3.8

3.2

25.28

25.44

mmol/l

0.32

188

1545

Diseases of external ear

726

6553

1.11

2.10

4.3

3.6

25.06

25.17

mmol/l

0.40

707

6360

Hereditary nephropathy, not elsewhere classified

2.69

2.09

6.5

2.8

25.08

24.65

mmol/l

0.23

Disorder of external ear, unspecified

491

1.43

2.08

6.0

3.2

24.71

25.27

mmol/l

0.87

477

Benign neoplasm: Pituitary gland, craniopharyngeal duct

730

1.34

2.06

3.2

3.3

24.72

25.27

mmol/l

1.02

700

Aphakia

223

1.65

2.06

6.9

3.0

26.06

25.08

mmol/l

0.71

214

Acquired atrophy of ovary and fallopian tube

3.24

2.06

2.9

2.2

27.63

24.45

mmol/l

—

Testicular hypofunction

425

1.46

2.06

3.9

4.1

25.69

24.98

mmol/l

0.83

411

Tracheo-bronchomalasia

4.10

2.05

4.2

1.9

25.73

26.32

mmol/l

—

Cryoglobulinemia

3.64

2.03

7.4

4.3

23.67

24.64

mmol/l

—

Other bursitis of hip

304

1.54

2.03

3.3

2.9

26.39

25.28

mmol/l

0.90

297

Pulmonary artery stenosis

4.20

2.01

3.3

8.4

26.22

23.26

mmol/l

—

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

4.16

2.01

4.2

3.3

23.90

23.87

mmol/l

—

Hereditary angioödema type 1

5.06

2.01

1.6

2.8

24.00

23.65

mmol/l

—

Dislocation, sprain and strain of joints and ligaments of knee

1171

9969

1.08

2.00

3.2

3.4

25.29

25.20

mmol/l

0.46

1126

9668

Achilles tendinitis

185

1514

1.23

2.00

4.6

3.5

25.61

25.10

mmol/l

1.31

178

1460

Myeloproliferative diseases

184

1507

1.23

2.00

3.1

3.2

24.68

25.32

mmol/l

1.69

176

1459

Malignant neoplasm of breast

766

4521

1.11

2.00

2.7

3.0

25.70

25.66

mmol/l

0.13

750

4382

Drug-induced autoimmune haemolytic anaemia

4.12

2.00

4.3

2.9

25.42

24.83

mmol/l

—

Familial erythrocytosis

2.29

2.00

3.4

3.0

24.70

24.97

mmol/l

0.13

Sequelae of inflammatory diseases of the central nervous system

2.71

2.00

4.7

3.5

26.18

24.58

mmol/l

—

Other specified/unspecified disorders of middle ear and mastoid

2.91

1.99

3.7

5.3

24.01

24.25

mmol/l

—

Convalescence

665

1.35

1.99

6.8

2.5

25.03

25.35

mmol/l

0.30

642

Crohn's disease (strict) with PSC

4.01

1.98

9.5

4.4

24.18

24.66

mmol/l

—

Ménière disease

201

1663

1.22

1.98

3.3

3.1

25.61

25.35

mmol/l

0.51

195

1610

Embedded teeth, including avohilmo

119

926

1.29

1.98

4.1

3.6

25.07

25.03

mmol/l

0.04

112

893

Foreign body on external eye

282

2404

1.18

1.97

3.7

3.8

25.07

25.17

mmol/l

0.20

271

2325

Complications of anaesthesia during pregnancy

4.76

1.97

2.4

2.7

24.10

23.35

mmol/l

—

Malignant neoplasm of gum, including Hilmo

158

0.37

1.94

2.7

29.47

25.44

mmol/l

—

153

Benign neoplasm: Heart

2.53

1.91

9.0

3.3

28.35

24.38

mmol/l

1.76

Calcification and ossification of muscle

3.03

1.91

7.2

3.3

22.51

24.02

mmol/l

—

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

2.52

1.91

7.2

2.8

25.45

25.07

mmol/l

0.19

Other/unspecified seropositive rheumatoid arthritis

558

4998

1.12

1.90

3.7

3.4

25.17

25.28

mmol/l

0.31

541

4850

Lichen ruber planus, wide definition including periferal and oral lichen planus

433

3821

1.14

1.89

3.5

3.4

25.36

25.32

mmol/l

0.10

422

3710

Perichondritis of external ear

277

1.55

1.89

4.5

3.2

25.37

25.03

mmol/l

0.32

272

Intracranial injury with prolonged coma

4.70

1.89

2.6

2.1

25.40

23.87

mmol/l

—

Premature rupture of membranes

177

1542

0.82

1.87

2.2

3.1

25.18

25.22

mmol/l

0.06

170

1481

Drug-induced Cushing's syndrome

4.53

1.87

1.4

2.7

24.90

25.03

mmol/l

—

Isolated patent ductus arteriosus

3.68

1.86

2.3

2.8

27.43

24.46

mmol/l

—

Nephropathy induced by other drugs, medicaments and biological substances

3.01

1.86

22.3

4.5

25.11

24.05

mmol/l

—

Other disorders of penis

200

1665

1.21

1.86

5.4

3.8

24.56

24.93

mmol/l

0.84

193

1616

Endometriosis of pelvic peritoneum

222

1776

1.20

1.85

2.5

3.0

25.52

25.35

mmol/l

0.34

216

1722

Use of donepezil

553

4751

1.12

1.84

2.9

3.4

25.63

25.14

mmol/l

3.04

537

4611

Urethral stricture

133

1064

1.26

1.83

4.9

3.3

25.06

24.92

mmol/l

0.12

128

1028

Seropositive rheumatoid arthritis, wide

564

5070

1.12

1.82

3.7

3.4

25.19

25.27

mmol/l

0.20

547

4922

Disorders of eyelid in diseases classified elsewhere

462

1.41

1.81

4.3

3.0

25.54

25.27

mmol/l

0.31

443

Other acquired deformities of musculoskeletal system and connective tissue

677

1.33

1.81

2.9

3.4

25.24

25.17

mmol/l

0.08

652

HSIL lesion of the vulva

216

1.61

1.80

3.5

2.8

25.33

25.46

mmol/l

0.09

211

Chronic laryngitis and laryngotracheitis

200

2386

0.83

1.80

3.8

3.4

25.88

25.20

mmol/l

2.13

189

2307

Disorders of conjunctiva

1604

13705

0.94

1.79

3.7

3.5

25.34

25.24

mmol/l

0.56

1561

13272

Benign neoplasm: Penis

2.88

1.79

1.8

3.9

26.54

24.58

mmol/l

—

Acute epiglottitis

185

1.65

1.79

3.6

3.5

25.57

25.21

mmol/l

0.26

178

D07AA Corticosteroids, weak (group I)

256

2182

1.18

1.78

3.2

3.6

24.97

25.14

mmol/l

0.34

248

2106

Patellar tendinitis

154

1.71

1.78

4.5

3.7

24.15

25.20

mmol/l

0.85

147

Drug-induced acute pancreatitis

3.15

1.78

7.1

2.4

25.63

24.21

mmol/l

—

Dextrocardia

4.28

1.77

5.4

5.2

26.68

23.23

mmol/l

—

Nightmares

3.48

1.77

4.5

4.2

25.77

23.89

mmol/l

—

Hypertrophy of breast

241

2048

1.18

1.77

3.0

2.9

25.18

25.52

mmol/l

0.97

231

1981

Subacute thyroiditis

481

1.39

1.77

3.2

3.0

25.34

25.39

mmol/l

0.06

468

Need for immunization against single bacterial diseases

2.81

1.77

34.6

9.5

25.60

23.85

mmol/l

—

Ankyloglossia

139

1.75

1.76

3.6

7.1

23.65

24.35

mmol/l

0.42

132

Pervasive developmental disorders excl. Autism + Asperger

116

1.82

1.75

5.6

7.9

25.10

24.31

mmol/l

0.63

110

Deformity of finger(s)

1.98

1.75

4.5

3.3

24.89

25.26

mmol/l

0.25

Benign neoplasm: Liver

274

1.52

1.74

4.9

3.4

25.30

25.18

mmol/l

0.07

268

Malignant neoplasm of cervix uteri

179

1.65

1.73

4.3

2.7

25.46

25.47

mmol/l

0.00

174

Lichen planopilaris

0.00

1.73

0.0

1.9

—

25.11

—

Abnormal findings in peritoneal fluid saliva

2.29

1.73

4.0

2.8

27.14

24.61

mmol/l

1.41

Carcinoma in situ of lip, oral cavity and pharynx

2.68

1.73

6.2

3.0

25.78

24.66

mmol/l

—

Cysts of oral region, not elsewhere classified

109

858

1.28

1.72

3.4

25.09

25.10

mmol/l

0.01

104

828

Haemophagocytic lymphohistiocytosis

3.45

1.72

15.3

3.6

25.67

24.49

mmol/l

—

Myeloid leukaemia

451

1.40

1.71

4.0

3.6

24.81

25.26

mmol/l

0.49

436

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

2.26

1.71

3.9

3.0

23.78

24.80

mmol/l

0.44

Plantar fascial fibromatosis

163

1343

1.22

1.70

2.4

3.2

25.48

25.25

mmol/l

0.41

157

1307

Other specified/unspecified hearing loss

180

1500

1.21

1.69

5.1

3.6

25.33

25.23

mmol/l

0.14

171

1452

Family history of malignant neoplasm

154

1262

1.23

1.69

3.1

2.6

25.25

25.32

mmol/l

0.09

145

1218

Torsion of ovary, ovarian pedicle and fallopian tube

196

1.60

1.67

3.9

3.2

25.26

25.42

mmol/l

0.10

189

285

1.49

1.67

3.6

3.4

25.78

25.11

mmol/l

0.71

277

Other disorders of bladder

260

2240

1.17

1.66

3.8

3.4

25.48

25.09

mmol/l

0.83

246

2161

Disorders of parathyroid gland, other and/or unspecified

113

1.84

1.66

4.3

3.0

22.89

25.06

mmol/l

1.07

113

Malignant neoplasm of vagina

2.69

1.66

5.9

2.1

24.07

26.16

mmol/l

—

Benign neoplasm: Extrahepatic bile ducts

2.46

1.64

2.2

3.8

25.32

24.66

mmol/l

—

Melanoma in situ of trunk

262

0.52

1.64

5.3

3.8

24.27

25.18

mmol/l

1.06

256

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

198

1.60

1.63

5.0

3.9

25.08

24.69

mmol/l

0.23

189

Mandibular retrognathia AND surgery (BSSO)

262

1.51

1.63

2.2

3.3

25.62

25.35

mmol/l

0.26

254

Other general symptoms and signs

526

1.35

1.62

4.0

3.4

25.46

24.85

mmol/l

0.80

504

Other/unspecified disorders of vestibular function

655

1.31

1.61

4.7

3.0

25.85

25.36

mmol/l

0.73

635

Hypertrichosis

167

1.64

1.60

3.2

2.8

25.44

25.35

mmol/l

0.05

162

malignant neoplasm of male genital organs

736

4105

1.10

1.59

3.7

3.5

24.90

25.03

mmol/l

0.42

713

3973

Striking against or struck by other objects

627

5706

1.10

1.59

3.7

3.8

25.27

25.11

mmol/l

0.54

606

5515

Hallux rigidus

213

2495

0.85

1.59

2.7

3.3

25.66

25.26

mmol/l

1.11

204

2430

Radiodermatitis

2.57

1.58

2.4

2.8

24.80

24.60

mmol/l

—

Cholera

3.60

1.56

2.4

4.5

22.70

23.33

mmol/l

—

Vascular dementia (multiple infarctions)

224

1.54

1.56

4.7

3.2

24.81

24.83

mmol/l

0.01

216

Infection due to other mycobacteria

217

1.55

4.1

2.7

26.26

25.42

mmol/l

0.53

211

Medical abortion

1021

5960

0.93

1.55

3.0

3.1

25.36

25.45

mmol/l

0.37

990

5783

Assault by drugs, medicaments and biological substances

3.06

1.55

2.2

4.4

26.40

24.01

mmol/l

—

Interstitial emphysema and related conditions originating in the perinatal period

3.53

1.55

36.0

11.8

23.88

23.03

mmol/l

—

L02BA Anti-estrogens

215

2510

0.85

1.54

2.7

3.0

26.06

25.46

mmol/l

1.83

209

2444

Toxic erythema

3.03

1.54

2.0

1.9

24.58

25.07

mmol/l

—

Voice disturbances

520

4706

1.11

1.53

3.3

25.52

25.25

mmol/l

1.03

505

4565

Other acute skin changes due to ultraviolet radiation

538

1.34

1.53

2.6

3.2

25.57

25.24

mmol/l

0.37

520

Use of other anti-dementia drugs

756

5767

1.09

1.53

2.5

3.4

25.44

25.12

mmol/l

1.94

722

5605

Use of memantine

756

5767

1.09

1.53

2.5

3.4

25.44

25.12

mmol/l

1.94

722

5605

Carcinoma in situ of breast, other/unspecified

217

0.50

1.52

2.5

2.6

26.01

25.58

mmol/l

0.21

211

Unspecified human immunodeficiency virus [HIV] disease

128

0.38

1.52

3.0

3.6

25.80

25.19

mmol/l

—

123

Disorders of breast

853

7162

1.08

1.52

3.4

3.0

25.48

25.46

mmol/l

0.04

830

6957

Dislocation, sprain and strain of joints and ligaments of elbow

767

1.27

1.51

5.1

3.4

24.74

25.26

mmol/l

0.85

745

Exposure to controlled fire, not in building or structure

2.49

1.49

2.9

4.1

26.08

24.66

mmol/l

—

Other congenital malformations of tongue, mouth and pharynx

131

1.70

1.49

4.3

5.2

23.55

24.34

mmol/l

0.48

126

Guttate psoriasis

179

1.59

1.49

5.7

3.2

25.21

24.94

mmol/l

0.23

174

Failure in dosage during surgical and medical care

2.98

1.49

3.5

3.1

24.77

24.52

mmol/l

—

Frostbite involving multiple body regions and unspecified frostbite

2.63

1.48

5.6

4.6

25.37

24.50

mmol/l

—

Bitten or struck by other mammals

172

1447

1.20

1.48

3.5

3.4

25.31

25.23

mmol/l

0.10

163

1400

Cytomegaloviral hepatitis

2.61

1.48

3.0

2.7

25.87

25.47

mmol/l

—

Other inflammation of eyelid

255

2216

1.16

1.48

3.9

3.3

25.22

25.25

mmol/l

0.06

245

2141

Endometriosis ASRM stages 1,2

229

1973

1.17

1.47

2.6

2.9

25.50

25.42

mmol/l

0.13

223

1902

Congenital mitral valve regurgitation

2.90

1.47

14.3

6.2

25.22

23.43

mmol/l

—

Delivery, wide proxy

566

3306

0.91

1.46

2.6

3.3

25.48

25.36

mmol/l

0.32

545

3219

Endocrine disorders, other/unspecified

253

0.54

1.46

2.9

3.4

24.14

25.20

mmol/l

0.51

246

Melanocytic naevi of upper limb, including shoulder

311

1.44

1.46

3.2

3.3

24.88

25.10

mmol/l

0.16

302

Absence of one kidney

2.38

1.44

12.3

3.9

24.69

24.08

mmol/l

—

Other disorders of skin and subcutaneous tissue related to radiation

2.59

1.44

2.6

3.2

26.51

25.05

mmol/l

—

Undescended testicle

118

1.73

1.43

4.3

6.8

25.62

24.40

mmol/l

0.74

113

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

263

1.47

1.42

2.9

3.1

25.60

25.59

mmol/l

0.00

253

Maxillary retrognathism

181

1.57

1.42

2.5

3.8

25.60

24.93

mmol/l

0.62

171

Malignant neoplasm of oropharynx, including Hilmo

339

1.41

4.4

2.9

26.33

25.11

mmol/l

1.20

329

Rosacea

195

1669

1.18

1.40

4.8

3.2

25.01

25.34

mmol/l

0.66

188

1604

Dental pulpitis, including avohilmo

1871

11540

1.05

1.40

3.8

3.4

25.11

25.23

mmol/l

0.82

1798

11186

Myeloproliferative diseases (CML excluded)

163

1376

1.20

1.40

3.2

24.64

25.29

mmol/l

1.47

155

1333

Autoimmune hyperthyroidism

758

1.26

1.39

2.8

2.7

25.07

25.47

mmol/l

0.55

732

Presence of other devices

531

4820

1.10

1.39

3.4

3.0

25.23

25.16

mmol/l

0.15

512

4669

Degenerative diseases of the nervous system

971

6655

1.08

1.39

3.0

3.5

25.30

25.12

mmol/l

0.85

933

6470

Adenocarcinoma and Papillary adenocarcinoma of kidney

183

1.57

1.39

7.2

2.8

24.27

25.29

mmol/l

0.99

178

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

538

1.31

1.38

3.5

2.9

26.05

25.61

mmol/l

0.66

522

Hypothyroidism, autoimmune, DX-based

2.21

1.37

3.5

2.8

26.17

24.03

mmol/l

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

575

1.30

1.37

5.7

3.1

25.34

25.45

mmol/l

0.12

555

Chloasma

2.21

1.36

1.8

2.8

25.71

24.40

mmol/l

—

Presbycusis

277

3108

0.88

1.35

2.9

3.3

25.11

25.14

mmol/l

0.06

257

3023

Injury of nerves at wrist and hand level

471

1.33

1.34

5.6

3.5

25.66

25.05

mmol/l

0.70

456

Cyst of spleen

2.64

1.33

10.2

2.9

23.77

23.93

mmol/l

—

Other congenital malformations of tongue, mouth and pharynx

175

1.55

1.33

3.7

4.8

23.55

24.34

mmol/l

0.59

170

Other zoonotic bacterial diseases, not elsewhere classified

3.00

1.32

2.4

2.7

25.54

23.58

mmol/l

—

Dysplastic lesion of the vulva of unknown severity

2.95

1.31

4.8

2.1

23.58

24.68

mmol/l

—

Contact with other hot metals

203

1.50

1.27

4.1

3.7

25.68

24.95

mmol/l

0.51

198

Secondary sideroblastic anaemia

2.32

1.27

4.8

3.1

21.59

23.71

mmol/l

—

Posteruptive colour changes of dental hard tissues

2.29

1.26

16.6

2.3

25.34

24.32

mmol/l

—

Obstructive hydrocephalus

220

1.48

1.26

3.9

3.6

25.08

24.98

mmol/l

0.06

215

Restless leg syndrome

251

2210

1.14

1.26

4.0

3.3

25.38

25.34

mmol/l

0.10

245

2144

Uterine polyps

159

1353

1.18

1.25

2.6

3.0

26.09

25.44

mmol/l

1.82

153

1321

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

2.86

1.25

5.4

2.2

28.24

25.98

mmol/l

—

Disorders of vagus nerve

2.84

1.25

30.2

5.2

25.00

24.26

mmol/l

—

Spontaneous abortion

701

4373

1.08

1.25

3.0

25.42

25.45

mmol/l

0.12

680

4235

General autosomal fish scale disease

2.82

1.25

3.4

4.5

25.06

24.47

mmol/l

—

Failed induction of labour

415

1.33

1.25

1.8

3.5

24.81

24.96

mmol/l

0.11

398

Subclinical iodine-deficiency hypothyroidism

2.81

1.24

3.6

3.2

24.92

24.03

mmol/l

—

Other congenital malformations of spinal cord

2.80

1.24

29.2

7.9

23.50

24.32

mmol/l

—

Abuse of non-dependence-producing substances

2.80

1.24

7.4

3.3

27.46

24.31

mmol/l

—

Other disorders of veins

726

7763

0.93

1.24

3.6

3.2

25.65

25.30

mmol/l

1.93

716

7531

Monoamine oxidase A inhibitors

205

1782

1.16

1.24

3.7

3.2

25.77

25.30

mmol/l

1.12

205

1724

Other congenital malformations

192

1661

1.16

1.22

4.3

3.7

25.71

25.14

mmol/l

1.41

186

1607

Cholera

2.42

1.21

2.2

4.1

22.92

24.22

mmol/l

—

Femoral hernia

766

1.24

1.20

4.2

3.1

25.50

25.29

mmol/l

0.22

743

Other sideroblastic anaemias

2.08

1.19

5.3

3.1

23.89

24.60

mmol/l

—

Congenital malformations of genital organs

118

977

1.21

1.19

4.5

3.5

25.19

25.23

mmol/l

0.04

111

943

Chalazion

199

1733

1.15

1.18

3.1

3.4

25.44

25.25

mmol/l

0.29

189

1670

Postdysenteric arthropathy

130

0.45

1.18

2.3

4.1

26.22

25.19

mmol/l

—

130

Seropositive rheumatoid arthritis, strict definition

278

2476

1.13

1.18

3.7

3.3

25.44

25.30

mmol/l

0.31

270

2400

Contact with other sharp object(s)

100

821

1.23

1.18

4.4

3.7

25.18

25.04

mmol/l

0.15

793

Injury of blood vessels at forearm level

2.12

1.18

7.0

5.4

24.37

24.40

mmol/l

—

Seronegative rheumatoid arthritis

222

1950

1.14

1.17

3.2

25.10

25.19

mmol/l

0.15

217

1897

Other nonautoimmune haemolytic anaemias

2.48

1.16

4.6

3.6

21.10

24.23

mmol/l

—

Schistosomiasis [bilharziasis]

0.00

1.16

0.0

3.9

—

24.86

—

Other chondrocalcinosis

225

1.46

1.16

4.6

3.4

25.04

24.99

mmol/l

0.03

220

Exfoliative dermatitis

167

1.53

1.15

3.7

3.6

23.85

24.85

mmol/l

0.62

161

Benign lipomatous neoplasm of of intra-abdominal organs

2.05

1.15

2.6

3.0

23.33

25.02

mmol/l

—

Parapsoriasis

267

1.41

1.15

3.1

3.3

25.00

mmol/l

0.00

257

Adenomyosis (Endometriosis of uterus)

174

2007

0.86

1.15

2.9

3.0

25.52

25.48

mmol/l

0.06

167

1961

Dyslexia and other symbolic dysfunctions, not elsewhere classified

2.06

1.14

4.8

4.3

27.10

25.20

mmol/l

—

Palatinal maxillary operation

1.93

1.13

7.5

4.2

23.74

24.35

mmol/l

0.25

Non-seminoma of testis

2.35

1.13

8.6

3.6

22.23

25.55

mmol/l

—

Other and specified injuries of hip and thigh

363

1.34

1.12

5.6

3.2

25.10

24.99

mmol/l

0.07

348

Use of peginterferon beta-1a

2.32

1.12

2.0

3.8

26.74

23.84

mmol/l

—

Injury of muscle and tendon at hip and thigh level

170

1472

1.16

1.11

2.7

3.5

25.33

25.22

mmol/l

0.17

164

1427

Photocontact dermatitis [berloque dermatitis]

2.52

1.11

4.8

5.1

27.70

24.91

mmol/l

—

Inflammatory myopathy

2.51

1.11

1.8

5.0

25.58

24.17

mmol/l

—

Separation of retinal layers (serosa)

593

1.26

1.11

4.4

3.2

25.37

25.38

mmol/l

0.01

575

conjunctival scars

2.50

1.11

6.0

2.5

23.86

24.17

mmol/l

—

Disorders of sexual preference

2.30

1.11

3.9

4.6

25.61

24.43

mmol/l

—

Neurofibromatosis, type 2

2.49

1.11

3.2

4.4

27.04

23.90

mmol/l

—

Kissing spine

2.48

1.11

2.8

3.8

26.72

24.44

mmol/l

—

Colitis due to radiation

169

1.51

1.10

5.5

3.3

25.52

24.82

mmol/l

0.21

162

Benign neoplasm of middle ear and respiratory system

157

1354

1.17

1.10

4.0

3.3

25.70

25.22

mmol/l

0.92

152

1313

Malignant neoplasm of breast, ER-positive, including Hilmo

583

4163

1.08

1.09

2.7

3.0

25.87

25.68

mmol/l

0.71

573

4041

Valgus deformity, not elsewhere classified

105

1.66

1.08

3.8

3.7

25.38

25.11

mmol/l

0.13

105

Use of ropinirole

605

1.25

1.08

3.2

3.4

25.77

25.12

mmol/l

1.10

586

Glaucoma, exfoliation

270

2418

1.12

1.08

3.7

3.3

24.94

25.22

mmol/l

0.65

261

2360

Benign neoplasm: Other and unspecified parts of mouth

507

1.28

1.07

2.9

3.2

25.24

25.30

mmol/l

0.05

490

Burn and corrosion of ankle and foot

195

1.46

1.07

7.1

3.7

25.03

24.85

mmol/l

0.11

190

FESS (DNB20)

164

1887

0.87

1.06

3.0

3.4

25.44

25.29

mmol/l

0.26

159

1823

Malignant neoplasm of breast, HER-positive

573

4139

1.08

1.06

2.7

3.0

25.86

25.69

mmol/l

0.64

563

4018

Atrophy of thyroid (acquired)

2.41

1.06

4.2

3.0

23.16

24.66

mmol/l

—

Use of rivastigmine

332

3646

0.90

1.06

2.4

3.4

25.35

25.21

mmol/l

0.37

320

3540

Endometriosis of ovary

256

2231

1.12

1.05

3.0

25.54

25.44

mmol/l

0.18

249

2168

Macular pucker

278

3089

0.90

1.05

4.7

3.3

25.01

25.21

mmol/l

0.55

273

3000

Primary open-angle glaucoma

790

7173

1.07

1.04

3.7

3.4

25.11

25.24

mmol/l

0.47

758

6975

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

100

836

1.21

1.02

2.7

3.1

25.21

25.53

mmol/l

0.44

816

N06DA Anticholinesterases

926

6892

1.06

1.02

2.7

3.5

25.44

25.12

mmol/l

2.33

896

6691

Use of anticholinesterases

926

6892

1.06

1.02

2.7

3.5

25.44

25.12

mmol/l

2.33

896

6691

Other and unspecified acute skin changes due to ultraviolet radiation

422

1.30

1.02

2.4

3.3

25.13

25.22

mmol/l

0.07

410

Atopic dermatitis, strict definition

425

3823

1.09

1.01

3.8

3.7

25.00

25.15

mmol/l

0.46

412

3686

Maternal care for other known or suspected fetal problems

248

1399

1.12

1.01

2.7

3.1

24.86

25.12

mmol/l

0.63

234

1341

Pedestrian injured in transport accident

119

1012

1.18

1.01

3.6

3.4

24.81

25.31

mmol/l

0.85

109

980

Carcinoma in situ of other and unspecified genital organs

240

1.39

1.00

3.7

2.6

24.76

25.52

mmol/l

0.87

235

Other melanin hyperpigmentation

353

1.32

1.00

4.8

2.8

25.31

25.38

mmol/l

0.05

341

Benign neoplasm: Central nervous system, other parts/unspecified

1.92

0.99

4.6

4.0

24.78

24.35

mmol/l

—

Optic atrophy

275

1.37

0.99

7.6

4.4

25.30

24.96

mmol/l

0.17

268

Rheumatic fever incl heart disease

505

1.26

0.98

6.9

3.2

24.53

25.14

mmol/l

0.79

489

In situ neoplasms

832

7849

1.06

0.97

4.1

3.3

25.14

25.25

mmol/l

0.42

812

7605

Carcinoma in situ of oral cavity and pharynx

2.37

0.97

2.2

2.8

25.72

24.27

mmol/l

—

Procreative management

451

4071

0.92

0.96

4.1

3.7

25.51

25.25

mmol/l

0.95

425

3935

Alcohol induced polyneuropathy

150

1.50

0.95

8.3

3.7

26.20

25.03

mmol/l

0.68

145

Malignant melanoma, including Hilmo

308

3382

0.91

0.94

3.1

3.2

25.21

25.22

mmol/l

0.01

303

3266

Postpartum hemorraghe, parous women as controls

229

2175

0.89

0.93

2.4

2.7

24.97

25.33

mmol/l

1.31

223

2097

Ethmoidectomy

176

1991

0.88

0.92

3.6

3.4

25.43

25.31

mmol/l

0.21

171

1923

Congenital retinoschisis

2.16

0.91

4.5

4.7

24.48

24.05

mmol/l

—

Erythrasma

2.15

0.91

8.5

4.7

24.28

24.13

mmol/l

—

Colorectal neuroendocrine tumor and carcinoma

185

1.43

0.91

5.5

2.7

24.83

25.07

mmol/l

0.16

180

Operations 1 for CAVS

1.98

0.91

5.3

4.0

25.89

24.65

mmol/l

—

Adrenomedullary hyperfunction

1.97

0.91

3.3

4.0

25.59

25.11

mmol/l

—

Other benign neoplasm of uterus: Cervix uteri

1.68

0.90

3.2

2.6

24.51

25.15

mmol/l

0.47

Biliary cirrhosis, NAS

1.93

0.89

3.5

4.2

23.98

24.96

mmol/l

—

Malignant neoplasm of prostate

711

4000

1.07

0.89

3.8

3.5

24.95

25.02

mmol/l

0.21

688

3874

Drug-induced interstitial lung disorders, unspecified

2.09

0.89

3.0

4.0

25.18

24.94

mmol/l

—

Corneal pigmentations and deposits

1.77

0.89

2.8

3.7

25.89

24.73

mmol/l

0.35

Malignant neoplasm of other and ill-defined sites, including Hilmo

264

1.35

0.88

3.5

2.8

24.35

25.34

mmol/l

1.02

255

Other disorders of patella

270

2450

1.11

0.88

3.7

3.1

25.10

25.21

mmol/l

0.20

257

2385

Other and unspecified disorders of orbit

1.71

0.87

3.3

4.1

27.51

24.87

mmol/l

1.63

Disorders of orbit

622

1.21

0.87

2.9

3.1

25.58

25.37

mmol/l

0.20

597

Single delivery by forceps and vacuum extractor

119

832

0.86

0.87

2.1

3.6

24.73

24.99

mmol/l

0.37

113

802

Other mosquito-borne viral fevers

2.01

0.86

1.3

3.8

25.60

24.40

mmol/l

—

Pityriasis rubra pilaris

2.00

0.86

3.3

3.4

24.45

25.17

mmol/l

—

Internuclear ophthalmoplegia

1.83

0.86

2.5

3.7

27.00

24.15

mmol/l

—

Contraceptive management

585

4376

0.94

0.85

3.6

3.5

25.33

25.25

mmol/l

0.22

565

4242

Complications specific to multiple gestation

1.97

0.85

1.2

2.7

24.98

25.63

mmol/l

—

Diseases of pulp and periapical tissues and dental caries

1783

8795

1.04

0.85

3.7

3.4

25.08

25.30

mmol/l

1.86

1723

8542

Malignant neoplasm of other and unspecified female genital organs

214

1.38

0.84

2.1

2.4

24.84

25.73

mmol/l

0.94

206

Toxic encephalopathy

1.95

0.84

5.0

3.4

27.00

25.16

mmol/l

—

Internal derangement of knee

746

7021

1.06

0.83

3.6

3.3

25.05

25.20

mmol/l

0.61

719

6822

Deviated nasal septum

693

6536

1.06

0.83

3.5

3.6

25.61

25.15

mmol/l

3.36

680

6337

Excessive attrition of teeth

1052

10042

1.05

0.83

4.1

3.5

25.06

25.22

mmol/l

0.88

1023

9727

Brain glioblastoma

198

1.38

0.82

2.6

2.8

25.87

25.45

mmol/l

0.35

192

Gonococcal infection

386

0.75

0.81

3.1

3.2

26.01

25.45

mmol/l

0.30

375

Cardiomyopathy due to drugs and other external agents

1.89

0.81

6.8

3.2

23.30

24.66

mmol/l

—

Benign neoplasm: Lip

339

1.28

0.80

2.5

3.4

25.73

25.17

mmol/l

0.54

331

Disorders of other and unspecified cranial nerves

1.71

0.80

8.4

3.7

25.17

24.80

mmol/l

0.19

Brain glioblastoma and astrocytoma

242

1.34

0.80

2.5

2.8

25.58

25.24

mmol/l

0.30

233

Inguinal of femoral hernia, unilateral

438

1.25

0.80

3.4

2.9

25.11

25.25

mmol/l

0.11

426

Inguinal hernia, unilateral

438

1.25

0.80

3.4

2.9

25.11

25.25

mmol/l

0.11

426

Femoral hernia, unilateral

438

1.25

0.80

3.4

2.9

25.11

25.25

mmol/l

0.11

426

Hirsutism in women

139

1.45

0.80

3.4

2.7

25.70

25.13

mmol/l

0.41

134

Ulcer of vagina/vulva

295

1.30

0.79

2.3

2.8

25.19

25.37

mmol/l

0.12

285

Use of galantamine

159

1785

0.89

0.79

2.3

3.3

25.10

25.11

mmol/l

0.01

151

1732

Qualitative platelet defects

1.75

0.78

1.8

3.8

27.14

24.39

mmol/l

—

Malignant neoplasm of eye and adnexa, including Hilmo

270

1.31

0.78

2.0

2.9

24.47

25.34

mmol/l

0.81

261

Aortic arch syndrome [Takayasu]

2.26

0.78

2.8

3.9

25.32

24.42

mmol/l

—

Congenital retinoschisis

1.81

0.77

4.5

4.3

24.48

24.30

mmol/l

—

Pregnancy examination and test

165

910

1.13

0.77

3.1

3.2

24.91

25.09

mmol/l

0.35

157

876

Erosion and ectropion of cervix uteri

368

1.26

0.77

4.0

3.1

25.14

25.44

mmol/l

0.29

361

All dysplastic lesions of the cervix uteri, vagina or vulva

351

3199

1.08

0.77

3.0

25.51

25.32

mmol/l

0.57

341

3090

Malignant neoplasm of oropharyng

2.18

0.76

4.6

2.5

28.06

24.50

mmol/l

—

Carcinoma in situ of larynx

2.18

0.76

2.4

4.0

28.42

24.58

mmol/l

—

Use of cabergoline

173

0.63

0.76

1.3

3.4

24.05

24.55

mmol/l

0.17

168

Malignant neoplasm of prostate, including Hilmo

726

4087

1.06

0.76

3.8

3.5

24.92

25.03

mmol/l

0.33

701

3957

Malignant neoplasm of eye and adnexa

133

1.46

0.75

2.0

2.9

24.31

25.23

mmol/l

0.51

128

Supervision of high-risk pregnancy

188

1259

0.90

0.75

2.6

3.0

24.91

25.20

mmol/l

0.57

180

1219

Benign neoplasm: Pelvic bones, sacrum and coccyx

1.67

0.75

5.0

3.9

25.21

24.56

mmol/l

—

Interstitial cystitis (chronic), drug-induced

1.66

0.74

1.9

3.4

24.34

25.03

mmol/l

—

Other specific arthropathies, wide

290

1.29

0.73

3.2

24.73

25.36

mmol/l

0.67

282

Benign neoplasm: Vertebral column

1.81

0.73

4.9

25.61

24.76

mmol/l

—

Injury of muscle and tendon at forearm level

255

1.31

0.73

2.7

3.1

24.35

24.97

mmol/l

0.36

248

Generalized pustular psoriasis

1.62

0.73

2.3

4.5

24.72

24.93

mmol/l

—

Horner syndrome

177

1.38

0.72

2.8

3.4

24.72

25.08

mmol/l

0.18

172

Osteochondrodysplasia with defects of growth of tubular bones and spine

1.99

0.72

1.2

6.6

25.96

23.68

mmol/l

—

Relapsing polychondritis

1.98

0.72

3.6

3.4

24.68

24.75

mmol/l

—

Graves disease, strict definition

144

1282

1.13

0.71

2.6

2.9

25.46

25.35

mmol/l

0.16

134

1233

Gonococcal infection

410

0.78

0.71

3.1

3.2

25.85

25.45

mmol/l

0.22

396

Cleft lip and palate

1.57

0.70

2.8

3.9

25.66

24.43

mmol/l

—

Medical treatment for female infertility

171

1887

0.90

0.70

2.6

2.9

25.29

25.24

mmol/l

0.09

158

1820

Rhabdomyosarcoma, including Hilmo

1.92

0.70

2.8

6.5

24.24

24.84

mmol/l

—

Optic atrophy

257

1.30

0.70

7.9

4.5

24.65

24.96

mmol/l

0.16

250

Nutritional marasmus

1.92

0.70

4.4

2.8

24.22

24.31

mmol/l

—

Gestational diabetes (for exclusion)

387

2508

1.07

0.70

3.1

2.9

24.86

25.25

mmol/l

1.53

378

2410

Simple and mucopurulent chronic bronchitis

685

1.18

0.69

4.8

3.3

25.61

24.73

mmol/l

1.22

666

Discharge from other and unspecified firearms

1.70

0.69

5.0

3.7

24.91

24.59

mmol/l

—

False labour

328

1893

1.08

0.69

2.5

3.2

24.94

25.22

mmol/l

0.98

317

1820

Thyrotoxicosis with toxic multinodular goitre

113

994

1.14

0.69

4.5

3.2

26.17

25.52

mmol/l

1.63

108

968

Benign neoplasm: Skin of lip

196

1.34

0.69

4.3

3.1

24.98

25.11

mmol/l

0.06

191

Erosion of teeth , including avohilmo

387

3615

1.07

0.69

4.8

3.5

25.22

25.19

mmol/l

0.07

377

3491

Dermatophytosis

1208

12531

0.96

0.69

3.3

3.5

25.18

25.21

mmol/l

0.15

1167

12155

Obstructed labour due to malposition and malpresentation of fetus

189

1943

0.91

0.68

2.6

3.2

25.13

25.42

mmol/l

0.86

180

1874

Medicines for HER+ breast cancer

613

6123

0.95

0.68

2.8

3.1

25.81

25.54

mmol/l

1.30

603

5957

Primary open-angle glaucoma, strict

628

5947

1.06

0.67

3.7

3.4

25.06

25.24

mmol/l

0.59

599

5780

Other abnormal products of conception

362

2230

1.08

0.67

2.5

3.0

25.17

25.31

mmol/l

0.33

345

2143

Alzheimer disease

861

6026

1.05

0.66

2.8

3.4

25.36

25.13

mmol/l

1.19

821

5856

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

140

1253

1.12

0.66

3.7

3.3

25.29

25.34

mmol/l

0.05

135

1212

Other disorders of white blood cells

848

1.15

0.65

4.5

3.4

25.18

25.17

mmol/l

0.01

819

Chronic drug-induced interstitial lung disorders

1.80

0.65

2.4

3.2

24.88

25.06

mmol/l

—

Burn and corrosion of head and neck

287

1.27

0.64

3.8

3.7

24.08

24.85

mmol/l

0.61

278

Ankylosis of teeth

1.74

0.64

9.2

4.0

26.10

24.58

mmol/l

—

Lesion of plantar nerve

869

1.15

0.64

3.3

3.0

25.51

mmol/l

0.00

849

Other benign neoplasms of connective and other soft tissue

167

1513

1.11

0.63

3.3

25.08

25.30

mmol/l

0.36

159

1463

Foreign body or object entering through skin

851

1.15

0.63

3.3

3.7

25.21

25.15

mmol/l

0.06

825

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

972

8008

0.96

0.63

3.4

3.3

25.28

25.22

mmol/l

0.22

936

7761

Pregnancy with abortive outcome

1117

6056

0.96

0.63

2.9

3.1

25.31

25.45

mmol/l

0.73

1082

5876

Antenatal screening

219

1342

0.91

0.62

3.0

25.44

25.20

mmol/l

0.70

211

1297

Overjet

242

1.28

0.62

14.9

5.1

24.34

24.73

mmol/l

0.48

229

Familial chondrocalcinosis

0.00

0.62

0.0

3.5

—

25.22

—

Neuromyelitis optica

1.70

0.62

15.8

2.5

24.62

24.74

mmol/l

—

Lipomatosis, not elsewhere classified

1.70

0.62

1.8

1.7

26.22

24.97

mmol/l

—

Unspecified hairloss

0.00

0.62

0.0

3.2

—

24.81

—

Amputation of ankle

0.00

0.62

0.0

4.2

—

23.82

—

L01XX Other antineoplastic agents

117

1042

1.13

0.61

3.6

3.1

24.63

25.34

mmol/l

1.25

110

1008

Adult-onset Still disease

1.60

0.61

5.8

2.1

26.88

24.84

mmol/l

—

Use of bromocriptine

0.00

0.61

0.0

2.9

—

23.26

—

Acquired coagulation factor deficiency

0.00

0.61

0.0

3.1

—

23.96

—

Postpartum hemorraghe, all women as controls

229

2446

0.92

0.61

2.4

3.0

24.97

25.21

mmol/l

0.71

223

2357

Dislocation of lens

254

1.27

0.61

3.8

3.0

24.94

25.19

mmol/l

0.15

247

Other and unspecified atrophic disorders of skin

1.57

0.61

11.1

2.6

23.99

24.88

mmol/l

0.47

Other congenital malformations of circulatory system

335

1.23

0.60

3.7

3.6

25.30

25.12

mmol/l

0.14

329

Scar conditions and fibrosis of skin

472

1.19

0.60

4.2

2.9

25.59

25.37

mmol/l

0.20

457

Sacrococcygeal disorders, not elsewhere classified

335

1.23

0.60

2.4

2.9

24.57

25.34

mmol/l

0.82

322

Injury of muscle and tendon at lower leg level

279

2594

1.08

0.60

4.2

3.6

25.11

25.12

mmol/l

0.01

272

2512

Early syphilis

162

0.67

0.59

4.5

3.5

25.29

24.95

mmol/l

0.26

157

Nonadministration of surgical and medical care

0.00

0.59

0.0

4.5

—

24.60

—

Acquired pure red cell aplasia [erythroblastopenia]

1.54

0.59

4.9

4.1

25.96

24.84

mmol/l

—

Other and unspecified cicatricial alopecia

1.76

0.59

1.5

2.3

23.85

24.83

mmol/l

—

Rheumatic valve diseases

373

1.22

0.59

8.4

3.3

24.60

25.11

mmol/l

0.46

362

Other articular cartilage disorders

373

1.22

0.59

2.8

3.5

25.38

24.99

mmol/l

0.27

362

Poor fetal growth

114

1016

1.12

0.58

2.8

2.9

25.31

25.16

mmol/l

0.18

107

971

Crushing injury of ankle and foot

1.51

0.58

1.5

3.6

27.38

24.88

mmol/l

—

Exposure to ignition or melting of other clothing and apparel

1.71

0.58

4.0

4.9

24.33

23.94

mmol/l

—

Diseases of thymus

1.71

0.58

1.5

3.6

25.43

24.34

mmol/l

—

Insomnia

1719

12880

0.97

0.58

3.2

3.4

25.07

25.28

mmol/l

2.02

1650

12484

Long labour

218

2019

0.92

0.56

1.9

3.2

25.10

25.36

mmol/l

0.65

203

1952

Other specified/unspecified nutritional deficiencies

1.49

0.55

7.8

3.2

25.13

24.83

mmol/l

0.16

Other zoonotic bacterial diseases, not elsewhere classified

1.50

0.55

1.8

3.3

26.64

24.01

mmol/l

—

Acquired keratosis [keratoderma] palmaris et plantaris

1.50

0.55

7.0

2.8

26.27

25.04

mmol/l

—

Glucosamine medication

1153

8900

1.04

0.54

3.0

3.4

25.47

25.30

mmol/l

1.01

1129

8640

Other hereditary haemolytic anaemias

1.51

0.54

3.9

3.8

27.58

24.83

mmol/l

1.70

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

119

1071

1.12

0.54

2.6

3.4

25.31

25.29

mmol/l

0.03

114

1039

Benign neoplasm: Connective and other soft tissue of abdomen

1.57

0.54

3.5

3.7

25.35

24.88

mmol/l

—

Other disorders of cornea

169

1549

1.09

0.53

3.0

3.2

24.85

25.40

mmol/l

1.11

159

1501

Benign neoplasm: Skin of eyelid, including canthus

298

2798

1.07

0.52

3.6

3.4

25.20

25.27

mmol/l

0.16

285

2721

Malignant cancer of tonsil and base of tongue, including Hilmo

398

1.19

0.51

4.8

2.9

27.05

25.21

mmol/l

2.59

385

Enteritis due to Yersinia enterocolitica

1.52

0.50

9.6

3.9

25.60

24.42

mmol/l

—

Pregnancy, childbirth and the puerperium

565

3089

0.95

0.50

2.8

3.3

25.41

25.39

mmol/l

0.06

547

3006

Leiomyoma of uterus

1146

6293

1.03

0.48

3.1

3.0

25.64

25.51

mmol/l

0.73

1116

6108

Benign neoplasm: Floor of mouth

1.52

0.48

1.9

3.6

23.60

24.16

mmol/l

—

Gingivitis and periodontal diseases

2472

13025

0.98

0.48

3.6

3.4

25.09

25.27

mmol/l

1.94

2369

12657

Marginal zone B-cell lymphoma, including Hilmo

263

1.23

0.48

3.4

2.9

24.63

25.28

mmol/l

0.57

256

Haemorrhagic and haematological disorders of fetus and newborn

190

1.27

0.48

4.6

9.7

24.95

23.91

mmol/l

0.97

179

Carcinoma in situ of endometrium

1.50

0.48

1.6

3.1

24.86

25.77

mmol/l

—

Juvenile Open Angle Glaucoma

1.49

0.48

15.6

3.7

25.53

24.74

mmol/l

—

Other hyperalimentation

1.49

0.48

3.4

2.8

26.69

25.05

mmol/l

—

Other coagulation defects

117

1062

1.11

0.47

5.4

3.3

25.37

25.22

mmol/l

0.20

112

1028

Single delivery by caesarean section

198

1053

1.08

0.47

2.9

3.5

24.56

25.12

mmol/l

1.34

188

1017

Other primary thrombocytopenia

1.45

0.46

1.6

3.0

25.47

25.12

mmol/l

—

Retinal breaks without detachment

259

2756

0.94

0.46

3.4

25.00

25.25

mmol/l

0.63

253

2671

Malignant neoplasm of oral cavity

546

0.85

0.46

3.6

2.7

26.77

25.23

mmol/l

2.01

529

Acetic acid derivatives and related substances

650

3512

0.96

0.46

3.2

4.2

25.29

24.93

mmol/l

1.76

623

3405

Retinal detachment with retinal break

258

2425

1.07

0.46

4.7

3.4

24.50

25.22

mmol/l

2.79

253

2348

L02BG Aromatase inhibitors

500

5212

0.96

0.44

2.8

3.1

25.72

25.54

mmol/l

0.63

494

5075

Benign leiomyoma with endometriosis

234

2494

0.94

0.44

2.8

3.0

25.74

25.46

mmol/l

0.75

228

2427

Benign neoplasm: Mediastinum

1.49

0.44

3.1

4.9

23.70

25.13

mmol/l

—

Behavioural syndromes associated with physiological disturbances and physical factors

1973

13685

1.02

0.44

3.4

3.5

25.10

25.28

mmol/l

1.65

1903

13266

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

160

1482

1.08

0.43

3.5

3.3

25.32

25.36

mmol/l

0.04

155

1435

Carcinoma in situ of oral cavity

1.60

0.43

3.2

2.7

26.18

24.68

mmol/l

—

Chronic Coagulation defects

285

1.20

0.43

5.5

3.8

25.92

25.12

mmol/l

0.74

278

Phlebitis and thrombophlebitis of femoral vein, drug-induced

0.00

0.43

0.0

2.9

—

24.90

—

Other parasitologically confirmed or unspecified malaria

1.59

0.43

5.0

4.2

22.82

24.78

mmol/l

—

Other endophthalmitis

1.38

0.43

12.8

3.5

24.45

24.96

mmol/l

0.20

Other hypertrichosis

1.58

0.42

1.4

2.6

22.84

24.21

mmol/l

—

Early syphilis

173

0.75

0.42

4.0

3.4

25.50

25.00

mmol/l

0.41

166

Pemphigus erythematosus

0.00

0.42

0.0

3.6

—

24.72

—

Malignant neoplasm of bronchus and lung, including Hilmo

483

3873

1.05

0.42

4.0

3.3

25.89

25.16

mmol/l

4.22

473

3751

Macular pucker, drug-induced

0.00

0.42

0.0

2.5

—

25.78

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

0.42

0.0

2.5

—

24.22

—

Ophthalmic devices associated with adverse incidents

0.00

0.42

0.0

2.4

—

23.95

—

Onychogryphosis

1.54

0.42

2.4

2.8

23.30

25.20

mmol/l

—

Malignant neoplasm of placenta, including Hilmo

0.00

0.42

0.0

1.9

—

23.14

—

Effects of other deprivation

1.54

0.42

1.0

3.8

25.74

24.81

mmol/l

—

Postpartum haemorrhage

229

2052

0.94

0.42

2.4

3.2

24.97

25.37

mmol/l

1.51

223

1981

Brain mixed glioma

0.00

0.42

0.0

3.6

—

25.92

—

Perioral dermatitis, drug-induced

0.00

0.41

0.0

2.2

—

24.19

—

Cutis laxa senilis

114

1.33

0.41

1.9

2.8

24.86

25.30

mmol/l

0.14

114

Macular hole

111

1015

1.10

0.41

3.4

3.1

25.34

25.37

mmol/l

0.03

105

984

Severe mental retardation

1.50

0.41

1.6

7.2

24.20

24.34

mmol/l

—

Eccrine sweat disorders

1.50

0.41

3.4

3.5

30.26

25.04

mmol/l

—

Unicornuate uterus

0.00

0.41

0.0

3.9

—

24.36

—

Carcinoma in situ of anus and anal canal

0.00

0.41

0.0

3.4

—

24.44

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

0.40

0.0

3.2

—

24.45

—

All dysplastic lesions of the vagina

315

1.18

0.40

4.4

2.8

25.18

25.74

mmol/l

0.69

305

Atypical mycobacterium lung infection

196

1.24

0.40

3.4

3.2

27.29

24.78

mmol/l

2.11

191

Burn and corrosion of wrist and hand

465

1.14

0.40

4.1

3.5

24.67

25.11

mmol/l

0.37

451

Liver disorders in diseases classified elsewhere

1.45

0.40

3.8

2.9

24.22

25.05

mmol/l

—

Haematosalpinx/Haematoma of broad ligament

0.00

0.39

0.0

2.0

—

24.04

—

Carcinoma in situ of skin of eyelid, including canthus

1.42

0.39

1.4

3.3

25.68

24.43

mmol/l

—

Traumatic spondylopathy

1.41

0.39

3.4

3.5

25.44

25.20

mmol/l

—

Sequelae of injuries of upper limb

150

1395

1.08

0.38

3.1

3.6

25.62

25.27

mmol/l

0.57

141

1350

Maternal care for known or suspected malpresentation of fetus

155

1206

0.93

0.37

2.5

3.1

25.38

25.18

mmol/l

0.44

149

1152

Malignant neoplasm of other and ill-defined digestive organs

134

1.28

0.37

1.9

2.9

24.67

25.12

mmol/l

0.20

128

Malignant neoplasm of tonsil, including Hilmo

272

1.19

0.37

3.6

2.8

26.67

25.14

mmol/l

1.27

265

Chronic rhinitis, nasopharyngitis and pharyngitis

528

5474

0.96

0.36

3.5

25.44

25.24

mmol/l

0.69

519

5305

Carcinoma in situ of skin of ear and external auricular canal

291

1.18

0.36

6.4

3.4

24.50

25.08

mmol/l

0.53

281

Bacterial meningitis

488

1.13

0.36

3.4

3.2

25.42

25.19

mmol/l

0.18

473

Cleft lip and cleft lip and palate

1.28

0.36

2.8

4.2

25.66

24.60

mmol/l

—

Respiratory tuberculosis, clinically confirmed

199

1.22

0.35

2.3

3.7

24.35

24.64

mmol/l

0.14

194

Neuroendocrine tumor and carcinoma of rectum

1.41

0.35

2.3

2.7

24.02

25.30

mmol/l

—

Injury of blood vessels of thorax

1.38

0.35

1.5

3.5

23.67

24.39

mmol/l

—

Other secondary gonarthrosis

883

1.09

0.34

3.6

3.4

25.57

25.31

mmol/l

0.29

859

Type 1 diabetes, wide definition, subgroup 2

210

0.80

0.34

10.3

3.6

24.66

24.99

mmol/l

0.10

204

Other predominantly sexually transmitted diseases, not elsewhere classified

246

2339

1.05

0.33

3.5

3.3

24.93

25.18

mmol/l

0.66

239

2254

Benign neoplasm: Cranial nerves

455

0.87

0.33

3.2

3.3

25.56

25.29

mmol/l

0.22

444

Rubella [German measles]

475

0.88

0.32

4.4

4.0

25.77

25.29

mmol/l

0.46

461

Malignant neoplasm of oropharynx

258

1.17

0.31

4.0

2.8

26.95

25.22

mmol/l

1.40

250

Dermatitis due to ingested food

319

1.15

0.31

7.0

5.5

24.31

24.43

mmol/l

0.10

305

Diving or jumping into water causing injury other than drowning or submersion

1.31

0.31

2.9

3.5

26.00

24.67

mmol/l

—

Vertical strabismus

467

1.12

0.30

3.0

3.1

25.50

25.28

mmol/l

0.19

446

Other infective otitis externa

890

0.92

0.30

4.4

3.3

24.64

25.26

mmol/l

1.01

858

Other predominantly sexually transmitted diseases, not elsewhere classified

186

1962

0.95

0.30

3.5

3.2

25.19

25.26

mmol/l

0.11

180

1888

Neonatal jaundice from other and unspecified causes

152

1.22

0.29

5.1

10.3

24.86

23.80

mmol/l

0.72

143

Alzheimer disease, including avohilmo

970

6676

1.02

0.29

2.9

3.5

25.28

25.13

mmol/l

0.68

932

6497

Other and unspecified disease of Bartholin gland

397

0.88

0.28

2.9

2.8

26.00

25.58

mmol/l

0.26

387

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

148

0.79

0.28

6.2

9.9

24.07

23.87

mmol/l

0.09

142

Contact with lifting and transmission devices, not elsewhere classified

248

0.84

0.28

3.1

3.6

25.72

24.87

mmol/l

0.75

241

Other congenital malformations of ear

1.28

0.28

2.4

4.0

26.07

24.48

mmol/l

1.00

Other superficial injuries of ankle and foot

1.28

0.28

12.3

3.8

24.39

24.77

mmol/l

—

Carcinoma in situ of skin of other and unspecified parts of face

193

1837

1.05

0.28

5.0

3.3

25.07

25.16

mmol/l

0.15

188

1787

Arteriovenous malformation of peripheral vessels

1.26

0.28

9.0

4.8

25.01

24.53

mmol/l

—

Malignant neoplasm of breast, HER-negative

316

3220

0.96

0.27

2.9

3.0

25.51

25.68

mmol/l

0.41

308

3124

Acquired clawhand, clubhand, clawfoot and clubfoot

1.24

0.27

1.4

3.5

26.40

24.82

mmol/l

—

Other specified and unspecified disorders of lens

159

1.21

0.27

3.7

2.8

26.36

25.33

mmol/l

0.66

154

Postmenopausal atrophic vaginitis

485

2593

1.03

0.27

3.3

3.1

25.63

25.54

mmol/l

0.25

475

2536

Acute myeloid leukaemia, including Hilmo

159

1.21

0.27

4.1

3.4

24.67

25.09

mmol/l

0.17

154

Acute myeloid leukaemia, helper endpoint

159

1.21

0.27

4.1

3.4

24.67

25.09

mmol/l

0.17

154

Acute myeloid leukaemia

159

1.21

0.27

4.1

3.4

24.67

25.09

mmol/l

0.17

154

Mumps

321

0.87

0.27

4.3

3.3

25.31

25.18

mmol/l

0.07

314

Spermatocele

153

1449

1.06

0.27

3.5

3.6

24.16

24.90

mmol/l

1.97

147

1407

Other hammer toe(s) (acquired)

349

3107

1.04

0.27

3.3

3.2

25.53

25.37

mmol/l

0.43

337

3032

Non-small cell lung cancer, squamous

847

1.08

0.26

3.8

2.9

26.90

24.94

mmol/l

5.23

816

Malignant neoplasm of tonsil

225

1.16

0.26

4.0

2.7

26.74

25.14

mmol/l

1.07

219

Dysplasia of cervi uteri

292

2194

0.96

0.25

2.8

3.0

25.39

25.31

mmol/l

0.15

283

2127

Pedestrian injured in collision with car, pick-up truck or van

359

1.12

0.25

4.7

3.1

25.03

25.23

mmol/l

0.12

348

Loose body in joint

371

0.89

0.24

3.2

3.3

24.59

25.00

mmol/l

0.34

360

Infliximab

170

1.18

0.24

2.6

3.7

25.03

25.08

mmol/l

0.02

163

Memory loss

166

1742

0.95

0.24

4.0

3.4

25.81

25.12

mmol/l

2.01

159

1692

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

103

967

1.07

0.24

3.2

25.12

25.11

mmol/l

0.01

940

Tinnitus

423

4108

1.03

0.24

3.1

3.5

25.36

25.27

mmol/l

0.26

405

3989

Invasive ventilation

126

1192

1.06

0.24

3.9

3.4

25.74

24.97

mmol/l

1.18

117

1152

LSIL lesion of the cervix uteri, vagina or vulva

157

1494

1.05

0.24

3.2

2.8

25.66

25.39

mmol/l

0.52

151

1435

Habitual aborter

124

1.21

0.24

3.9

3.6

24.01

25.17

mmol/l

0.92

118

Behçet disease

1.33

0.23

2.0

3.0

25.88

24.47

mmol/l

—

Other protozoal intestinal diseases

222

0.85

0.23

7.5

2.8

23.47

25.30

mmol/l

1.58

214

Unspecified privation

166

1739

0.95

0.23

5.4

3.4

24.97

25.27

mmol/l

0.59

158

1679

Chronic conjunctivitis

411

0.90

0.23

3.4

3.3

26.28

25.16

mmol/l

1.43

399

Other and unspecified disorders of psychological development

104

1.23

0.23

1.7

6.6

24.76

24.29

mmol/l

0.29

Laboratory evidence of human immunodeficiency virus [HIV]

0.00

0.22

0.0

2.5

—

25.41

—

Benign neoplasm: Female genital organ, unspecified

1.23

0.22

1.6

2.3

26.54

24.68

mmol/l

—

Pemphigus vegetans

0.00

0.22

0.0

4.5

—

24.72

—

Lichen ruber moniliformis

0.00

0.22

0.0

1.9

—

24.31

—

Plasmodium vivax malaria

0.00

0.22

0.0

4.1

—

23.21

—

Glanders and melioidosis

0.00

0.22

0.0

2.4

—

25.28

—

Chlamydial lymphogranuloma (venereum)

0.00

0.22

0.0

7.5

—

25.35

—

Disorders of conjunctiva in diseases classified elsewhere

0.00

0.22

0.0

3.8

—

25.66

—

Crushing injuries involving multiple body regions

0.00

0.22

0.0

5.0

—

25.08

—

Palsy of conjugate gaze

0.00

0.22

0.0

3.4

—

24.93

—

Diphyllobothriasis and sparganosis

0.00

0.22

0.0

2.2

—

23.88

—

Other congenital malformations of integument

0.00

0.22

0.0

3.6

—

25.30

—

Degeneration of iris and ciliary body

0.00

0.22

0.0

4.5

—

24.33

—

Complicated migraine, drug-induced

0.00

0.21

0.0

3.8

—

23.68

—

Carcinoma in situ of liver, gallbladder and bile ducts

0.00

0.21

0.0

6.7

—

23.33

—

Other and unspecified disorders of sclera

0.00

0.21

0.0

2.8

—

24.38

—

Traumatic amputation at neck level

0.00

0.21

0.0

2.4

—

24.42

—

Hydroxyapatite deposition disease

0.00

0.21

0.0

3.6

—

23.32

—

Schistosomiasis [bilharziasis]

0.00

0.21

0.0

4.4

—

25.30

—

Coccidioidomycosis

0.00

0.21

0.0

2.3

—

24.31

—

Genetic anomalies of leukocytes

0.00

0.21

0.0

3.2

—

24.95

—

Occupant of railway train or railway vehicle injured in transport accident

0.00

0.21

0.0

2.9

—

25.68

—

Chronic bullous disease of childhood

0.00

0.21

0.0

3.3

—

24.55

—

Compression of brain

0.00

0.21

0.0

3.5

—

25.20

—

Encephalocele

0.00

0.21

0.0

3.0

—

24.52

—

Other specified diseases of spinal cord, drug-induced

0.00

0.20

0.0

3.6

—

23.96

—

Aggressive periodontitis

303

0.89

0.20

2.5

3.4

26.11

25.02

mmol/l

0.98

297

Unspecified pneumoconiosis

0.00

0.20

0.0

7.4

—

25.14

—

Benign neoplasm of mesothelial tissue

0.00

0.20

0.0

4.6

—

24.32

—

Selective deficiency of immunoglobulin A [IgA]y

1.26

0.20

16.2

5.3

22.85

24.45

mmol/l

—

Polydactyly

0.00

0.20

0.0

6.5

—

22.72

—

Triptan medication for migraine, single purchase ok

1345

9238

0.99

0.20

3.2

3.5

25.31

25.35

mmol/l

0.22

1304

8944

Migraine, single triptan purchase ok & required. ICD-code if available is included

1345

9238

0.99

0.20

3.2

3.5

25.31

25.35

mmol/l

0.22

1304

8944

Serous carcinoma of ovary

114

0.78

0.20

1.7

2.5

24.24

25.63

mmol/l

—

109

Juvenile cataract

1.18

0.19

3.0

4.5

23.75

24.37

mmol/l

—

Complications of labour and delivery

919

5022

1.02

0.19

2.9

3.2

25.37

25.52

mmol/l

0.71

898

4875

Carcinoma in situ of skin

179

1722

1.04

0.19

5.0

3.3

25.04

25.21

mmol/l

0.30

174

1672

Systemic disorders of connective tissue in diseases classified elsewhere

1.16

0.19

2.0

3.1

24.50

24.75

mmol/l

—

Granulosa cell carcinoma of ovary

1.16

0.19

3.0

2.4

26.58

25.58

mmol/l

—

Use of antiglaucoma preparations and miotics

173

1664

1.04

0.19

4.8

3.2

24.59

25.19

mmol/l

1.14

164

1623

Congenital malformations of breast

154

0.84

0.19

2.5

2.7

25.26

24.84

mmol/l

0.18

149

Normotensive glaucoma

162

1686

0.96

0.19

3.0

3.1

25.31

25.28

mmol/l

0.03

151

1651

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

301

0.89

0.19

6.7

3.2

24.63

25.01

mmol/l

0.24

295

Malignant neoplasm of tongue

301

0.89

0.19

3.3

2.8

27.23

25.46

mmol/l

1.67

294

170

1636

1.04

0.18

5.3

3.7

23.62

25.01

mmol/l

3.46

165

1585

Other orthopaedic follow-up care

726

1.06

0.18

3.4

2.7

25.79

25.22

mmol/l

0.75

704

Lagophthalmos

214

1.13

0.18

4.5

3.4

24.69

25.00

mmol/l

0.22

209

Anti-inflammatory and antirheumatic products, non-steroids

714

3654

0.98

0.17

3.2

4.3

25.13

24.94

mmol/l

0.70

688

3539

Other fibroblastic disorders

1.14

0.17

2.7

2.8

26.43

24.64

mmol/l

—

Benign neoplasm: Long bones of lower limb

397

1.09

0.17

2.5

3.4

25.34

25.13

mmol/l

0.18

385

Other and unspecified glaucoma

144

1384

1.04

0.17

4.3

3.2

24.85

25.23

mmol/l

0.60

136

1348

Infections with a predominantly sexual mode of transmission

384

3925

0.98

0.17

4.8

3.4

25.26

25.19

mmol/l

0.16

371

3792

Benign neoplasm: Eye, unspecified

1.19

0.17

4.3

3.9

23.57

24.87

mmol/l

—

Vaginal lichen planus

1.18

0.17

5.8

2.4

25.88

25.51

mmol/l

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

224

0.89

0.15

3.0

3.2

25.48

25.24

mmol/l

0.19

219

Anogenital herpesviral [herpes simplex] infection

115

1103

1.04

0.15

3.3

3.2

24.85

25.16

mmol/l

0.76

109

1064

Acquired stenosis of external ear canal

161

0.86

0.15

5.9

3.5

23.96

24.97

mmol/l

0.56

155

Follow-up examination after treatment for malignant neoplasms

165

1706

0.97

0.15

3.7

3.0

25.93

25.16

mmol/l

1.47

157

1657

Malignant neoplasm of bronchus and lung

391

3312

0.98

0.14

3.8

3.2

25.91

25.18

mmol/l

3.43

382

3200

Degenerative myopia

1.19

0.14

4.6

3.4

25.77

24.78

mmol/l

0.83

Pathological resorption of teeth

469

1.07

0.14

4.3

3.3

26.31

25.07

mmol/l

1.49

457

Recurrent dislocation and subluxation of joint

801

1.05

0.14

3.1

3.3

25.48

25.16

mmol/l

0.37

777

Erectile dysfunction

161

1662

0.97

0.14

4.8

3.7

24.94

24.90

mmol/l

0.05

152

1604

Carcinoma in situ of breast, lobular

0.83

0.14

3.7

2.7

24.79

25.44

mmol/l

—

Female infertility, cervical, vaginal, other or unspecified origin

323

2147

0.98

0.14

3.1

2.9

25.16

25.31

mmol/l

0.42

315

2081

Inflammation of lacrimal passages (chronic)

276

1.09

0.14

3.6

3.1

24.95

24.90

mmol/l

0.03

267

Malignant cancer of tonsil and base of tongue

325

0.92

0.13

3.8

2.9

26.86

25.24

mmol/l

1.32

316

Malignant neoplasm of tongue, including Hilmo

432

1.07

0.13

4.5

2.7

26.80

25.23

mmol/l

1.63

419

Endometriosis of intestine

113

1.15

0.13

2.1

3.1

25.77

25.08

mmol/l

0.40

108

Pollen allergy

225

2166

1.03

0.13

3.0

3.8

25.27

25.07

mmol/l

0.41

211

2089

Other hearing loss

611

5892

1.02

0.13

3.7

3.4

25.15

25.16

mmol/l

0.03

579

5722

Carcinoma in situ of skin of upper limb, including shoulder

488

0.94

0.12

4.5

3.2

24.19

25.11

mmol/l

1.24

472

Propionic acid derivatives

717

3653

0.99

0.12

3.1

4.3

25.05

24.94

mmol/l

0.35

690

3538

Circumscribed brain atrophy

336

1.07

0.12

3.7

3.4

25.79

25.10

mmol/l

0.57

327

Malignant neoplasm of other and unspecified parts of mouth

1.17

0.12

5.4

2.5

27.12

25.14

mmol/l

0.76

Benign neoplasm of ovary

275

2694

1.02

0.12

3.2

3.1

25.66

25.50

mmol/l

0.29

269

2625

Disorders of acoustic nerve

415

0.94

0.11

3.1

3.5

25.63

25.36

mmol/l

0.24

403

Postpartum care and examination

121

792

0.97

0.11

3.3

3.2

24.90

25.10

mmol/l

0.29

113

761

Carcinoma in situ of vulva

105

1.15

0.11

6.1

2.5

24.40

25.62

mmol/l

0.69

105

Benign neoplasm of male genital organs

348

1.07

0.10

2.7

3.8

25.06

25.01

mmol/l

0.03

335

Artificial joint re-operation

129

1254

1.03

0.10

4.6

3.1

25.06

25.35

mmol/l

0.38

124

1216

Other inflammation of vagina/vulva

339

1.06

0.10

1.8

2.9

25.42

25.36

mmol/l

0.03

332

Femoral hernia, bilateral

1.14

0.10

5.0

3.3

24.88

25.08

mmol/l

—

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

351

0.94

0.10

3.0

2.7

26.45

25.28

mmol/l

0.73

344

Labyrinthine fistula

1.09

0.10

4.4

3.3

24.68

24.18

mmol/l

—

Caries in Clefts patients

1.15

0.09

6.7

5.3

25.48

24.87

mmol/l

—

Lesion of medial popliteal nerve

1.07

0.09

2.7

3.4

24.27

25.26

mmol/l

—

Apocrine sweat disorders, other sweat gland disorders

1.12

0.08

5.1

2.9

26.36

25.34

mmol/l

—

Acute hepatitis B

1.10

0.08

2.1

4.0

25.99

24.54

mmol/l

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

150

0.91

0.07

5.4

9.7

24.64

23.92

mmol/l

0.28

144

Triptan medication for migraine, min. 3 purchases

816

6273

0.99

0.07

2.9

3.3

25.19

25.31

mmol/l

0.50

791

6070

Tic disorders

118

1.10

0.07

4.7

24.40

24.48

mmol/l

0.04

113

Carcinoma in situ of skin, other sites/unspecified

265

1.06

0.07

5.5

3.3

26.05

25.31

mmol/l

0.81

258

Dermatitis herpetiformis

265

0.94

0.07

3.8

3.4

25.42

24.92

mmol/l

0.37

259

Female infertility

368

2209

1.01

0.06

3.1

2.9

25.17

25.31

mmol/l

0.40

359

2142

Other disorders of amniotic fluid and membranes

125

1196

1.02

0.06

3.2

3.1

25.23

25.20

mmol/l

0.03

116

1145

Carcinoma in situ of skin of scalp and neck

513

1.04

0.06

5.9

3.4

24.65

24.95

mmol/l

0.26

498

Inguinal or femoral hernia, bilateral

218

2209

0.99

0.06

3.5

3.7

25.27

25.01

mmol/l

0.53

209

2139

Congenital malformations of breast

141

0.92

0.05

2.5

25.26

24.91

mmol/l

0.14

136

Inguinal hernia, bilateral

214

2165

0.99

0.05

3.5

3.7

25.27

25.00

mmol/l

0.53

205

2097

Disorders of lacrimal system and orbit in diseases classified elsewhere

323

0.96

0.05

2.9

3.3

24.95

25.51

mmol/l

0.46

314

Malignant neoplasm of breast, ER-negative, including Hilmo

368

3477

1.01

0.04

2.9

3.0

25.52

25.70

mmol/l

0.52

359

3376

Benign neoplasm: Skin of trunk

605

1.03

0.04

3.9

3.2

25.46

25.13

mmol/l

0.33

585

Sleep disorders

1834

13207

1.00

0.04

3.2

3.4

25.08

25.28

mmol/l

1.99

1762

12799

Malignant neoplasm of respiratory system and intrathoracic organs

455

3761

1.01

0.04

3.7

3.3

25.86

25.16

mmol/l

3.81

442

3644

Caries of dentine, including avohilmo

2013

10312

1.00

0.04

3.7

3.4

25.05

25.29

mmol/l

2.44

1941

10021

Non-small cell lung cancer, squamous, helper endpoint

924

0.98

0.03

3.8

3.5

26.90

24.90

mmol/l

5.41

896

Mucosal proctocolitis

180

1783

1.01

0.03

4.3

3.4

24.57

25.21

mmol/l

1.38

172

1729

Maternal care for known or suspected abnormality of pelvic organs

260

1781

0.99

0.02

2.2

3.1

24.92

25.29

mmol/l

0.97

252

1713

Sudden idiopathic hearing loss

170

1712

0.99

0.02

3.4

3.5

24.93

25.33

mmol/l

0.82

165

1664

Dental caries, including avohilmo

1917

9791

1.00

0.02

3.8

3.4

25.08

25.30

mmol/l

2.02

1848

9510

Tic and related disorders

123

1.06

0.01

4.7

4.5

24.40

24.71

mmol/l

0.18

118

Infections with a predominantly sexual mode of transmission

522

4875

1.00

0.01

4.3

3.3

25.02

25.19

mmol/l

0.63

505

4701

All dysplastic lesions of the cervix uteri

271

2676

1.00

0.01

2.8

2.9

25.44

25.27

mmol/l

0.40

263

2578

Deep bite that required surgery

134

1.05

0.00

3.6

3.1

26.09

25.20

mmol/l

0.54

128

Benign neoplasm: Spinal cord

194

1.03

0.00

3.0

3.4

25.64

25.09

mmol/l

0.28

189

Chronic diseases of tonsils and adenoids

1568

9901

1.00

0.00

3.6

3.5

25.23

mmol/l

0.00

1520

9583

Pleural plaque with presence of asbestos

161

1604

1.00

0.00

3.6

3.8

25.97

24.84

mmol/l

2.96

152

1550

Excessive earwax

1210

11806

1.00

0.00

3.3

3.6

24.92

25.25

mmol/l

3.15

1160

11489

Other superficial mycoses

127

1275

1.00

0.00

3.8

3.3

25.09

25.22

mmol/l

0.16

120

1233

Labour and delivery complicated by fetal stress [distress]

204

1336

1.00

0.00

2.4

3.0

24.47

25.20

mmol/l

2.64

191

1283

Other disorders of breast and lactation associated with childbirth

128

1.02

0.00

2.3

3.2

25.64

24.93

mmol/l

0.70

122

Coxibs

672

3537

1.00

0.00

3.1

4.2

25.11

24.94

mmol/l

0.63

647

3428

Other benign neoplasm of uterus: Corpus uteri

111

0.99

0.00

2.2

2.9

25.47

25.48

mmol/l

0.00

111

Benign neoplasm: Prostate

117

1.03

0.00

2.8

3.5

24.00

24.98

mmol/l

0.49

112

Benign neoplasm: Other parts of oropharynx

115

1.05

0.00

5.0

3.8

26.68

24.88

mmol/l

1.04

115

Malignant neoplasm of parotid gland, including Hilmo

164

0.97

0.00

1.6

3.0

25.16

25.21

mmol/l

0.02

159

Benign neoplasm: Mesothelial tissue of peritoneum

0.00

0.0

6.0

—

24.36

—

Carcinoma in situ of other/unspecified female genital organs

0.00

0.0

3.3

—

23.83

—

Other hypersecretion of intestinal hormones

0.00

0.0

3.7

—

24.83

—

Mosquito-borne viral encephalitis

0.00

0.0

1.9

—

23.84

—

Malignant neoplasm of placenta

0.00

0.0

2.2

—

22.80

—

Systemic sclerosis induced by drugs and chemicals

0.00

0.0

1.8

—

25.28

—

Disorders of plasma-protein metabolism, not elsewhere classified, drug-induced

0.00

0.0

1.4

—

23.08

—

Imbalance of constituents of food intake

0.00

0.0

2.4

—

25.24

—

Enophthalmos

0.00

0.0

3.0

—

24.97

—

Benign neoplasm: Endocrine gland, other/unspecified

0.98

-0.00

2.4

2.6

26.22

24.43

mmol/l

—

Obstetric and gynaecological devices associated with adverse incidents

0.00

-0.00

0.0

2.0

—

23.09

—

Malignant neoplasm of meninges

0.00

-0.00

0.0

4.6

—

26.81

—

Operations of war

0.00

-0.00

0.0

3.0

—

24.27

—

Other specified disorders of eye and adnexa in diseases classified elsewhere

0.00

-0.00

0.0

3.8

—

23.20

—

Accident to nonpowered aircraft causing injury to occupant

0.00

-0.00

0.0

3.8

—

23.28

—

Pedal cyclist injured in collision with train or tram

0.00

-0.00

0.0

1.0

—

25.07

—

Sequelae of toxic effects of substances chiefly nonmedicinal as to source

0.00

-0.00

0.0

4.7

—

23.54

—

Congenital edentulism

0.00

-0.00

0.0

2.8

—

25.23

—

Neurological devices associated with adverse incidents

0.00

-0.00

0.0

4.4

—

24.77

—

Pseudomembranous colitis, drug-induced

0.00

-0.00

0.0

2.1

—

24.11

—

Bilateral

0.00

-0.00

0.0

1.6

—

23.14

—

Pneumoconiosis associated with tuberculosis

0.00

-0.00

0.0

4.6

—

20.50

—

Traumatic amputations involving multiple body regions

0.00

-0.00

0.0

2.4

—

24.96

—

Bacterial vaccines

0.00

-0.00

0.0

1.5

—

25.32

—

Disorders of visual cortex

0.00

-0.00

0.0

7.0

—

25.20

—

Anhidrosis

0.00

-0.00

0.0

3.7

—

24.16

—

Scleritis and episcleritis (ICD-9) only

0.00

-0.00

0.0

6.2

—

23.42

—

Retained (old) foreign body following penetrating wound of orbit

0.00

-0.00

0.0

8.1

—

22.40

—

Deformity of orbit

0.00

-0.00

0.0

1.8

—

24.25

—

Air embolism (traumatic)

0.00

-0.00

0.0

10.2

—

25.33

—

Disorders of other visual pathways

0.00

-0.00

0.0

8.4

—

23.82

—

Echinococcosis

0.00

-0.00

0.0

7.3

—

24.61

—

Malnutrition in pregnancy

0.00

-0.00

0.0

1.7

—

24.79

—

Other chronic figurate erythema

0.00

-0.00

0.0

2.8

—

24.02

—

Benign neoplasm: Pluriglandular involvement

0.00

-0.00

0.0

6.0

—

25.32

—

Carcinoma in situ, other and unspecified urinary organs

0.00

-0.00

0.0

3.1

—

24.57

—

Dietary calcium deficiency

0.00

-0.00

0.0

2.8

—

24.20

—

Other fluke infections

0.00

-0.00

0.0

3.4

—

26.44

—

Strongyloidiasis

0.00

-0.00

0.0

7.0

—

24.50

—

Fetal blood loss

0.00

-0.00

0.0

8.0

—

24.94

—

Familial dysautonomia

0.00

-0.00

0.0

3.3

—

23.88

—

Other specified acquired deformities of limbs

0.95

-0.00

4.7

4.1

25.43

25.32

mmol/l

—

Plague

0.00

-0.00

0.0

3.1

—

24.72

—

Carcinoma in situ of other/unspecified male genital organs

0.00

-0.00

0.0

4.9

—

22.61

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

-0.00

0.0

5.3

—

24.73

—

Toxic myoneural disorders

0.00

-0.00

0.0

3.2

—

25.20

—

Congenital syphilis

0.00

-0.00

0.0

2.0

—

23.36

—

Immobility syndrome (paraplegic)

0.00

-0.00

0.0

3.0

—

23.88

—

Carcinoma in situ, thyroid and other endocrine glands

0.00

-0.00

0.0

3.5

—

23.33

—

Biliary cirrhosis, secondary

0.00

-0.00

0.0

2.5

—

24.07

—

Other neonatal haemorrhages

0.00

-0.00

0.0

9.0

—

22.54

—

Drug photoallergic response

0.00

-0.00

0.0

2.1

—

24.74

—

Linear scleroderma

0.00

-0.00

0.0

2.4

—

22.89

—

Testicular hyperfunction

0.00

-0.00

0.0

7.0

—

23.44

—

Use of tolcapone

0.00

-0.00

0.0

4.1

—

23.39

—

Acquired keratosis follicularis

0.00

-0.00

0.0

9.7

—

23.42

—

Androgen resistance syndrome

0.00

-0.00

0.0

4.0

—

22.80

—

Delta-beta thalassaemia

0.00

-0.00

0.0

3.5

—

24.90

—

Diastrofic dysplasy

0.00

-0.00

0.0

3.0

—

22.33

—

Trichuriasis

0.00

-0.00

0.0

4.0

—

21.58

—

Spotted fever [tick-borne rickettsioses]

0.00

-0.00

0.0

2.3

—

24.18

—

Drug-induced chorea

0.00

-0.00

0.0

2.6

—

21.60

—

Ascariasis

0.00

-0.00

0.0

3.7

—

24.03

—

Thalassaemia trait

0.00

-0.00

0.0

1.9

—

22.13

—

Other protozoal diseases, not elsewhere classified/unspecified

0.00

-0.00

0.0

9.2

—

23.05

—

Pulmonary haemorrhage originating in the perinatal period

0.00

-0.00

0.0

2.6

—

22.42

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

-0.00

0.0

3.1

—

23.49

—

Exposure to high-pressure jet

0.00

-0.00

0.0

2.6

—

23.30

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Bicarbonate [Moles/volume] in Venous blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS